Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3022250	p-ld	u/l (u/l)	42320	178184	0.05%
3022250	p-ld	— (—)	4586	8185	100.00%	Distribution not available
3022250	p-laktaattidehydrogenaasi	u/l (u/l)	160	289	0.00%
3022250	laktaattidehydrogenaasi	u/l (u/l)	14	21	0.00%
3022250	s-laktaattidehydrogenaasi,pitoisuus(s-ld-is)	u/l (u/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm of bronchus and lung

1786

5696

3.01

322.08

4.0

2.5

260.62

241.72

u/l

3.56

1733

5227

Anaemia in chronic diseases classified elsewhere

475

759

12.29

321.57

4.5

249.76

239.30

u/l

0.62

454

721

Finngen Rheumatological endpoints

7446

26252

1.69

319.99

4.1

4.3

237.50

242.14

u/l

1.52

7026

24878

Conduction disorders

2680

10019

2.41

319.06

3.7

4.4

252.74

242.98

u/l

2.79

2531

9406

All influenza

2267

9918

2.56

318.18

5.6

3.9

245.10

241.37

u/l

0.52

2139

9314

Other CVD (FINNGEN)

1159

2670

4.00

318.00

3.6

4.7

238.38

239.09

u/l

0.05

1075

2510

Diabetes mellitus

7911

29338

1.65

311.82

3.8

4.4

237.90

244.22

u/l

3.39

7448

27786

Insulin, intermediate and long-acting

4855

27220

1.88

310.21

3.6

4.3

238.37

245.30

u/l

2.83

4586

25708

Pulmonary embolism

2854

13943

2.31

309.86

4.7

4.0

258.09

245.21

u/l

3.55

2740

13051

Diabetes, varying definitions

7875

29324

1.65

309.20

3.8

4.4

238.15

244.21

u/l

3.14

7414

27771

Other arrhythmias

4653

19609

1.90

309.08

4.2

4.4

240.55

236.07

u/l

1.26

4382

18520

Other diseases of the digestive system

3155

15997

2.21

308.80

4.2

4.0

244.90

248.59

u/l

0.61

2965

15005

Symptoms and signs involving the digestive system and abdomen

8004

25350

1.66

308.73

4.4

4.2

240.40

244.99

u/l

1.31

7581

23962

Malignant neoplasm of digestive organs

3024

11637

2.25

308.34

3.5

2.7

254.19

240.52

u/l

1.84

2880

10739

Viral pneumonia (unknown virus, not influenza)

892

2429

4.84

308.29

5.6

4.3

265.05

245.72

u/l

2.61

874

2297

General examination and investigation of persons without complaint and reported diagnosis

4979

14446

1.90

308.07

4.9

3.9

239.69

246.45

u/l

2.07

4670

13718

Cerebrovascular diseases (FINNGEN)

2505

6309

3.11

307.65

4.9

4.7

248.68

236.64

u/l

2.42

2390

5965

Pain, not elsewhere classified

2271

9414

2.66

307.65

4.1

3.6

237.82

239.73

u/l

0.23

2149

8851

All-cause Heart Failure

6959

20419

2.84

307.65

4.5

4.2

262.04

243.17

u/l

14.87

6603

19228

Hypertensive diseases

6314

17957

2.13

307.65

4.5

238.38

244.38

u/l

2.04

6015

16990

Hypothyroidism and >3 levothyroxin purchases

1652

2091

4.83

307.65

5.0

2.3

228.38

219.03

u/l

2.32

1576

1980

First line medication for Crohn's disease

11832

25631

2.78

307.65

5.2

3.5

246.06

238.58

u/l

3.72

11315

24093

Second line medication for Crohn's disease

5277

25789

2.26

307.65

4.6

4.3

242.54

242.38

u/l

0.02

5050

24417

Any reimbursement code in KELA

4200

7529

3.00

307.65

5.2

2.4

239.20

223.13

u/l

5.74

4000

7041

Viral Sepsis

2511

8199

3.78

307.65

5.5

3.9

252.15

243.67

u/l

1.63

2386

7685

Hypertensive heart and/or renal disease

2639

8607

2.60

307.65

3.4

4.5

246.48

249.93

u/l

0.50

2487

8089

Osteopathies and chondropathies

4862

24694

1.99

307.65

4.4

4.2

239.76

244.36

u/l

1.58

4584

23283

Fever of other and unknown origin

7813

19232

4.40

307.65

6.5

3.6

252.36

241.19

u/l

4.88

7533

18100

Purpura and other haemorrhagic conditions

2037

5361

5.27

307.65

7.2

4.1

267.18

241.02

u/l

5.30

1972

5061

Disorders resulting from impaired renal tubular function

640

1305

8.41

307.65

3.2

4.6

235.04

255.20

u/l

1.49

627

1235

Major coronary heart disease event

7089

24384

1.88

307.65

4.5

253.37

241.27

u/l

6.24

6736

22993

Glomerular diseases

2454

7717

4.12

307.65

3.9

4.4

240.82

242.82

u/l

0.28

2381

7271

Bleeding

7686

29801

1.99

307.65

4.5

4.2

251.21

243.15

u/l

3.44

7267

28140

Other diseases of pleura

5337

20324

2.70

307.65

4.0

4.2

247.84

246.90

u/l

0.16

5108

19071

Agranulocytosis

1596

4122

5.37

307.65

9.0

3.8

249.25

243.34

u/l

0.66

1553

3888

Coronary revascularization (ANGIO or CABG)

6817

22730

1.99

307.65

4.5

253.98

241.08

u/l

6.60

6492

21450

Other soft tissue disorders, not elsewhere classified

7868

27146

1.80

307.65

4.0

4.3

237.79

244.55

u/l

2.82

7431

25721

Diseases of liver

3364

15539

2.45

307.65

3.7

4.4

251.72

243.25

u/l

1.59

3176

14686

Calcific aortic valvular stenosis, operated

3391

14876

2.60

307.65

3.2

3.9

269.32

247.65

u/l

13.13

3205

13883

Diseases of the digestive system

4307

22888

2.06

307.65

4.1

240.50

246.58

u/l

1.79

4063

21518

Bronchitis

8679

34799

1.65

307.65

5.0

3.9

238.71

242.86

u/l

1.79

8224

32859

Non-ischemic cardiomyopathy

3487

11209

2.97

307.65

4.6

4.4

261.29

243.94

u/l

5.83

3301

10522

Ulcer of lower limb, not elsewhere classified

1723

6439

3.32

307.65

3.7

4.1

249.01

244.77

u/l

0.64

1630

6035

Iron deficiency anaemia secondary to blood loss (chronic)

1980

6466

3.81

307.65

5.1

4.1

246.96

250.44

u/l

0.34

1867

6076

Renal tubulo-interstitial diseases

10767

29058

3.22

307.65

4.4

4.2

248.27

240.65

u/l

4.27

10251

27396

Myeloproliferative diseases

2188

3294

17.36

307.65

9.7

3.7

281.57

244.73

u/l

12.36

2131

3085

Myeloid leukaemia

602

972

13.93

307.65

18.1

3.9

297.67

251.37

u/l

2.33

592

912

Other and unspecified iron deficiency

4787

14557

4.19

307.65

3.3

4.0

232.31

247.01

u/l

8.61

4454

13692

Other diseases of blood and blood-forming organs, wide

4003

9066

6.68

307.65

8.1

3.9

256.86

240.62

u/l

6.44

3863

8527

Lung cancer and mesothelioma

2243

6577

3.52

307.65

4.1

3.9

253.34

248.24

u/l

0.51

2184

6143

Disorders of lipoprotein metabolism and other lipidaemias

7009

24270

1.92

307.65

3.7

4.4

242.31

244.95

u/l

0.63

6621

22947

Diffuse large B-cell lymphoma, including Hilmo

1239

1407

28.75

307.65

7.9

3.0

315.22

236.10

u/l

8.29

1207

1308

Renal failure

7610

19540

4.63

307.65

4.4

4.1

252.57

246.53

u/l

1.99

7280

18302

Polyarthropathies

6881

20594

2.41

307.65

4.2

4.5

244.80

244.71

u/l

0.01

6544

19517

Heart failure and bmi 25plus

3854

10663

2.87

307.65

4.4

4.1

258.09

241.17

u/l

7.60

3632

9985

Chronic kidney disease

5367

13849

5.38

307.65

4.2

4.0

244.21

248.08

u/l

0.92

5154

12918

Other and unspecified anaemias

8054

18250

6.09

307.65

4.5

3.9

247.06

247.53

u/l

0.08

7588

17129

Lymphoid leukaemia

1345

2269

14.12

307.65

14.3

3.7

239.68

250.45

u/l

0.88

1308

2146

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

626

775

20.08

307.65

12.5

2.5

226.27

241.23

u/l

2.58

612

715

Diseases of arteries, arterioles and capillaries (FINNGEN)

2628

4927

4.38

307.65

3.8

4.9

252.20

236.98

u/l

3.30

2512

4658

STROKE

4319

15610

2.02

307.65

4.7

247.22

240.36

u/l

1.75

4091

14752

Other disorders of white blood cells

910

1933

7.41

307.65

8.1

3.8

248.97

246.46

u/l

0.11

874

1831

Dental caries

3266

9981

3.83

307.65

6.8

4.0

243.48

249.82

u/l

1.07

3138

9469

Neoplasms

6606

13094

2.91

307.65

5.5

2.5

241.82

233.45

u/l

2.40

6354

12228

Malignant neoplasm of skin

4292

13242

2.46

307.65

5.6

2.7

242.42

240.07

u/l

0.38

4093

12232

Diseases of oesophagus, stomach and duodenum

9356

31254

1.92

307.65

3.8

4.3

237.45

244.61

u/l

3.00

8779

29653

Bacterial infection, other or unspecified

8249

20471

4.49

307.65

6.1

3.7

254.33

241.81

u/l

6.53

7901

19178

Other and unspecified disorders of white blood cells

719

1375

8.85

307.65

9.0

3.9

247.25

247.17

u/l

0.00

689

1292

Dialysis, with operation codes

2672

4823

10.01

307.65

6.2

4.5

260.89

241.68

u/l

4.91

2640

4559

Aplastic and other anaemias

8640

19403

5.96

307.65

4.5

4.0

248.07

247.00

u/l

0.19

8143

18227

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

776

847

31.94

307.65

15.5

2.6

230.36

239.49

u/l

1.46

756

790

Thrombocytopenia, unspecified

1291

2711

7.78

307.65

7.5

3.9

273.20

244.72

u/l

3.36

1247

2562

Caries of dentine

2920

8834

3.95

307.65

6.7

4.1

242.69

250.85

u/l

1.41

2799

8381

Malignant neoplasm of respiratory system and intrathoracic organs

2178

6543

3.27

307.65

4.1

2.6

256.62

241.55

u/l

3.12

2117

6021

Bacterial pneumonia, not elsewhere classified

3469

15217

2.21

307.65

4.7

3.7

248.32

241.97

u/l

1.50

3303

14274

Intestinal infectious diseases

7841

35981

1.75

307.65

4.7

4.1

239.34

243.27

u/l

1.47

7389

34048

ILD medications: immunosuppressive drugs

7183

23656

3.25

307.65

5.6

3.7

244.09

240.62

u/l

0.96

6913

22341

Endocrine, nutritional and metabolic diseases

5967

16924

1.88

307.65

4.5

4.3

236.41

242.84

u/l

1.71

5639

16092

Pneumonia, organism unspecified

9913

28116

2.79

307.65

5.1

3.9

248.94

239.60

u/l

5.72

9471

26514

ILD medications: prednisolone, methylprednisolone, prednisone

11549

27099

2.65

307.65

5.0

3.6

245.84

240.46

u/l

2.28

11007

25532

Insulin, combination of fast acting with intermediate-acting or long-acting

5420

28997

1.84

307.65

3.7

4.2

239.57

245.34

u/l

2.24

5127

27355

Hypothyroidism, drug reimbursement

813

1194

5.21

307.65

4.4

2.4

234.86

217.25

u/l

3.86

766

1119

Infections, IBD-co-morbidities

2004

3335

5.21

307.65

6.8

4.9

248.64

253.02

u/l

0.34

1908

3197

ILD medications: azathioprine

1389

4591

3.51

307.65

3.9

3.8

246.78

236.30

u/l

1.52

1340

4336

Coagulation defects, purpura and other haemorrhagic conditions

2678

7852

4.43

307.65

6.5

4.1

260.98

239.74

u/l

5.55

2587

7388

Inflammatory bowel disease treatment related agents

11344

30235

2.29

307.65

4.8

3.9

244.89

240.57

u/l

1.56

10785

28539

ILD medications

11824

27405

2.59

307.65

5.3

3.6

244.46

240.61

u/l

1.31

11285

25829

Hernia of abdominal wall, postoperative

1577

4725

3.81

307.65

4.0

3.1

236.38

244.74

u/l

1.01

1490

4432

Hypothyroidism (congenital or acquired)

1676

2097

4.88

307.65

5.1

2.3

228.27

219.01

u/l

2.29

1599

1986

Secondary uncertain malignant neoplasm

2722

4314

10.99

307.65

7.1

2.6

268.11

237.58

u/l

10.69

2639

3962

Insulin medication

5415

25073

1.97

307.65

3.7

4.5

239.52

247.79

u/l

3.88

5123

23722

Other bacterial diseases

11976

27619

3.42

307.65

5.5

3.7

253.80

239.57

u/l

11.89

11447

25982

Non-rheumatic valve diseases

5410

14289

3.21

307.65

3.9

4.5

266.21

239.99

u/l

21.52

5135

13472

Ischemic heart diseases

6925

23290

1.92

307.65

4.5

252.63

240.77

u/l

5.67

6598

21988

Any gastric operation

7292

12020

3.33

307.65

4.9

2.9

242.33

237.49

u/l

1.00

6922

11262

Other bacterial diseases

11899

27379

3.16

307.65

5.4

3.7

252.55

238.64

u/l

11.38

11376

25764

Other diseases of intestines

8523

28877

1.77

307.65

4.3

4.2

234.46

245.18

u/l

7.27

8027

27396

All pneumoniae

10883

29986

2.72

307.65

5.2

3.9

249.39

238.96

u/l

7.96

10411

28282

Pulmonary heart disease, diseases of pulmonary circulation

3168

15430

2.32

307.65

4.9

4.0

259.60

245.77

u/l

4.50

3046

14455

Malignant melanoma, including Hilmo

2014

5928

4.24

307.65

7.3

2.6

239.25

238.58

u/l

0.05

1954

5463

Autoimmune diseases excluding thyroid diseases

9448

27837

1.98

307.65

4.0

4.3

241.02

242.65

u/l

0.37

8993

26277

Influenza and pneumonia

11179

29645

2.68

307.65

5.2

3.8

248.76

238.44

u/l

7.90

10687

27965

Solid cancers, helper endpoint

8098

18730

2.84

307.65

5.3

2.8

250.73

236.12

u/l

7.39

7798

17422

Autoimmune diseases

9250

27954

1.78

307.65

4.1

4.3

238.97

242.66

u/l

1.24

8797

26392

Cardiovascular diseases (excluding rheumatic etc)

4794

11081

2.68

307.65

4.8

4.2

238.86

231.14

u/l

1.74

4593

10509

Gout, FINNGEN

3435

14711

2.77

307.65

5.5

4.0

249.46

246.37

u/l

0.51

3271

13830

Used for control exclusion in common control thyroid runs

8689

26110

1.77

307.65

4.3

4.2

239.20

243.13

u/l

1.26

8252

24640

COPD/asthma/ILD related infections

8924

23291

2.05

307.65

4.8

3.7

243.34

239.91

u/l

1.04

8469

21976

All chronic kidney diseases

7862

19859

4.03

307.65

4.1

4.2

244.78

245.03

u/l

0.04

7523

18669

Other heart diseases

4427

8898

3.65

307.65

5.1

4.5

253.69

234.09

u/l

9.24

4261

8421

Calcific aortic valvular stenosis

3391

14876

2.60

307.65

3.2

3.9

269.32

247.65

u/l

13.13

3205

13883

Calcific aortic valvular stenosis, including rheumatic fever

3392

14889

2.59

307.65

3.2

3.9

270.13

246.97

u/l

14.61

3206

13895

Operations 2 for CAVS

3385

14853

2.60

307.65

3.2

3.9

269.29

247.22

u/l

13.82

3199

13860

Heart failure and antihypertensive medication

3228

5182

5.08

307.65

5.9

5.3

266.61

245.80

u/l

5.65

3107

4916

Systemic connective tissue disorders

3364

15729

2.41

307.65

3.4

4.1

239.20

245.90

u/l

1.95

3172

14787

DVT of lower extremities and pulmonary embolism

3905

20735

2.07

307.65

4.7

4.0

254.11

245.05

u/l

2.81

3724

19461

Calcific aortic valvular stenosis, diagnosis (helper)

3385

14853

2.60

307.65

3.2

3.9

269.29

247.22

u/l

13.82

3199

13860

Diverticular disease of intestine

6180

22466

1.89

307.65

4.1

4.3

236.70

248.72

u/l

7.16

5806

21255

Chronic lymphocytic leukaemia, helper endpoint

776

847

31.94

307.65

15.5

2.6

230.36

239.49

u/l

1.46

756

790

Asthma (only as main-diagnosis), excluding more controls

4917

13960

2.14

307.65

3.5

3.8

235.98

237.31

u/l

0.22

4656

13165

Emergency coronary revascularization (for ACS)

7503

25377

1.94

307.65

4.4

255.64

242.06

u/l

7.54

7137

23907

Diarrhoea and gastroenteritis of presumed infectious origin

5812

30304

1.84

307.65

4.5

4.0

239.23

243.48

u/l

1.43

5484

28656

Heart failure, not strict

9357

22055

3.44

307.65

4.7

4.4

256.39

239.63

u/l

11.61

8925

20834

Other pleural conditions

1433

4393

4.36

307.65

4.1

3.9

243.77

246.17

u/l

0.22

1383

4112

Cardiovascular diseases

4276

9742

2.51

307.65

4.8

4.2

236.64

231.57

u/l

0.80

4085

9266

Metabolic disorders

8909

26784

2.21

307.65

4.3

244.35

243.60

u/l

0.14

8422

25332

Diffuse large B-cell lymphoma, helper endpoint

1239

1407

28.75

307.65

7.9

3.0

315.22

236.10

u/l

8.29

1207

1308

GASTRO-related operations

7292

12020

3.33

307.65

4.9

2.9

242.33

237.49

u/l

1.00

6922

11262

L04AX Other immunosuppressants

5155

25077

2.27

307.65

4.6

4.3

243.00

242.61

u/l

0.06

4931

23738

Heart failure, strict

7102

20701

2.86

307.65

4.7

4.2

262.26

243.14

u/l

15.57

6739

19499

Venous thromboembolism

4925

26569

1.95

307.65

4.7

4.0

253.48

244.16

u/l

3.48

4701

24959

Continuous positive airway pressure

1747

5228

3.20

307.65

4.1

5.4

250.74

245.16

u/l

0.66

1630

5007

Glomerular disorders in diseases classified elsewhere

1793

4785

5.32

307.65

3.8

4.4

242.74

242.22

u/l

0.05

1746

4526

Asthma

5772

15801

2.03

307.65

3.7

3.9

236.21

240.93

u/l

1.31

5470

14895

Asthma (only as main-diagnosis)

5111

15801

1.98

307.65

3.5

3.9

236.99

240.93

u/l

0.94

4829

14895

Heart failure and coronary heart disease

4960

15157

2.73

307.65

4.9

4.3

264.73

242.78

u/l

15.41

4695

14205

Septicaemia

5675

17348

3.76

307.65

5.6

3.6

257.96

242.60

u/l

7.69

5425

16232

Primary_lymphoid and hematopoietic malignant neoplasms

6895

10135

16.52

307.65

9.9

3.1

257.20

241.62

u/l

5.23

6733

9454

ILD differential diagnosis

6371

15950

2.13

307.65

4.6

3.9

241.10

240.64

u/l

0.07

6061

15033

Valvular operations

2030

5485

4.91

307.65

3.3

4.3

294.73

243.19

u/l

23.67

1947

5147

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3214

8123

2.70

307.65

4.5

239.27

231.20

u/l

2.24

3077

7680

Complications of medical and surgical care

6614

33261

1.98

307.65

5.0

4.0

247.06

242.28

u/l

1.40

6264

31411

Symptoms and signs involving the skin and subcutaneous tissue

5784

33577

1.80

307.65

4.9

4.1

234.02

243.77

u/l

6.48

5479

31750

Care involving dialysis

1798

2761

13.20

307.65

4.2

246.65

235.01

u/l

2.84

1781

2612

Diseases of arteries, arterioles and capillaries

6448

25760

2.03

307.65

3.6

4.3

250.05

244.75

u/l

1.61

6098

24282

Any death

6939

22242

2.59

307.65

5.5

4.1

298.02

229.35

u/l

65.93

6621

21018

Dyspnoea

8739

32420

2.18

307.65

4.1

4.2

246.63

241.81

u/l

2.19

8247

30645

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6970

29109

2.42

307.65

4.6

4.1

241.97

245.63

u/l

1.15

6639

27389

Asthma, unspecified (mode), excluding more controls

4284

13101

2.67

307.65

3.7

3.9

238.09

237.75

u/l

0.05

4053

12339

Implicit viral Sepsis

3316

12322

3.19

307.65

5.1

3.8

250.65

242.29

u/l

2.17

3155

11559

Transplanted organ and tissue status

2056

3323

11.35

307.65

11.3

4.1

248.10

242.84

u/l

0.56

2037

3151

Certain infectious and parasitic diseases

5889

15658

1.99

307.65

4.6

3.6

239.56

242.11

u/l

0.45

5589

14764

Persons encountering health services in other circumstances, wide

9956

30776

1.76

307.65

4.4

4.1

242.62

243.30

u/l

0.12

9478

28984

Persons encountering health services for specific procedures and health care

11382

28570

2.66

307.65

5.0

3.8

256.20

235.08

u/l

19.98

10912

26845

Chronic lymphocytic leukaemia

776

847

31.94

307.65

15.5

2.6

230.36

239.49

u/l

1.46

756

790

General symptoms and signs

10644

22013

2.66

307.65

5.0

3.6

242.90

240.29

u/l

0.61

10125

20747

Antihypertensive medication - note that there are other indications

4088

10757

2.12

307.65

4.4

4.5

234.59

234.30

u/l

0.04

3881

10249

Multiple myeloma and malignant plasma cell neoplasms

1110

1977

13.15

307.65

11.4

3.7

228.25

248.91

u/l

3.19

1090

1857

Autoimmune diseases related-to ILD

6898

35731

1.75

307.65

3.6

4.3

234.92

242.72

u/l

4.84

6535

33784

Other heart diseases, wide

8090

23058

2.33

307.65

4.8

4.3

248.85

236.15

u/l

9.06

7710

21827

Other special examinations and investigations of persons without complaint or reported diagnosis

5212

14480

1.93

307.65

4.4

3.9

238.58

246.49

u/l

2.95

4951

13745

Other medical care

6359

18502

3.83

307.65

6.1

3.8

278.67

238.61

u/l

27.08

6148

17272

Presence of cardiac and vascular implants and grafts

4807

16860

2.41

307.65

4.6

4.1

265.96

244.81

u/l

15.64

4520

15893

Persons encountering health services for other counselling and medical advice, not elsewhere classified

9159

30593

1.72

307.65

4.4

4.2

241.90

243.29

u/l

0.28

8759

28832

Medical observation and evaluation for suspected diseases and conditions

5875

14476

2.23

307.65

4.8

3.9

235.86

246.47

u/l

4.91

5501

13743

Hypo-osmolality and hyponatraemia

1874

7272

3.03

307.65

3.7

4.2

247.47

245.32

u/l

0.17

1751

6821

Care involving use of rehabilitation procedures

4876

25238

1.89

307.65

4.0

3.9

248.22

237.17

u/l

3.77

4660

23684

Bacterial Sepsis

6278

18685

3.50

307.65

4.8

3.9

253.14

242.82

u/l

5.00

5942

17562

Hypertension

6304

17945

2.13

307.65

4.5

238.36

244.40

u/l

2.06

6005

16978

Examination and observation for other reasons

5521

14324

2.43

307.65

4.7

3.9

238.66

246.40

u/l

2.12

5253

13620

Multiple myeloma

626

775

20.08

307.65

12.5

2.5

226.27

241.23

u/l

2.58

612

715

Anaemias

3836

1947

17.27

307.65

5.7

2.3

245.57

219.75

u/l

12.27

3664

1843

Hypertensive diseases (excluding secondary)

4072

8677

2.97

307.65

4.6

4.5

237.22

233.84

u/l

0.62

3894

8205

Preparatory care for dialysis

996

1634

14.31

307.65

3.4

4.5

238.68

246.18

u/l

0.58

991

1553

Hard cardiovascular diseases

6934

22640

1.96

307.65

4.6

4.5

252.42

240.38

u/l

5.77

6602

21388

Excluding asthma or asthma-COPD overlap

6425

15947

2.15

307.65

4.6

3.9

240.93

241.10

u/l

0.03

6109

15029

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

10473

30273

2.64

307.65

5.1

4.0

248.20

239.90

u/l

5.18

10005

28569

Malignant neoplasm, wide definition for exclusion

9221

19368

3.16

307.65

6.3

2.8

250.00

236.71

u/l

6.91

8908

18033

Symptoms and signs involving the urinary system

6506

29772

1.78

307.65

3.9

4.3

240.79

244.89

u/l

0.96

6092

28157

Explicit Sepsis

5803

18682

3.52

307.65

5.6

3.9

257.36

242.22

u/l

7.78

5548

17567

Asthma (mode)

5601

15950

1.99

307.65

3.6

3.9

237.44

240.64

u/l

0.72

5304

15033

Depression medications

1657

2203

4.02

307.65

3.8

2.3

223.69

217.49

u/l

1.16

1563

2088

Certain infectious and parasitic diseases

8572

20807

2.22

307.65

4.9

3.5

243.53

239.26

u/l

1.19

8123

19608

Implicit viral Sepsis

2509

8182

3.79

307.65

5.5

3.9

252.08

243.66

u/l

1.61

2384

7669

Diffuse large B-cell lymphoma

1239

1407

28.75

307.65

7.9

3.0

315.22

236.10

u/l

8.29

1207

1308

Hodgkin lymphoma, hilmo

636

916

15.00

307.65

7.2

4.3

233.41

244.48

u/l

0.98

618

870

Acute renal failure

3439

9492

5.00

307.65

5.1

4.1

265.69

245.86

u/l

5.87

3287

8873

Malignant neoplasm

9246

18942

3.30

307.65

6.5

2.8

251.24

236.80

u/l

7.76

8942

17626

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

9373

29136

2.29

307.65

5.6

3.9

249.23

239.53

u/l

4.75

8915

27573

Pneumonias (Asthma/COPD co-morbidities)

10872

29854

2.75

307.65

5.2

3.9

249.33

238.93

u/l

7.90

10398

28153

Other anaemias

8096

18364

6.06

307.65

4.5

3.9

247.21

247.50

u/l

0.05

7627

17237

Implicit bacterial Sepsis

5532

17088

3.52

307.65

4.7

3.9

254.24

243.74

u/l

4.52

5229

16056

Nutritional anaemias

6596

22191

3.49

307.65

3.9

4.0

241.23

247.59

u/l

1.87

6158

20868

Extracorporeal dialysis

1282

2314

11.02

307.65

4.5

4.3

248.17

244.51

u/l

0.30

1269

2195

Hypothyroidism, levothyroxine purchases

1652

2091

4.83

307.65

5.0

2.3

228.38

219.03

u/l

2.32

1576

1980

Non-Hodgkin lymphoma, all

1040

1368

17.81

307.65

9.6

2.5

336.81

236.55

u/l

8.97

1018

1260

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9819

23287

2.87

307.65

5.1

3.7

249.29

239.91

u/l

5.43

9390

21972

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5232

29719

1.87

307.65

5.1

4.0

246.60

242.47

u/l

1.00

4944

28039

Hypertension, essential

6255

17567

2.17

307.65

3.9

4.5

238.72

243.07

u/l

1.23

5957

16615

9220

30305

1.65

307.65

4.8

3.9

238.60

243.68

u/l

2.43

8714

28624

Non-follicular lymphoma

2510

4000

16.27

307.65

8.1

4.0

282.64

240.14

u/l

8.20

2452

3768

Implicit bacterial Sepsis

5905

18172

3.41

307.65

4.6

3.9

252.89

243.19

u/l

4.27

5580

17078

Malignant melanoma

1744

4797

4.65

307.65

7.5

2.6

240.00

238.35

u/l

0.11

1696

4413

Acute myeloid leukaemia and myelodysplastic syndromes

442

552

17.09

307.65

17.2

2.5

304.50

238.90

u/l

3.49

424

510

Secondary and unspecified malignant neoplasm of lymph nodes

2192

2514

22.31

307.65

7.7

2.9

258.03

234.51

u/l

7.81

2133

2338

Condition for Implicit Sepsis (Organ dysfunction codes)

8765

27518

2.42

307.65

4.5

4.0

250.92

238.74

u/l

7.94

8303

26002

Abnormal findings on examination of blood, without diagnosis

4751

22022

2.22

307.65

4.4

4.2

244.29

244.64

u/l

0.04

4530

20765

Symptoms and signs involving the circulatory and respiratory systems

7830

23200

1.78

307.65

4.1

4.2

239.47

241.32

u/l

0.39

7422

21980

Viral pneumonia

1571

4632

4.24

307.65

5.9

3.9

257.94

240.50

u/l

4.03

1515

4349

Percutaneous Coronary Intervention

6868

22723

2.01

307.65

4.5

254.28

241.08

u/l

6.82

6543

21444

Other and unspecified types of non-Hodgkin lymphoma, hilmo

911

1614

11.96

307.65

8.1

4.1

273.99

248.91

u/l

2.05

887

1519

Other septicaemia

5075

15889

3.79

307.65

5.6

3.6

259.15

243.18

u/l

7.17

4848

14862

Liquid cancers, helper endpoint

10610

11269

17.06

307.65

8.9

2.1

259.81

236.35

u/l

18.82

10317

10360

Codes for special purposes

6016

24245

2.86

307.65

4.9

3.9

246.71

242.79

u/l

1.17

5824

22808

Provisional assignment of new diseases of uncertain etiology

6008

24207

2.86

307.65

4.9

3.9

246.72

242.73

u/l

1.20

5816

22773

Certain disorders involving the immune mechanism

1892

7601

2.91

307.65

5.6

4.4

239.13

240.63

u/l

0.17

1817

7212

Type 2 diabetes, wide definition

7093

24848

1.98

307.65

3.7

4.6

237.84

247.71

u/l

6.14

6675

23521

Autoimmune diseases excluding thyroid diseases, strict definition

9130

27079

1.98

307.65

4.0

4.2

241.40

242.91

u/l

0.32

8695

25553

Heart failure,strict

6602

16829

3.34

307.65

4.8

4.3

262.04

241.15

u/l

17.11

6272

15855

Other diseases of blood and blood-forming organs

1343

2506

9.45

307.65

7.1

3.9

260.53

244.77

u/l

2.24

1282

2366

Essential (haemorrhagic) thrombocythaemia

1045

1050

33.82

307.65

9.2

2.5

279.88

234.99

u/l

14.09

1013

972

Covid-19 confirmed case

4912

16883

3.60

307.65

4.9

3.9

250.39

245.80

u/l

1.17

4756

15824

Diabetic nephropathy, excluding more controls

1708

5310

3.28

307.65

3.1

3.9

238.75

238.86

u/l

0.01

1641

4972

Other disorders of skin and subcutaneous tissue

6127

30808

1.91

307.65

4.3

4.1

240.96

243.96

u/l

0.77

5777

29066

Asthma, excluding more controls

5514

13960

2.19

307.65

3.7

3.8

235.89

237.31

u/l

0.24

5235

13165

Erysipelas

5227

21883

2.34

307.65

4.0

3.7

249.37

241.26

u/l

3.23

4937

20526

Complications of procedures, not elsewhere classified

6999

32735

1.90

307.65

4.2

4.0

246.99

241.80

u/l

1.61

6633

30933

Malaise and fatigue

5616

16474

3.14

307.65

4.0

3.6

241.34

243.08

u/l

0.30

5287

15462

Enlarged lymph nodes

2922

5162

8.42

307.65

6.7

3.8

242.80

241.04

u/l

0.15

2848

4856

Haemorrhage from respiratory passages

3346

14296

2.35

307.65

4.5

4.2

256.41

244.61

u/l

3.13

3147

13461

Pain in throat and chest

6783

22546

1.92

307.65

3.9

4.2

239.10

241.35

u/l

0.46

6407

21342

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2558

4723

2.89

307.65

4.6

3.8

241.31

241.32

u/l

0.00

2428

4463

Headache

4699

19601

2.03

307.65

4.0

3.6

235.98

239.32

u/l

0.52

4423

18483

Nausea and vomiting

2637

11072

2.63

307.65

4.7

4.0

241.93

247.03

u/l

0.73

2502

10373

Syncope and collapse

3688

15760

2.17

307.65

3.7

3.6

239.53

242.95

u/l

0.70

3429

14801

Any event in cancer register

9480

21231

2.95

307.65

6.4

2.7

250.98

234.28

u/l

10.83

9140

19841

Abnormal findings on diagnostic imaging of lung

5229

23404

2.45

307.65

4.7

4.1

243.31

246.64

u/l

0.82

5001

21990

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1077

3209

4.51

307.65

3.9

3.8

226.55

246.18

u/l

4.01

1006

3002

Abnormalities of breathing

7887

23155

2.13

307.65

4.1

4.2

243.05

241.38

u/l

0.40

7463

21937

Oedema, not elsewhere classified

3253

12066

3.05

307.65

4.3

3.6

242.63

244.36

u/l

0.28

3075

11308

Malignant melanoma of skin

1307

3558

4.71

307.65

8.2

2.7

242.83

237.14

u/l

0.36

1273

3285

Implicit Sepsis

8551

25996

2.84

307.65

4.4

4.0

251.12

240.41

u/l

6.21

8064

24526

Oxycodone

5423

15144

4.05

307.65

5.9

4.0

264.34

245.63

u/l

8.10

5187

14297

L01XE Protein kinase inhibitors

887

2180

6.51

307.65

12.2

4.3

285.59

247.21

u/l

5.23

869

2056

Gout

3435

11995

3.02

307.65

5.5

4.4

249.46

248.11

u/l

0.17

3271

11325

Tramadol

7317

20585

2.38

307.65

4.0

237.83

241.13

u/l

0.92

6926

19455

Acute tubulo-interstitial nephritis

5787

24109

2.28

307.65

3.8

4.0

241.31

241.94

u/l

0.11

5446

22668

Parasetamol

6029

15684

2.06

307.65

4.3

4.2

235.25

245.79

u/l

4.10

5694

14902

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3079

5003

10.64

307.65

7.1

2.7

259.89

236.30

u/l

9.74

2996

4624

Pain in limb

6857

26604

1.84

307.65

4.1

4.3

239.29

244.59

u/l

1.78

6481

25198

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3200

8603

4.79

307.65

5.8

2.7

278.58

239.63

u/l

17.08

3120

7961

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1018

1521

13.56

307.65

5.6

2.5

227.73

237.55

u/l

1.75

975

1404

Opioids

8329

22335

2.07

307.65

4.3

4.0

239.11

238.85

u/l

0.05

7884

21132

Marginal zone B-cell lymphoma, including Hilmo

407

425

30.23

307.65

6.7

2.6

237.55

237.58

u/l

0.00

401

L04AA Selective immunosuppressants

2678

8603

3.84

307.65

5.2

4.4

248.76

240.64

u/l

2.02

2602

8140

L01XX Other antineoplastic agents

1632

2359

24.07

307.65

12.7

3.6

281.41

247.37

u/l

8.36

1590

2216

Codeine or tramadol medication

9347

31713

1.70

307.65

3.9

4.2

235.80

243.22

u/l

4.74

8790

30042

Oral corticosteroids

10886

29596

2.40

307.65

4.8

3.9

246.25

240.78

u/l

2.32

10347

27925

Codeine

7706

22085

2.02

307.65

3.9

4.0

233.93

239.09

u/l

2.18

7248

20905

Condition for Implicit Sepsis (Organ dysfunction codes)

8759

27359

2.52

307.65

4.4

4.0

252.80

238.99

u/l

9.66

8270

25839

Other pulmonary diagnosis

6381

15947

2.14

307.65

4.6

3.9

241.59

241.10

u/l

0.07

6066

15029

Kidney transplant status

1020

1722

10.81

307.65

3.8

4.8

242.19

251.59

u/l

0.68

1014

1638

Malignant melanoma of skin, including Hilmo

1622

4855

4.14

307.65

7.7

2.7

240.66

237.55

u/l

0.21

1577

4468

Malignant neoplasm of bronchus and lung, including Hilmo

2141

6785

3.08

307.65

4.1

2.5

257.66

242.16

u/l

3.15

2079

6246

All kidney diseases

11151

29612

2.92

307.65

4.5

4.1

247.36

240.05

u/l

3.93

10635

27942

Erysipelas

6737

23974

2.36

307.65

4.0

3.8

246.38

240.19

u/l

2.61

6366

22512

Rare circulating lymphoid malignancy, including Hilmo

665

842

17.47

307.65

13.1

2.9

265.11

237.84

u/l

1.86

649

799

Asthma, unspecified (mode)

4439

14831

2.45

307.65

3.6

3.9

237.94

241.06

u/l

0.66

4195

13959

Non-Hodgkin lymphoma, all, including Hilmo

3685

4379

21.87

307.65

7.9

2.6

268.01

237.99

u/l

8.09

3598

4020

Non-small cell lung cancer, including Hilmo

1604

5163

3.49

307.65

4.3

2.5

242.66

240.35

u/l

0.27

1565

4733

Complications of surgical and medical care, not elsewhere classified

9120

33688

2.00

307.65

4.8

4.0

245.35

241.84

u/l

1.17

8628

31817

Myelodysplastic syndrome, including Hilmo

672

870

17.38

307.65

11.7

2.4

258.07

237.35

u/l

3.16

646

799

Bacterial infection, other or unspecified

8685

21412

4.34

307.65

6.0

3.7

253.24

241.48

u/l

6.30

8317

20069

COPD/asthma related infections

8924

23291

2.05

307.65

4.8

3.7

243.34

239.91

u/l

1.04

8469

21976

Non-invasive ventilation

2085

6505

3.21

307.65

3.8

5.2

247.67

241.12

u/l

1.05

1935

6236

Unspecified kidney failure

1469

4106

4.86

307.65

4.3

3.9

246.28

246.23

u/l

0.00

1413

3815

Polycythaemia vera

847

987

22.95

307.65

9.9

2.5

290.74

235.78

u/l

16.85

835

922

Mantle cell lymphoma, including Hilmo

355

405

26.55

307.65

9.6

2.4

244.23

240.18

u/l

0.25

345

380

Multiple myeloma, including Hilmo

1081

1408

18.80

307.65

11.6

2.6

229.38

237.40

u/l

1.12

1062

1298

Other disorders of fluid, electrolyte and acid-base balance

3595

13339

3.03

307.65

3.7

4.2

248.57

247.88

u/l

0.07

3356

12550

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1960

6404

3.72

307.65

4.7

2.7

270.80

239.25

u/l

6.95

1907

5906

Nephropathy related operations

2499

4970

8.92

307.65

6.3

4.4

258.91

242.83

u/l

3.82

2470

4719

9819

23287

2.87

307.65

5.1

3.7

249.29

239.91

u/l

5.43

9390

21972

COPD differential diagnosis

6373

15952

2.13

307.65

4.6

3.9

241.10

240.64

u/l

0.07

6063

15034

L04AD Calcineurin inhibitors

1928

3721

8.25

307.65

8.6

4.4

251.01

247.62

u/l

0.30

1903

3545

Atrial fibrillation and flutter with reimbursement

2311

4925

3.38

307.65

4.5

4.9

246.41

237.55

u/l

1.54

2209

4648

Pleural effusion

2482

6999

4.99

307.65

4.0

235.53

245.99

u/l

2.59

2418

6546

Follicular lymphoma, hilmo

1051

1662

17.29

307.65

7.2

4.1

236.13

247.19

u/l

0.97

1025

1564

Atrial fibrillation and flutter

2851

5905

3.54

307.65

4.9

254.39

236.00

u/l

5.56

2734

5584

Implicit Sepsis

8807

27112

2.68

307.65

4.4

4.0

251.69

239.59

u/l

7.74

8305

25604

Bacterial pneumoniae

3644

16016

2.20

307.65

4.7

3.8

247.82

241.87

u/l

1.42

3468

15034

Pure hypercholesterolaemia

6235

23194

1.88

307.65

3.7

4.4

244.51

245.34

u/l

0.13

5863

21930

Secondary hypertension

1125

2001

7.56

307.65

3.3

4.4

234.11

243.38

u/l

0.85

1091

1893

Valvular heart disease excluding rheumatic fever

5455

14356

3.22

307.65

3.9

4.5

266.35

240.72

u/l

20.24

5180

13538

Iron deficiency anaemia

5917

18906

3.84

307.65

3.8

4.0

237.76

246.74

u/l

3.91

5520

17777

Myeloproliferative diseases (CML excluded)

1952

2995

16.76

307.65

9.4

3.8

284.56

246.45

u/l

11.37

1898

2811

Haemolytic anaemias

723

1185

11.96

307.65

14.5

3.6

343.48

251.73

u/l

9.60

695

1121

COPD (mode)

2774

9709

2.50

307.65

3.3

3.9

237.38

245.57

u/l

1.90

2601

9088

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

16478

25413

5.78

307.65

5.1

3.7

248.34

239.56

u/l

5.84

15633

24004

Cardiac arrhythmias

4561

13550

2.35

307.65

4.7

4.6

244.37

234.59

u/l

3.79

4333

12887

Acquired haemolytic anaemia

560

830

16.02

307.65

16.3

3.5

374.62

255.18

u/l

9.98

537

785

Other and unspecified diseases of blood and blood-forming organs

510

863

11.20

307.65

7.7

3.7

255.47

248.88

u/l

0.24

502

812

Pulmonary heart disease

2854

14016

2.30

305.61

4.7

4.0

258.09

245.49

u/l

3.42

2740

13123

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1160

2470

3.92

303.76

4.8

5.0

262.24

262.43

u/l

0.01

1104

2360

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7375

27979

1.67

302.72

3.6

4.5

236.82

245.60

u/l

5.37

6938

26483

Streptococcal septicaemia

1038

3154

4.15

301.85

5.4

3.8

252.98

240.00

u/l

1.74

996

2957

Azathioprine

1389

4936

3.25

300.50

3.9

4.3

246.78

235.89

u/l

1.65

1340

4671

Gastrointestinal diseases

4169

10978

2.00

299.51

4.6

3.8

240.50

242.00

u/l

0.17

3934

10445

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4962

23145

1.87

299.41

3.5

4.5

236.96

249.83

u/l

7.01

4624

21887

GI-bleeding

3136

16049

2.18

298.50

4.2

4.0

245.04

248.87

u/l

0.64

2954

15046

Diseases of the skin and subcutaneous tissue

7880

25117

1.65

296.84

4.5

4.0

240.37

243.57

u/l

0.87

7427

23739

Explicit bacterial Sepsis

1179

3909

3.67

294.54

5.5

4.0

251.51

241.11

u/l

1.33

1130

3681

Symptoms and signs concerning food and fluid intake

1084

3399

3.81

293.01

3.2

3.6

227.39

240.63

u/l

2.57

1015

3194

Type 2 diabetes

7572

28224

1.65

291.86

3.7

4.4

237.77

244.64

u/l

3.78

7114

26719

Other bacterial intestinal infections

1823

7594

2.78

290.96

5.7

4.0

247.21

244.31

u/l

0.30

1715

7133

Bacterial pneumonia (organism specified)

4015

20173

1.96

290.81

5.2

4.0

249.35

245.97

u/l

0.69

3827

18916

Benign neoplasm of colon, rectum, anus and anal canal

5472

28786

1.78

287.68

3.9

4.3

237.73

246.92

u/l

2.62

5147

27167

AV-block

1778

6395

2.79

283.41

3.4

4.2

259.01

244.27

u/l

3.48

1685

5980

Adjustment and management of implanted device

1867

8008

2.70

280.71

4.4

3.7

256.82

243.21

u/l

3.76

1798

7432

Diabetes, insulin treatment (Kela reimbursement)

7854

30873

1.61

280.48

3.6

4.5

237.38

245.88

u/l

5.19

7390

29212

Endocarditis

549

1115

7.35

280.12

3.6

4.2

281.99

239.10

u/l

4.72

530

1047

Gout, idiopatic and unspecified

2579

12706

2.34

279.30

4.1

243.01

246.91

u/l

0.66

2433

11967

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3571

12804

2.04

279.03

4.4

2.7

243.13

240.37

u/l

0.58

3378

11825

Other systemic involvement of connective tissue (FG)

2283

10452

2.40

278.38

3.2

4.2

235.44

246.22

u/l

3.02

2134

9839

Infections of the skin and subcutaneous tissue

4651

26990

1.82

277.64

4.7

4.3

240.58

242.35

u/l

0.29

4427

25582

Coronary atherosclerosis

5287

19926

1.80

277.44

4.2

4.5

250.79

240.39

u/l

4.17

4983

18772

Intestinal infectious diseases

9003

34458

1.56

276.76

4.4

4.1

238.03

244.02

u/l

3.14

8479

32618

Bacterial intestinal infections, IBD co-morbidities

1836

7860

2.70

276.48

5.7

4.0

246.68

244.38

u/l

0.23

1730

7392

Constipation

7115

31712

1.64

274.82

3.8

4.3

238.49

245.45

u/l

2.94

6624

30044

Non-small cell lung cancer

1076

3481

3.70

274.63

4.3

2.6

246.15

240.18

u/l

0.66

1052

3183

Asthma, hospital admissions 3, pneumonia

3287

17485

2.06

274.27

4.0

4.2

243.68

247.51

u/l

0.84

3118

16388

Asthma-related pneumonia or sepsis

3287

17485

2.06

274.27

4.0

4.2

243.68

247.51

u/l

0.84

3118

16388

Asthma-related pneumonia

3279

17452

2.06

273.18

4.0

4.2

243.65

247.47

u/l

0.83

3110

16358

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1594

6498

2.95

272.50

3.3

4.5

250.27

243.45

u/l

0.63

1518

6151

Cytomegalovirus infection, IBD co-morbidity

417

694

11.01

269.45

12.2

4.7

272.01

244.13

u/l

2.57

408

661

Gout, unspecified

2165

10138

2.50

268.68

4.2

4.0

242.91

246.18

u/l

0.47

2047

9542

Disorders of mineral metabolism

953

2953

4.03

268.15

4.5

4.4

251.30

245.10

u/l

0.51

901

2810

Other/unspecified cytomegaloviral diseases

380

582

13.05

267.74

12.4

4.9

274.42

240.98

u/l

3.15

373

554

Chronic myeloproliferative disease

340

482

21.97

267.25

18.0

4.1

456.10

245.33

u/l

32.36

333

452

Factors influencing health status and contact with health services

2236

4816

2.47

266.63

4.3

3.6

244.73

236.09

u/l

1.08

2118

4535

Other bacterial intestinal infections

2116

9727

2.45

266.21

5.5

4.0

244.63

244.96

u/l

0.03

1985

9133

Idiopathic thrombocytopenic purpura

494

967

8.16

265.85

7.2

3.8

260.70

255.55

u/l

0.12

481

918

Insulin, fast-acting

3127

16544

2.07

265.83

3.6

4.3

240.51

244.46

u/l

0.95

2971

15605

Persons encountering health services in other circumstances

3213

16997

2.03

264.93

3.8

4.1

239.66

242.11

u/l

0.34

3042

15999

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3372

12226

2.04

264.15

4.5

2.6

244.11

240.40

u/l

0.78

3187

11279

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1031

3390

3.69

260.74

4.2

2.7

234.25

239.26

u/l

0.56

1007

3123

Diseases of the respiratory system

4780

13780

1.83

260.68

4.4

3.9

241.59

241.61

u/l

0.00

4519

12988

Cardiomyopathy

1606

6632

2.77

259.06

7.2

4.4

261.02

243.60

u/l

3.27

1526

6235

Peripheral artery disease

4088

18742

1.90

258.43

3.3

4.2

247.84

246.91

u/l

0.13

3835

17606

Cytomegaloviral disease

418

727

10.10

257.51

12.2

4.7

271.83

241.20

u/l

3.10

409

691

Abdominal and pelvic pain

7715

25344

1.60

256.68

4.3

4.2

239.08

244.97

u/l

2.07

7298

23956

Ascites

911

2842

4.11

256.26

4.1

4.2

265.85

248.46

u/l

1.14

879

2690

Reimbursement for rheumatic diseases

4493

26584

1.80

255.85

3.0

4.3

241.17

242.84

u/l

0.34

4261

25092

Hypertensive Heart Disease

2220

8127

2.40

255.74

3.4

4.5

248.36

250.77

u/l

0.28

2081

7626

Implicit fungal Sepsis

817

2381

4.45

255.50

6.5

3.9

252.83

245.75

u/l

0.54

779

2242

Symptoms and signs involving cognition, perception, emotional state and behaviour

7483

33704

1.59

254.98

3.7

4.3

240.36

242.76

u/l

0.61

6998

31956

Asthma-related infections

4714

27766

1.77

254.65

3.7

4.2

237.75

244.49

u/l

3.01

4463

26187

Asthma, hospital admission 2, infections

4714

27766

1.77

254.65

3.7

4.2

237.75

244.49

u/l

3.01

4463

26187

Dermatitis

4896

29678

1.75

254.63

4.7

4.2

240.57

243.38

u/l

0.56

4664

28067

Diabetes medication

7858

30928

1.57

254.25

3.6

4.4

236.11

244.82

u/l

5.79

7386

29300

Drug-induced neutropenia

873

2680

4.29

254.16

8.8

4.3

257.42

246.67

u/l

1.00

856

2536

Hyperkalaemia

764

2163

4.72

251.58

4.7

4.2

246.84

244.48

u/l

0.16

721

2035

Other autoimmune haemolytic anaemias

316

441

22.04

251.27

18.9

3.5

306.75

243.65

u/l

6.60

305

419

Paroxysmal tachycardia

1596

5406

2.69

250.73

6.1

4.7

246.43

235.98

u/l

2.06

1514

5108

Other diseases of pericardium

596

1409

5.81

250.41

4.3

4.1

264.56

241.58

u/l

1.84

576

1319

Other and unspecified dermatitis

4121

24180

1.82

246.29

4.7

4.1

241.99

243.39

u/l

0.20

3927

22845

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4687

28489

1.76

245.19

4.1

4.2

246.46

243.16

u/l

0.65

4424

26892

Malignant neoplasm of urinary organs

971

3207

3.67

243.74

4.3

2.7

235.19

238.20

u/l

0.28

945

2957

Enterocolitis due to Clostridium difficile

1191

4440

3.25

242.52

6.5

4.0

252.03

247.77

u/l

0.34

1129

4159

Gout, strict definition

1935

9045

2.52

242.45

4.2

4.1

242.45

245.21

u/l

0.38

1824

8521

Ischaemic heart disease, wide definition

6072

23972

1.66

241.97

4.2

4.5

250.12

242.16

u/l

2.56

5755

22634

Disorders of lens

5348

20680

1.72

239.57

4.2

4.5

240.37

246.34

u/l

1.79

5041

19647

Benign neoplasms

7417

27041

1.58

239.25

4.4

4.1

235.47

243.98

u/l

3.11

7026

25610

Insulin, fast-acting or short human

3138

17230

1.98

237.34

3.6

4.3

240.38

244.34

u/l

0.97

2981

16250

Mantle cell lymphoma

243

263

36.30

236.15

9.8

2.5

243.91

241.01

u/l

0.14

238

248

Unspecified haematuria

3760

17991

1.88

235.27

3.9

4.3

244.90

246.87

u/l

0.29

3548

17007

Gastro-oesophageal reflux disease

5207

28118

1.69

235.16

3.6

4.4

233.61

245.70

u/l

10.05

4846

26678

Disorders of gallbladder, biliary tract and pancreas

7639

32442

1.55

234.76

4.2

241.79

242.86

u/l

0.18

7236

30642

Diabetic nephropathy

1719

7693

2.66

234.67

3.0

3.8

238.71

u/l

0.00

1652

7199

Other acute lower respiratory infections

4288

24499

1.78

234.04

5.0

4.0

239.44

244.84

u/l

1.78

4076

23051

Other abnormal findings of blood chemistry

613

1580

5.36

231.44

4.9

4.1

235.17

244.51

u/l

0.67

602

1494

Pacemaker

3137

16751

2.00

230.95

4.2

4.0

263.14

248.66

u/l

5.92

2957

15660

Persons encountering health services for examination and investigation

4833

14480

1.75

230.29

4.5

3.9

235.26

246.49

u/l

5.51

4559

13745

Malignant neoplasm of kidney, except renal pelvis

891

2915

3.72

227.57

4.3

2.8

235.05

238.46

u/l

0.30

869

2696

Genitourinary diseases

4381

12828

1.80

227.13

4.5

239.24

246.02

u/l

1.18

4168

12218

Acute upper respiratory infections of multiple and unspecified sites

5625

26585

1.64

227.04

5.3

3.9

236.05

243.63

u/l

3.41

5336

25151

Other systemic involvement of connective tissue

2343

11897

2.18

226.18

3.2

4.1

234.95

244.35

u/l

2.92

2192

11175

Pregnancy hypertension

2570

11858

2.07

225.86

3.7

4.0

234.91

234.70

u/l

0.02

2454

11226

Disorders of other endocrine glands

3408

19087

1.88

225.60

4.0

4.2

238.48

243.67

u/l

0.97

3201

17998

Other functional intestinal disorders

3589

19227

1.85

223.56

3.9

4.2

235.67

249.71

u/l

6.27

3363

18147

Myelodysplastic syndrome

254

304

20.73

222.93

12.5

2.5

259.40

239.05

u/l

1.99

239

282

Viral infections characterized by skin and mucous membrane lesions

3321

18857

1.89

222.72

5.9

4.2

241.91

243.36

u/l

0.23

3166

17817

Benign neoplasm: Colon

4587

27216

1.73

222.22

3.9

4.3

237.44

247.41

u/l

2.40

4320

25659

Disorders of choroid and retina

6442

30330

1.59

221.08

3.9

4.3

244.00

244.55

u/l

0.08

6055

28645

Use of hypnotics and sedatives

8055

31772

1.52

219.17

4.3

4.2

237.83

243.86

u/l

2.98

7584

30099

Atherosclerosis, excluding cerebral and coronary sclerosis

3779

17666

1.85

218.60

3.3

4.1

249.06

247.30

u/l

0.25

3542

16581

Type 2 diabetes, definitions combined

6991

27438

1.56

218.40

3.8

4.5

237.53

245.25

u/l

4.27

6567

25962

Low back pain

5733

26585

1.62

218.08

3.9

4.3

234.05

243.54

u/l

5.92

5366

25265

Fibrosis and cirrhosis of liver

892

3037

3.74

217.81

3.3

4.4

238.46

244.15

u/l

0.61

862

2881

Basal cell carcinoma, including avohilmo

3216

12280

1.93

217.47

4.5

2.6

246.20

240.28

u/l

1.32

3034

11325

Type 2 diabetes, strict (exclude DM1)

7012

27647

1.55

214.39

3.8

4.5

237.49

245.50

u/l

4.56

6587

26163

Fungal Sepsis

549

1382

5.54

214.38

8.2

4.0

261.86

244.93

u/l

1.23

529

1303

Basal cell carcinoma

3115

11908

1.94

213.35

4.5

2.7

246.27

240.63

u/l

1.18

2938

10978

Other arthritis (FG)

2459

12931

2.06

211.32

3.6

4.4

239.09

244.88

u/l

0.71

2348

12252

Pre-eclampsia

1380

5781

2.62

210.73

4.3

4.0

243.51

235.09

u/l

0.67

1321

5458

Left ventricular outflow tract obstruction (LVOTO), broad definition

990

3590

3.30

210.65

4.2

5.0

292.08

244.73

u/l

10.09

955

3437

Acute bronchitis

3332

18889

1.86

209.61

4.9

4.0

237.77

245.23

u/l

2.59

3161

17686

Osteoporosis

2288

11051

2.15

209.48

4.2

3.9

242.49

248.60

u/l

1.56

2128

10334

Disorders of calcium metabolism

726

2222

4.13

209.33

4.9

4.3

260.01

248.67

u/l

0.86

690

2100

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

209

217

36.56

208.38

8.9

2.5

201.77

241.42

u/l

6.93

202

203

Hyperlipidaemia, other/unspecified

3282

17444

1.88

208.21

3.6

4.3

242.72

246.70

u/l

0.90

3100

16463

Major coronary heart disease event excluding revascularizations

4805

20098

1.70

207.96

4.2

4.5

252.77

240.80

u/l

3.86

4533

18914

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2801

13250

1.95

207.48

3.6

4.0

233.93

236.38

u/l

0.29

2673

12537

Diarrhoea and gastroenteritis of presumed infectious origin

7558

34367

1.51

206.14

4.3

4.1

236.74

244.01

u/l

4.17

7124

32524

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

7289

31982

1.52

206.01

4.3

4.2

244.82

242.20

u/l

0.74

6868

30240

Glomerulonephritis

1028

3863

3.20

205.80

4.0

4.5

236.51

247.86

u/l

1.70

995

3656

Other disorders of urethra and urinary system

5311

24701

1.63

205.08

3.9

4.1

240.69

243.58

u/l

0.59

4973

23355

Implicit fungal Sepsis

507

1245

5.72

204.66

8.1

4.0

263.49

246.08

u/l

1.16

491

1175

Gastroduodenal ulcer

2351

12356

2.09

204.01

3.7

4.2

248.56

251.33

u/l

0.18

2210

11614

Cough

3063

16432

1.88

202.98

4.5

4.3

240.60

244.49

u/l

0.71

2896

15537

Later onset COPD, excluding more controls

1864

6893

2.34

202.59

3.0

3.7

237.63

247.51

u/l

2.06

1748

6418

malignant neoplasm of male genital organs

2337

7244

2.15

201.53

5.0

2.7

251.90

240.40

u/l

1.92

2240

6729

Cirrhosis of liver, NAS

691

2138

4.39

201.35

3.4

4.3

239.84

249.23

u/l

0.88

671

2031

Pre-eclampsia or eclampsia

1459

6392

2.50

201.25

4.3

4.1

245.35

235.75

u/l

0.80

1397

6031

Aortic valve malfunction, age under 60 years

927

3330

3.35

201.18

4.2

4.9

293.62

241.87

u/l

11.46

893

3185

Other disorders of kidney and ureter

1312

5616

2.76

200.72

3.8

4.4

242.36

245.34

u/l

0.28

1266

5310

Myocardial infarction

3983

16991

1.77

200.67

4.2

4.5

251.35

240.62

u/l

3.37

3760

15994

Chronic gastritis

2380

12679

2.07

200.03

3.8

4.3

246.00

248.97

u/l

0.30

2205

11946

ILD, hospital admission 2, with pulmonary infections

996

3731

3.18

199.58

4.9

3.6

271.57

242.74

u/l

5.32

950

3484

Hypokalaemia

1120

4445

2.92

197.75

3.1

4.3

244.21

242.96

u/l

0.11

1043

4197

Dizziness and giddiness

5737

30268

1.58

194.73

3.7

4.3

241.07

243.46

u/l

0.55

5374

28657

Presence of other functional implants

4601

20172

1.68

194.07

3.8

4.1

244.71

244.29

u/l

0.04

4287

19015

Clear cell adenocarcinoma of kidney

524

1370

5.09

192.19

4.4

2.7

223.29

235.51

u/l

1.80

514

1277

Non-small cell lung cancer, adenocarcinoma

654

1980

4.15

191.30

4.3

2.8

255.97

237.76

u/l

2.11

640

1825

Dorsalgia

7350

27188

1.50

190.85

3.8

4.3

233.97

243.37

u/l

5.30

6885

25826

Volume depletion

980

3720

3.11

190.70

3.7

4.1

238.81

246.22

u/l

1.13

913

3490

Cerebrovascular diseases

5881

27740

1.57

190.40

4.1

4.3

248.47

245.32

u/l

0.73

5528

26219

Pre-eclampsia or poor fetal growth

1832

8932

2.19

189.44

3.9

3.8

239.05

231.07

u/l

0.81

1751

8447

Abnormalities of heart beat

2669

14592

1.92

188.15

3.7

4.2

235.04

243.09

u/l

2.12

2501

13746

Rheumatoid arthritis

2566

12674

1.96

187.68

3.0

4.4

248.61

246.55

u/l

0.28

2420

11975

Pneumocystosis

344

686

9.43

187.30

11.6

4.2

268.48

256.85

u/l

0.40

338

651

Other specified/unspecified arthritis

2151

11287

2.07

186.38

3.6

4.5

240.33

245.75

u/l

0.55

2059

10696

Pain (limb, back, neck, head abdominally)

5470

17811

1.60

186.31

4.3

238.87

246.96

u/l

2.18

5161

16896

Type 2 diabetes, definitions combined, including avohilmo

6848

27399

1.51

186.26

3.8

4.5

238.59

245.37

u/l

3.26

6418

25933

Pain in joint

4259

16861

1.69

186.25

3.6

4.3

235.59

245.38

u/l

2.74

3995

16038

Chronic apical periodontitis

8313

33706

1.46

186.09

4.3

4.1

238.91

242.40

u/l

1.15

7874

31870

Other retinal disorders

5146

26396

1.61

185.91

3.7

4.2

244.85

245.13

u/l

0.03

4838

24864

Malignant immunoproliferative diseases

255

398

20.33

185.65

9.9

4.2

224.91

241.77

u/l

1.23

247

376

Polyneuropathies and other disorders of the peripheral nervous system

1989

10295

2.17

185.20

4.8

4.2

242.13

246.00

u/l

0.47

1894

9689

Other nutritional deficiencies

4667

28406

1.62

185.12

3.5

4.4

236.93

239.98

u/l

0.61

4401

26980

Convulsions, not elsewhere classified

1650

7734

2.27

185.12

3.7

3.8

241.24

240.96

u/l

0.02

1549

7295

Other diseases of urinary system

7487

29420

1.49

184.85

3.9

4.3

238.09

243.21

u/l

1.74

7024

27900

Fall on same level

8331

32368

1.45

184.44

3.8

4.4

237.67

243.62

u/l

3.32

7852

30745

Any operation in hilmo

242

17.55

184.21

3.9

2.0

235.67

213.16

u/l

0.92

230

Hernia

6853

31823

1.50

183.73

4.0

4.3

239.98

244.44

u/l

1.80

6460

30081

Spondylopathies

5995

24112

1.55

182.61

3.6

4.3

239.66

245.71

u/l

1.84

5618

22866

Diaphragmatic hernia

2957

17291

1.85

181.99

3.7

4.3

237.53

247.60

u/l

4.02

2771

16267

Other antidepressants

7852

28375

1.47

180.98

3.5

4.5

233.61

245.43

u/l

8.51

7336

26974

Senile cataract

4830

19135

1.64

180.65

4.1

4.5

241.62

247.77

u/l

1.65

4532

18151

Malignant neoplasm of mesothelium and soft tissue

467

1180

5.26

179.03

4.6

2.7

263.19

234.26

u/l

0.89

459

1099

Other (not insulin) diabetes medications

7066

29235

1.49

178.75

3.6

4.5

235.07

245.76

u/l

7.44

6607

27680

Gastric ulcer

1633

7960

2.30

177.98

3.9

4.2

251.83

251.15

u/l

0.03

1538

7485

Cardiomyopathies, Primary/intrinsic

1092

4515

2.77

176.37

8.7

4.5

261.35

240.28

u/l

3.22

1037

4244

1064

4315

2.75

175.87

6.6

4.3

256.35

240.46

u/l

0.86

1017

4060

Exposure to unspecified factor

7302

37208

1.47

175.77

3.7

4.3

238.75

243.04

u/l

1.61

6885

35230

Pneumonia due to other infectious organisms, not elsewhere classified

427

1028

5.67

175.35

10.5

3.7

268.16

241.51

u/l

1.96

416

974

Other gastritis (incl. Duodenitis)

1904

9892

2.12

172.25

3.9

4.4

233.69

248.34

u/l

5.15

1776

9331

Early onset COPD, excluding more controls

1504

7133

2.30

171.41

3.6

4.0

240.04

243.35

u/l

0.29

1411

6711

Type 1 diabetes

1915

9908

2.09

171.20

3.4

4.5

237.32

243.55

u/l

1.27

1833

9382

Cardiomyopathy (excluding other)

1114

4714

2.69

170.88

8.6

4.4

260.40

239.44

u/l

3.33

1059

4429

Periodontitis

7114

33678

1.47

170.52

4.4

4.2

240.45

243.60

u/l

0.87

6709

31880

Chronic periodontitis, including avohilmo

7091

33660

1.47

169.54

4.4

4.2

240.45

243.63

u/l

0.88

6688

31863

Disorders of thyroid, IBD co-morbidities

1245

3704

2.53

169.42

5.3

4.7

233.57

248.50

u/l

2.06

1177

3552

ILD, hospital admissions 3, with pneumonia sepsis

879

3374

3.13

169.20

5.0

3.8

273.30

243.96

u/l

4.62

840

3155

Gestational [pregnancy-induced] hypertension

1505

7119

2.26

169.11

3.5

3.9

224.71

231.30

u/l

1.53

1437

6727

Amputation

1059

4459

2.82

168.34

3.7

3.9

253.09

244.05

u/l

0.97

995

4179

Lower back pain or/and sciatica

7703

36132

1.44

168.13

3.9

4.2

237.04

242.56

u/l

2.15

7236

34214

Other necrotizing vasculopathies

782

2851

3.40

168.10

3.9

4.2

248.64

248.17

u/l

0.02

743

2689

3216

19350

1.75

168.01

3.6

4.3

232.22

243.80

u/l

6.01

3055

18280

Retention of urine

2986

14597

1.82

166.99

3.6

4.2

242.23

247.64

u/l

0.69

2784

13780

Benzodiazepine use

7380

36332

1.45

166.72

3.8

4.2

234.51

243.49

u/l

5.64

6874

34445

Asthma (diagnoses ohter than nonallergic)

6352

36905

1.48

166.27

3.5

4.2

236.22

243.08

u/l

4.03

6012

34870

Other disorders involving the immune mechanism, not elsewhere classified

410

1003

5.70

166.07

6.0

4.7

240.01

245.43

u/l

0.33

395

952

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1389

6300

2.38

165.84

3.4

4.6

254.85

245.46

u/l

1.20

1342

5980

Dermatitis and eczema

8064

36221

1.43

165.22

4.4

4.1

239.02

243.21

u/l

1.42

7644

34246

Noninfective enteritis and colitis

3424

21204

1.71

164.66

4.1

4.3

233.57

243.55

u/l

4.07

3236

20048

Other and unspecified polyneuropathies, also in other diseases

1743

8997

2.18

164.09

4.7

4.2

239.52

246.19

u/l

1.08

1659

8463

Neurological diseases, wide definition

1945

4849

2.11

163.33

4.2

4.5

235.93

250.97

u/l

1.69

1840

4660

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1315

5864

2.42

163.23

3.4

4.6

255.72

245.86

u/l

1.20

1273

5569

Diseases of spleen

294

566

8.50

161.99

7.4

4.0

292.51

239.97

u/l

3.18

287

537

Other cataract

3461

16231

1.72

161.59

4.1

4.4

237.55

247.87

u/l

4.25

3267

15373

Zoster [herpes zoster]

1600

8029

2.23

161.54

6.5

4.0

246.83

246.37

u/l

0.04

1521

7523

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1273

5862

2.46

160.92

4.5

4.1

244.77

244.24

u/l

0.04

1187

5517

Hypertensive Renal Disease

468

1281

4.80

160.87

3.0

4.2

244.42

247.36

u/l

0.14

454

1187

Vocal cord dysfunction

959

3403

2.75

160.56

3.8

5.3

237.89

246.36

u/l

0.73

905

3266

Viral infections characterized by skin and mucous membrane lesions

6189

37167

1.48

160.20

5.3

4.0

239.29

242.53

u/l

1.13

5903

35145

Type 1 diabetes, wide definition, subgroup 1

1558

7683

2.20

159.83

3.3

4.5

237.94

242.25

u/l

0.70

1490

7283

Vascular disorders of the intestines

751

2746

3.34

159.26

4.2

3.8

247.11

252.86

u/l

0.36

701

2580

Other diseases of liver

1456

7088

2.28

158.09

3.7

4.5

238.63

240.78

u/l

0.23

1380

6716

Paralytic ileus and intestinal obstruction

2116

11671

1.97

157.78

3.7

4.1

231.58

251.99

u/l

9.22

1993

10983

Other reaction to severe stress, and adjustment disorders

2373

13449

1.87

157.47

5.0

4.2

237.82

237.21

u/l

0.07

2255

12812

Fentanyl

959

3925

2.78

157.33

5.0

3.8

251.98

247.24

u/l

0.30

903

3677

Other necrotizing vasculopathies (FG)

644

2178

3.66

157.25

3.1

4.5

246.46

244.42

u/l

0.12

610

2057

Hydronephrosis

1018

4307

2.70

156.61

4.5

4.2

248.55

242.09

u/l

0.55

987

4035

Oesophageal varices

516

1551

4.46

156.38

4.0

4.1

243.42

244.84

u/l

0.07

500

1463

Soft tissue disorders

7425

27406

1.44

155.42

3.9

4.3

236.24

244.42

u/l

3.73

6987

25955

Suppurative and necrotic conditions of lower respiratory tract

640

2197

3.70

154.26

3.4

4.1

225.39

246.91

u/l

3.24

619

2076

Mycoses

2098

11651

1.96

153.76

5.5

4.2

250.23

241.23

u/l

1.35

1989

10986

Injuries to the head

8003

36012

1.41

153.68

3.8

4.3

237.90

243.52

u/l

2.85

7514

34119

Biguanides

6896

30027

1.45

153.67

3.4

4.4

234.08

245.83

u/l

8.43

6434

28451

Chronic lower respiratory diseases

8650

34010

1.40

152.86

3.7

4.3

237.38

243.80

u/l

3.51

8182

32185

Intestinal stricture

2543

14980

1.84

152.82

3.9

4.2

233.36

247.85

u/l

5.83

2409

14072

Cellulitis

1754

9225

2.08

152.26

4.7

4.4

243.72

241.01

u/l

0.32

1664

8732

Protozoal diseases

407

1069

5.48

152.08

10.6

4.3

261.86

251.66

u/l

0.51

396

1017

Cutaneous abscess, furuncle and carbuncle

1949

10584

1.99

151.97

4.8

4.3

236.98

240.89

u/l

0.58

1861

10036

Localized swelling, mass and lump of skin and subcutaneous tissue

2409

13964

1.86

151.51

5.3

4.1

234.77

245.49

u/l

3.03

2289

13170

Other and unspecified aplastic anaemias

219

341

12.21

151.28

11.5

3.8

251.74

242.65

u/l

0.42

209

320

Other noninfective gastroenteritis and colitis

1903

10272

2.01

151.28

4.7

4.3

237.16

244.56

u/l

1.46

1797

9663

Weight loss

959

4055

2.77

150.25

3.1

4.2

229.91

249.17

u/l

3.05

899

3809

Immunodeficiency with predominantly antibody defects

340

775

6.13

150.24

9.2

4.2

236.46

256.47

u/l

0.95

335

739

Malignant neoplasm of other connective and soft tissue, including Hilmo

443

1217

4.63

149.84

6.0

2.7

282.14

234.60

u/l

1.66

432

1136

Other dorsopathies, not elsewhere classified

7238

27247

1.44

149.21

3.7

4.3

237.18

243.34

u/l

1.99

6778

25883

Acute upper respiratory infections

7560

33950

1.42

149.17

5.0

3.9

235.67

244.23

u/l

5.89

7151

32065

Intracranial trauma

3996

18185

1.61

148.71

3.7

4.6

236.02

243.97

u/l

2.86

3745

17354

Other specific joint derangements/joint disorders

5012

21971

1.53

147.73

3.7

4.4

235.35

242.68

u/l

2.11

4706

20899

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

374

932

5.54

147.73

6.0

4.6

238.48

244.69

u/l

0.38

361

885

Malignant neoplasm of colon, including Hilmo

1383

6749

2.25

147.44

3.3

2.6

245.09

241.63

u/l

0.35

1312

6216

Other coagulation defects

689

2484

3.27

147.38

4.5

3.8

235.62

243.42

u/l

0.63

666

2344

Immunodeficiencies

510

1562

4.11

146.83

7.9

4.2

234.87

251.01

u/l

1.29

500

1480

Nephrotic syndrome

397

1046

5.19

145.54

4.3

4.5

243.65

258.42

u/l

0.66

386

993

Myocardial infarction, without ST-elevation

3433

20074

1.67

145.42

3.5

4.1

250.47

247.76

u/l

0.43

3220

18864

SLE (Finngen)

373

923

5.15

145.17

3.6

4.5

244.60

258.72

u/l

0.55

360

875

Peripheral arterial reconstruction

1625

8572

2.14

144.58

3.3

4.0

250.85

248.10

u/l

0.27

1508

8041

Angina pectoris

4222

18634

1.59

144.26

3.9

4.5

251.48

240.82

u/l

2.68

3990

17547

Obesity

4254

27480

1.56

143.76

3.5

4.4

235.86

239.90

u/l

1.06

4009

26113

Myocardial infarction, strict

3555

16210

1.66

143.73

4.2

4.5

251.34

240.92

u/l

2.74

3363

15251

Obesity and other hyperalimentation

4272

27592

1.56

143.44

3.5

4.4

236.05

239.90

u/l

0.98

4025

26224

Other skin changes

1562

8107

2.14

143.18

5.8

4.0

239.86

246.35

u/l

1.07

1480

7629

Abnormal weight loss

894

3752

2.82

142.98

2.9

4.2

230.01

249.98

u/l

2.91

835

3525

Acute sinusitis

3420

20193

1.64

142.60

5.2

4.1

231.97

240.72

u/l

3.37

3233

19144

Other respiratory diseases principally affecting the interstitium

1626

8644

2.11

140.22

4.6

4.0

266.69

248.08

u/l

4.20

1544

8105

Peripheral artery operations in Hilmo

1206

5773

2.37

138.96

3.4

4.0

250.42

246.53

u/l

0.32

1132

5391

Obesity due to excess calories

3185

20204

1.66

138.92

3.4

4.4

235.95

239.49

u/l

0.72

3009

19190

COPD

3688

19794

1.62

137.87

3.3

4.4

239.09

248.32

u/l

3.64

3460

18650

Abnormal findings on diagnostic imaging of other body structures

1125

5242

2.41

137.59

4.1

240.14

246.55

u/l

0.62

1079

4948

Other viral diseases

1962

10960

1.90

136.38

6.6

4.3

247.29

238.83

u/l

1.66

1901

10399

Pyothorax

515

1681

3.99

136.31

3.2

4.1

219.91

242.53

u/l

5.00

498

1584

Hepatomegaly and splenomegaly, not elsewhere classified

189

280

12.72

136.17

8.0

4.6

251.11

259.27

u/l

0.17

184

271

Type 1 diabetes, wide definition

1593

8370

2.05

136.04

3.3

4.5

237.62

243.17

u/l

1.04

1523

7927

Diagnoses used for exclusion with ILD

2076

11931

1.89

135.98

3.9

4.1

245.13

245.44

u/l

0.03

1952

11223

Other CVD

1746

9592

2.02

135.07

3.4

3.9

247.60

250.49

u/l

0.32

1616

8954

Substance abuse, excluding more controls

4054

23144

1.56

134.78

2.9

4.6

231.90

244.44

u/l

4.88

3780

22077

Disorders of parathyroid gland

1672

8924

2.03

134.43

3.8

3.9

237.56

248.01

u/l

2.44

1567

8335

Cardiomyopathy, other and unspecified

689

2610

3.07

133.68

7.6

4.4

264.09

238.35

u/l

2.83

656

2451

Other symptoms and signs involving the digestive system and abdomen

1253

6108

2.24

133.63

4.6

4.1

233.34

247.17

u/l

3.23

1169

5749

Diabetic retinopathy, excluding more controls

2070

6530

1.95

131.94

3.4

3.9

236.74

238.20

u/l

0.23

1967

6126

Amputation of toe

758

3090

2.98

130.88

3.4

4.1

254.60

246.46

u/l

0.74

723

2904

Other and unspecified coagulation defects

474

1479

3.88

130.61

4.4

4.0

233.31

245.04

u/l

0.72

461

1403

Other diseases of intestine

1201

5858

2.29

130.44

3.9

4.4

233.05

249.10

u/l

4.02

1142

5556

Viral hepatitis, IBD co-morbidity

415

1171

4.00

129.21

3.5

5.1

237.13

246.47

u/l

0.47

390

1122

Other and unspecified acquired haemolytic anaemias

194

320

12.61

128.91

15.4

3.4

429.08

236.88

u/l

8.84

181

304

Colorectal cancer

1595

8370

2.01

128.45

3.1

2.6

248.52

241.15

u/l

0.86

1520

7711

Leukaemia of unspecified cell type

191

313

12.64

127.61

16.2

4.1

402.74

240.70

u/l

2.82

185

297

Hepatic failure, not elsewhere classified

437

1346

4.23

126.53

3.6

4.4

295.71

246.42

u/l

2.17

414

1272

Other or unspecified ileus, impaction or obstruction

1518

8099

2.05

126.45

3.7

4.2

230.23

253.86

u/l

9.07

1431

7628

Hypothyroidism, strict autoimmune

4958

22779

1.48

126.07

4.2

4.1

243.82

241.59

u/l

0.42

4677

21457

Candidiasis

2040

11880

1.84

125.71

4.5

4.1

237.17

239.93

u/l

0.45

1910

11219

Sulfasalazine

1925

10997

1.86

125.45

3.0

4.1

238.43

239.87

u/l

0.21

1823

10363

Rheumatoid arthritis, including avohilmo

2781

17574

1.68

125.17

3.0

4.2

246.49

244.47

u/l

0.32

2631

16520

Seropositive rheumatoid arthritis

1859

10533

1.89

124.57

2.8

4.3

250.55

246.07

u/l

0.62

1761

9913

Undetermined asthma, excluding more controls

846

3600

2.55

124.13

3.8

233.05

237.16

u/l

0.35

794

3364

Episodal and paroxysmal disorders

7765

29580

1.37

124.06

3.9

4.3

236.96

244.91

u/l

3.82

7303

28031

Hypercalcemia

488

1630

3.86

124.05

5.4

4.0

260.54

252.00

u/l

0.42

463

1531

Haemorrhage, not elsewhere classified

418

1256

4.16

123.71

4.9

3.4

283.37

242.51

u/l

3.84

394

1179

Osteonecrosis

603

2243

3.25

123.67

6.7

4.4

242.44

246.69

u/l

0.22

579

2132

Sequelae of external causes of morbidity and mortality

1989

11609

1.85

123.28

4.5

4.2

240.46

243.33

u/l

0.41

1891

10911

Pericarditis

374

1042

4.47

123.28

3.6

4.0

242.14

241.43

u/l

0.02

362

981

Other chronic obstructive pulmonary disease

3506

19233

1.60

123.09

3.2

4.3

238.20

248.49

u/l

4.43

3280

18115

Stroke, excluding SAH

4664

23859

1.50

122.63

4.1

4.2

248.30

246.56

u/l

0.32

4380

22486

Missing teeth due to accident, extraction or parodontitis

4389

28857

1.51

122.11

4.1

4.3

237.51

245.41

u/l

2.70

4041

27376

Other/unspecified dorsalgia

2663

16552

1.68

122.01

4.0

4.3

233.15

243.94

u/l

4.53

2499

15694

Cardiodefibrillation

2962

19185

1.66

121.84

4.7

4.2

262.18

245.30

u/l

5.46

2805

18112

Other viral diseases

2375

14343

1.73

121.64

6.1

4.2

245.58

236.84

u/l

2.13

2295

13634

Candidiasis

1075

5168

2.31

120.85

5.5

4.1

243.99

242.99

u/l

0.08

1009

4878

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

191

334

12.25

120.80

8.4

4.5

285.40

255.84

u/l

0.54

184

313

Stroke, including SAH

4831

24787

1.48

120.21

4.1

4.3

249.39

246.00

u/l

0.72

4535

23377

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

766

3213

2.72

120.11

5.1

4.1

243.75

247.19

u/l

0.21

734

3041

Malignant neoplasm of head and neck

657

2558

2.95

120.09

4.7

2.9

231.11

237.00

u/l

0.39

637

2365

Malignant neoplasm of colon

1073

5153

2.29

119.87

3.1

2.5

243.89

241.90

u/l

0.17

1020

4728

Dysphagia

1893

10970

1.86

119.43

3.6

4.1

237.70

248.41

u/l

2.12

1771

10293

Hypotension

1514

8282

2.03

119.18

3.4

3.9

241.50

248.89

u/l

1.11

1390

7725

Diseases of the musculoskeletal system and connective tissue

3626

11901

1.58

118.80

4.3

236.56

248.53

u/l

2.98

3412

11366

Systemic lupus erythematosus

373

1069

4.40

118.69

3.6

4.3

244.60

250.01

u/l

0.24

360

1020

Other neurological diseases

5338

30286

1.44

118.30

3.9

4.2

241.52

245.36

u/l

1.11

5021

28564

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1524

5066

2.00

117.64

3.2

3.5

214.69

222.21

u/l

1.44

1465

4802

ILD, hospital admissions

1343

7115

2.12

117.63

4.6

4.0

266.87

245.19

u/l

5.00

1277

6690

Diseases of the eye and adnexa

5307

18847

1.45

116.76

4.6

4.3

239.40

241.39

u/l

0.29

5033

17946

SLE, ICD10

363

1038

4.44

116.22

3.6

4.3

245.02

246.84

u/l

0.07

350

986

SLE, strict definition

363

1038

4.44

116.22

3.6

4.3

245.02

246.84

u/l

0.07

350

986

Follow-up examination after treatment for conditions other than malignant neoplasms

2845

11895

1.65

116.17

4.0

3.8

234.56

245.42

u/l

3.63

2691

11299

Diseases of oral cavity, salivary glands and jaws

4537

16156

1.50

116.04

4.2

3.8

242.40

252.27

u/l

2.95

4254

15233

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

961

4481

2.39

115.95

5.0

2.4

244.78

243.01

u/l

0.16

907

4085

Malignant neoplasm, without specification of site, including Hilmo

445

1433

3.70

115.91

5.5

2.5

312.95

237.89

u/l

4.07

424

1315

Other interstitial pulmonary diseases

1357

7256

2.10

115.45

4.6

4.0

266.88

245.02

u/l

5.17

1289

6826

Alcoholic liver disease

911

4216

2.49

115.41

2.4

4.7

253.38

240.93

u/l

0.76

846

4000

All influenza (not pneumonia)

1065

5159

2.25

115.25

5.2

3.9

244.63

238.47

u/l

0.59

1014

4851

Interstitial lung disease

1357

7264

2.10

115.07

4.6

4.0

266.88

244.92

u/l

5.21

1289

6832

Interstitial lung disease endpoints

1357

7264

2.10

115.07

4.6

4.0

266.88

244.92

u/l

5.21

1289

6832

Other obstetric conditions, not elsewhere classified

1545

5216

1.97

114.50

3.3

3.5

215.13

222.50

u/l

1.42

1484

4948

Alcohol use disorder, Swedish definition

3978

25243

1.51

113.96

2.9

4.5

235.01

243.93

u/l

2.44

3721

23949

Other diseases of anus and rectum

2221

13570

1.74

113.32

4.3

4.1

238.40

250.28

u/l

3.14

2063

12786

Cystic kidney disease

361

1054

4.44

113.00

2.9

4.3

224.42

253.43

u/l

1.80

356

994

Diabetic maculopathy, excluding more controls

909

4209

2.42

112.86

3.2

4.5

238.09

245.04

u/l

0.90

870

3986

Cholelithiasis, broad definition with cholecystitis

6099

30342

1.40

112.68

4.1

239.81

243.25

u/l

0.91

5750

28619

Obesity related asthma

2409

15085

1.69

112.25

3.3

4.4

237.83

243.99

u/l

1.58

2281

14276

Concussion

3318

18007

1.56

111.90

3.5

4.5

235.31

244.22

u/l

3.13

3094

17181

Arthropathies

6138

22800

1.40

111.50

3.8

4.4

232.58

243.41

u/l

5.87

5787

21644

Visual disturbances and blindness

3674

25213

1.53

111.44

4.1

240.84

244.47

u/l

0.60

3437

23794

Other chronic obstructive pulmonary disease, including avohilmo

4149

24048

1.50

111.10

3.2

4.3

236.86

247.51

u/l

5.79

3862

22712

Chronic nephritic syndrome

423

1379

3.87

110.83

3.6

4.2

236.76

248.09

u/l

0.81

413

1304

Sarcoidosis

1051

5201

2.25

109.89

4.5

4.4

241.15

244.00

u/l

0.22

999

4930

Ischaemic Stroke, excluding all haemorrhages

4369

22992

1.49

109.85

3.9

4.2

246.38

246.73

u/l

0.05

4098

21655

Nonischemic cardiomyopathy

858

3938

2.48

109.72

7.5

4.3

259.49

240.07

u/l

2.45

815

3709

Neurological diseases

5892

21618

1.41

109.59

4.0

4.5

237.03

244.20

u/l

1.95

5554

20614

Cystitis

5905

25833

1.40

109.37

3.8

4.1

234.33

243.36

u/l

4.14

5549

24450

Acute peritonitis

618

2474

2.96

109.25

4.1

4.0

244.92

244.17

u/l

0.04

604

2345

Chronic periodontitis, complicated

3912

27083

1.50

108.79

4.4

239.28

243.87

u/l

1.13

3703

25671

Cystic kidney disease

376

1154

4.15

108.68

2.9

4.3

223.82

254.15

u/l

2.11

370

1090

Non-small cell lung cancer, adenocarcinoma, helper endpoint

654

2720

2.92

108.64

4.3

4.1

255.97

246.72

u/l

0.66

640

2550

Malignant neoplasm of prostate

2002

7049

1.81

108.37

4.7

2.7

253.21

240.50

u/l

2.10

1906

6545

4317

26919

1.47

108.25

3.0

4.5

235.60

243.05

u/l

1.92

4043

25542

Chronic ulcer of skin, not elsewhere classified

666

2776

2.83

108.16

4.1

4.0

251.10

247.05

u/l

0.22

629

2607

Eosinophilic disease (BM)

198

375

7.42

107.72

4.0

3.9

254.46

257.64

u/l

0.04

191

353

Spinal stenosis

3825

20097

1.52

107.63

3.6

4.3

244.87

247.88

u/l

0.44

3570

19024

Other infectious diseases

807

3648

2.53

107.51

5.8

4.2

245.81

247.34

u/l

0.09

783

3429

4146

26420

1.48

106.90

3.0

4.5

236.03

243.41

u/l

1.80

3887

25057

Osteoporosis with pathological fracture (FG)

639

2618

2.85

106.84

3.9

4.0

255.20

250.93

u/l

0.30

591

2444

Nerve, nerve root and plexus disorders

7433

34837

1.34

106.32

3.7

4.3

239.47

243.03

u/l

1.00

6982

32957

Persons with potential health hazards related to communicable diseases

2250

13838

1.69

106.25

4.0

4.2

230.25

235.35

u/l

1.15

2169

13169

Injuries to the abdomen, lower back, lumbar spine and pelvis

2872

18742

1.60

106.09

3.8

4.1

238.82

244.31

u/l

1.42

2678

17615

Other complications of surgical and medical care, not elsewhere classified

774

3438

2.52

105.87

5.0

4.1

241.37

242.78

u/l

0.10

743

3250

Hyperparathyroidism

1429

7835

1.97

105.70

3.6

3.9

235.02

249.53

u/l

3.53

1347

7304

Congenital malformations, deformations and chromosomal abnormalities

3664

24063

1.50

105.65

3.7

4.3

238.70

239.70

u/l

0.16

3509

22806

Persons encountering health services for specific procedures, not carried out

642

2619

2.75

105.50

3.8

4.0

227.58

231.16

u/l

0.39

607

2467

Statin medication

4271

16769

1.48

104.99

4.3

4.7

242.29

241.93

u/l

0.04

4045

15870

Other external causes of accidental injury

5732

21029

1.41

104.87

3.9

4.5

237.16

246.91

u/l

4.11

5386

20028

Zoster [herpes zoster]

3560

24214

1.52

104.78

5.5

4.0

242.54

245.28

u/l

0.60

3387

22779

Mental and behavioural disorders due to psychoactive substance use

4186

27510

1.47

104.54

3.0

4.5

232.24

243.10

u/l

4.06

3906

26104

Malignant neoplasm of other connective and soft tissue

266

659

5.28

104.39

5.8

2.7

298.09

239.02

u/l

1.14

261

619

Need for other prophylactic measures

542

2076

3.10

104.36

4.7

4.4

246.01

253.28

u/l

0.38

531

1971

Any mental disorder

7773

29875

1.34

104.21

3.7

4.5

236.65

245.60

u/l

4.79

7260

28453

Sequelae with surgical and medical care as external cause

1576

9058

1.89

103.89

4.5

4.2

241.19

243.26

u/l

0.24

1499

8515

Undetermined asthma

846

3887

2.35

103.86

3.8

233.05

240.34

u/l

0.78

794

3641

Thoracic aortic aneurysm

1227

6577

2.09

103.79

3.6

4.6

253.15

243.22

u/l

1.53

1169

6228

Malignant neoplasm of prostate, including Hilmo

2028

7200

1.78

103.68

4.6

2.7

250.93

240.73

u/l

1.51

1932

6684

Other infectious diseases

703

3051

2.66

103.48

6.1

4.0

248.27

247.24

u/l

0.05

679

2872

Falls/tendency to fall

7421

28356

1.34

103.36

3.8

4.4

236.66

244.57

u/l

4.54

6997

26954

Dorsopathies

7092

27355

1.35

103.01

3.9

4.3

234.26

243.57

u/l

4.89

6658

25989

Disorders of eyelid, lacrimal system and orbit

5956

33884

1.38

102.80

4.3

4.1

238.64

243.69

u/l

1.69

5619

31997

Dental operations

4680

17130

1.45

102.54

4.2

3.9

241.27

250.79

u/l

3.68

4412

16123

Accidents

5713

21029

1.40

102.38

4.0

4.5

236.97

246.91

u/l

4.26

5367

20028

Mood disorders, excluding more controls

6437

28943

1.37

102.09

3.7

4.5

232.00

244.72

u/l

9.56

6011

27580

Diseases of pulp and periapical tissues, including avohilmo

7483

29724

1.34

101.82

4.1

237.18

244.65

u/l

3.92

7070

28075

Noninfectious colitis NAS

1035

5218

2.18

101.75

4.8

4.3

235.88

244.70

u/l

1.05

982

4931

Osteomyelitis

612

2525

2.86

101.52

3.4

4.2

248.33

246.78

u/l

0.08

582

2396

Phlebitis and thrombophlebitis (not including DVT)

1652

9652

1.84

101.48

5.0

4.2

244.49

243.29

u/l

0.11

1564

9100

Acute posthaemorrhagic anaemia

357

1099

4.00

101.40

4.0

3.8

258.60

247.56

u/l

0.44

326

1028

Anxiety disorders, excluding more controls

5445

26097

1.40

101.33

4.0

4.5

232.34

244.04

u/l

7.40

5103

24897

Substance abuse

4054

27038

1.47

101.08

2.9

4.5

231.90

243.20

u/l

4.22

3780

25661

COPD, hospital admission 2, with asthma infections

2590

14492

1.64

100.72

3.3

4.1

238.08

248.85

u/l

3.50

2415

13611

ILD, hospital admissions 1, main diag only

1183

6330

2.10

100.70

4.7

4.1

267.65

245.94

u/l

4.24

1124

5960

Urticaria and erythema

2331

14825

1.65

100.52

4.9

4.2

243.49

240.93

u/l

0.29

2202

14024

External causes of morbidity and mortality

4527

16070

1.45

100.42

4.2

4.3

236.91

245.75

u/l

3.17

4264

15313

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

838

3957

2.41

100.32

10.4

4.3

251.30

244.38

u/l

0.64

789

3738

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

538

2086

2.98

99.73

3.8

2.7

258.76

236.74

u/l

1.25

520

1926

Other and unspecified drugs and medicaments

712

3148

2.58

99.61

4.9

4.2

243.59

249.49

u/l

0.38

682

2966

Myalgia

1579

9118

1.84

99.45

3.5

4.4

230.80

241.43

u/l

2.44

1463

8643

Left ventricular outflow tract obstruction, narrow definition

448

1593

3.35

99.02

3.7

4.8

289.00

255.36

u/l

2.52

432

1514

Cholelithiasis

5795

29913

1.38

98.77

4.1

240.49

243.34

u/l

0.66

5458

28199

Fitting and adjustment of other devices

2539

14909

1.62

98.77

4.0

3.8

239.03

241.68

u/l

0.44

2357

13872

Congenital malformations, deformations and chromosomal abnormalities

4013

26256

1.46

98.23

3.7

4.3

239.05

239.88

u/l

0.14

3834

24888

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1640

9525

1.80

98.17

3.0

4.4

226.57

235.95

u/l

1.44

1517

9116

Other respiratory disorders and diseases

1649

9788

1.83

96.96

3.8

4.0

262.10

248.97

u/l

2.32

1552

9150

Other diseases of the respiratory system

1649

9788

1.83

96.96

3.8

4.0

262.10

248.97

u/l

2.32

1552

9150

IgA nephropathy (IgA glomerulonephritis)

280

767

4.86

96.81

4.3

4.5

236.78

237.16

u/l

0.02

272

727

Malignant neoplasm of eye, brain and central nervous system

361

1141

3.72

96.51

5.1

3.1

248.26

236.29

u/l

0.86

351

1069

Visual disturbances

3332

23103

1.51

96.04

4.2

237.79

244.06

u/l

1.56

3131

21803

Polymyalgia rheumatica

1129

6043

2.09

95.53

2.9

3.9

239.22

248.80

u/l

1.41

1033

5640

Misadventures to patients during surgical and medical care

1081

5676

2.09

94.95

4.5

4.1

256.23

242.81

u/l

1.35

1034

5367

Idiopathic gout

851

4175

2.34

93.69

3.5

4.1

241.02

242.96

u/l

0.15

797

3942

COPD, early/later onset

3543

21029

1.50

93.60

3.2

4.2

238.94

247.62

u/l

3.08

3313

19822

Other embolism and thrombosis

1019

5277

2.13

93.59

5.4

4.2

247.78

244.24

u/l

0.30

975

4974

COPD, hospital admissions

3510

20869

1.50

93.47

3.2

4.2

238.63

247.69

u/l

3.31

3282

19669

Hepatocellular carcinoma, including Hilmo

300

875

4.33

93.27

3.3

2.5

242.62

237.29

u/l

0.26

294

803

Systemic lupus erythematosus, unspecified

304

896

4.27

92.96

3.7

4.3

249.24

246.34

u/l

0.10

292

855

Aortic aneurysm

1897

11592

1.73

92.33

3.5

4.2

254.07

247.33

u/l

0.99

1797

10907

3176

20216

1.53

92.17

4.7

3.9

246.46

248.43

u/l

0.27

2987

18953

Mixed connective tissue disease

527

2107

2.89

92.14

3.3

4.3

241.33

248.36

u/l

0.48

498

1994

Non-allergic asthma (mode), excluding more controls

1118

5864

2.00

92.12

3.6

3.8

241.92

243.10

u/l

0.07

1057

5480

Sub-endpoint used in defining T1D endpoints

2033

12588

1.67

91.82

3.3

4.2

236.19

242.24

u/l

1.59

1945

11828

Benign neoplasm of other and ill-defined parts of digestive system

1364

7801

1.91

91.74

4.3

4.2

232.53

244.65

u/l

3.35

1280

7344

Other joint disorders

5755

22753

1.37

91.34

3.6

4.4

234.99

243.04

u/l

2.92

5401

21598

Secondary polycythaemia

270

750

4.72

91.17

2.9

4.0

235.54

249.96

u/l

0.54

250

707

Gingivitis and periodontal diseases

7206

28799

1.33

91.16

4.3

4.0

239.60

245.49

u/l

2.54

6789

27242

Charcot foot

215

506

5.77

90.96

3.4

4.8

235.00

234.26

u/l

0.03

204

477

In situ neoplasms

2723

18395

1.56

90.67

4.7

3.9

244.59

244.93

u/l

0.04

2593

17250

Congenital malformations of aortic and mitral valves

390

1355

3.47

90.28

3.7

4.7

285.91

247.63

u/l

4.33

376

1290

Skin changes due to chronic exposure to nonionizing radiation

3026

19298

1.54

90.05

4.8

3.8

247.08

249.10

u/l

0.26

2851

18083

Colorectal adenocarcinoma

1271

7091

1.92

90.04

3.0

2.6

247.58

241.73

u/l

0.59

1208

6542

Congenital malformations of the urinary system

492

1924

2.97

90.04

3.1

4.6

229.21

252.96

u/l

2.21

486

1828

Covid-19 suspected case

1354

7691

1.87

89.97

4.7

4.2

240.20

236.66

u/l

0.34

1311

7249

Budesonide

925

4665

2.14

89.60

4.3

4.1

225.33

235.65

u/l

2.04

882

4386

Actinic keratosis

2958

18881

1.54

89.59

4.8

3.8

247.55

249.28

u/l

0.21

2784

17688

Congenital malformations of the urinary system

515

2067

2.88

89.23

3.0

4.6

228.75

252.85

u/l

2.47

508

1964

COPD related to multimorbidity

3109

18234

1.52

89.07

3.1

4.2

240.51

248.93

u/l

2.52

2896

17157

Benign neoplasm: Colon, unspecified

1956

12407

1.70

88.76

3.6

4.2

242.61

245.40

u/l

0.16

1806

11684

Symptoms and signs involving the nervous and musculoskeletal systems

3991

28948

1.43

88.57

3.5

4.2

238.30

244.11

u/l

1.35

3768

27357

Malignant neoplasm of bladder, including Hilmo

875

4338

2.20

88.43

3.9

2.5

234.53

241.09

u/l

0.70

823

3982

Amyloidosis

268

761

4.71

88.39

5.6

4.6

241.83

242.06

u/l

0.01

261

720

Congenital malformations of heart and great arteries

909

4456

2.16

87.91

3.6

4.7

272.91

247.13

u/l

3.55

876

4235

Other inflammatory liver diseases

555

2327

2.75

87.80

4.0

4.4

253.03

243.39

u/l

0.67

525

2202

COPD, hospital admissions 3, with asthma pneumonia sepsis

2212

12299

1.64

87.43

3.3

4.1

238.97

248.32

u/l

2.35

2060

11519

malignant neoplasm of female genital organs

900

4510

2.14

87.27

4.2

2.6

247.75

241.68

u/l

0.71

862

4138

Disorders of the thyroid gland

6484

32632

1.33

87.10

4.4

4.1

241.30

241.45

u/l

0.03

6123

30820

Other (seronegative) rheumatoid arthritis, wide

1379

8016

1.86

86.86

3.1

4.2

246.87

244.48

u/l

0.30

1294

7525

Coronary artery bypass grafting

2103

10046

1.67

86.76

3.4

4.4

256.65

241.99

u/l

3.80

1987

9399

Diseases of the myoneural junction and muscle

974

5112

2.11

86.65

3.0

4.3

262.99

245.85

u/l

2.38

897

4812

Myocarditis

343

1110

3.48

86.51

5.5

4.6

269.16

237.08

u/l

2.87

330

1047

Fracture of lumbar spine and pelvis

1666

10182

1.76

86.50

4.1

3.9

244.12

246.43

u/l

0.29

1553

9502

Viral pneumonia (known virus, not influenza)

300

928

4.20

86.47

8.4

4.2

249.29

257.23

u/l

0.27

285

879

Coxarthrosis [arthrosis of hip](FG)

3792

19108

1.45

86.31

3.7

4.4

240.95

246.02

u/l

1.36

3546

18052

Diseases of pulp and periapical tissues and dental caries

4939

18730

1.39

85.88

4.1

4.0

240.68

250.35

u/l

4.12

4651

17626

Other disorders of lacrimal gland

2339

15468

1.59

85.75

4.6

4.1

239.28

245.70

u/l

1.00

2189

14567

Other specified/unspecified systemic involvement of connective tissue

473

1857

2.94

85.69

3.2

4.4

240.67

249.96

u/l

0.62

451

1756

Diseases of peritoneum

816

4043

2.25

85.51

4.0

4.1

244.59

246.13

u/l

0.10

790

3816

Functional dyspepsia

1744

10780

1.71

85.28

3.9

4.4

228.82

244.57

u/l

6.18

1638

10172

Amyloidosis, other/unspecified

234

626

5.22

84.88

6.0

4.5

245.66

241.05

u/l

0.30

229

593

Dental caries, including avohilmo

5458

21032

1.37

84.59

4.0

4.1

240.35

249.13

u/l

3.96

5147

19818

Neurotic, stress-related and somatoform disorders

5623

29999

1.35

83.82

4.0

4.3

231.58

242.28

u/l

6.80

5274

28504

Injuries to the thorax

3234

22887

1.48

83.46

4.0

4.2

237.06

244.69

u/l

3.08

3022

21610

Obesity, other/unspecified

2054

13236

1.62

83.44

3.5

4.3

230.45

237.72

u/l

1.71

1943

12575

Malignant neoplasm of breast, including Hilmo

2055

8409

1.64

83.10

3.9

2.7

262.08

236.49

u/l

5.53

1927

7778

Malignant neoplasm of breast, HER2-negative, including Hilmo

2054

8409

1.64

82.93

3.9

2.7

262.09

236.49

u/l

5.53

1926

7778

Gonarthrosis [arthrosis of knee](FG)

4986

21680

1.38

82.90

3.7

4.4

240.89

245.20

u/l

1.11

4661

20500

Colon adenocarcinoma

810

4025

2.21

82.82

2.9

2.5

242.35

241.04

u/l

0.09

767

3679

Congenital malformations of the circulatory system

985

5072

2.04

82.54

3.8

4.7

270.95

246.37

u/l

3.68

942

4823

Malignant neoplasm of small intestine, including Hilmo

287

879

4.03

82.36

5.7

2.8

227.18

239.48

u/l

1.28

273

819

Other intervertebral disc disorders

5557

25460

1.35

82.30

3.7

4.3

237.13

244.75

u/l

2.76

5208

24172

Disorders of lacrimal system

2834

19578

1.51

82.18

4.5

4.1

239.47

245.14

u/l

1.03

2659

18423

Respiratory insufficiency

614

2738

2.48

82.18

3.2

3.7

262.41

250.85

u/l

0.80

569

2553

Asthma, hospital admissions , main diagnosis only

5430

36644

1.34

82.16

3.5

4.2

237.38

243.37

u/l

2.55

5130

34659

Problems related to lifestyle

715

3389

2.30

82.05

2.9

4.6

231.57

237.67

u/l

0.51

670

3203

Anxiety disorders

5683

30342

1.34

81.81

4.0

4.3

231.56

242.33

u/l

6.98

5332

28819

Irritable bowel syndrome

1697

10531

1.69

81.03

3.4

4.2

227.51

243.74

u/l

5.02

1576

9981

Sleep apnoea

6327

31871

1.32

80.97

3.7

4.4

236.63

244.95

u/l

5.07

5942

30229

Depression

6211

32675

1.32

80.76

3.7

4.4

231.43

242.97

u/l

8.03

5816

31042

Acute pancreatitis

1438

8637

1.79

80.12

4.2

4.3

248.16

245.95

u/l

0.13

1348

8122

Open wound of head

3800

26774

1.42

80.07

3.7

4.3

239.51

246.94

u/l

2.53

3556

25318

Substance use, excluding alcohol

1257

7246

1.84

79.80

2.9

4.7

226.17

237.37

u/l

2.21

1149

6915

Malignant neoplasm of small intestine

228

616

4.79

79.73

5.9

2.7

227.58

241.27

u/l

1.29

215

580

Seropositive rheumatoid arthritis, wide

1857

11893

1.66

79.46

2.8

4.2

250.57

244.71

u/l

1.01

1760

11158

Caries of dentine, including avohilmo

5730

22402

1.34

79.44

4.1

239.34

248.53

u/l

4.62

5395

21149

DVT of lower extremities

1401

8400

1.79

78.76

4.6

4.1

245.05

244.40

u/l

0.06

1315

7897

Drug-induced osteoporosis with pathological fracture

213

565

5.40

78.76

4.7

4.0

256.55

252.18

u/l

0.10

198

529

Sciatica+with lumbago

3322

21872

1.45

78.50

3.7

4.4

239.87

243.72

u/l

0.53

3142

20787

Chronic pancreatitis

966

5223

2.04

78.48

3.2

4.5

232.13

241.97

u/l

1.07

925

4937

Mycoses

5626

37847

1.33

78.40

4.3

4.2

242.07

241.40

u/l

0.10

5276

35884

Malignant neoplasm of breast

2000

8316

1.63

78.17

3.9

2.7

262.85

236.74

u/l

5.48

1875

7694

Methotrexate

939

4993

2.02

78.12

2.7

4.1

244.94

241.22

u/l

0.45

885

4682

Unspecified acute lower respiratory infection

1073

5971

1.94

77.95

5.9

4.3

245.94

243.28

u/l

0.22

1032

5635

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1800

11513

1.66

77.50

2.8

4.2

250.96

244.75

u/l

1.06

1706

10801

L02BX Other hormone antagonists and related agents

575

2649

2.67

77.50

6.7

4.1

277.13

239.90

u/l

4.00

555

2508

Unspecified fall

3446

24595

1.43

77.16

3.5

4.2

239.04

245.89

u/l

2.26

3208

23209

Fracture of rib(s), sternum and thoracic spine

2188

14628

1.58

77.05

4.0

4.2

236.31

245.77

u/l

3.19

2028

13768

Malignant neoplasm, without specification of site

290

926

3.73

76.91

5.5

2.4

331.79

237.47

u/l

3.12

274

845

Other diseases of hard tissues of teeth

4199

15959

1.41

76.84

4.1

3.8

237.43

252.34

u/l

6.45

3942

15066

Collagenous colitis

700

3416

2.29

76.34

4.6

4.2

230.94

249.63

u/l

2.89

660

3237

Other metabolic disorders

831

4271

2.09

76.22

8.3

4.2

235.32

239.75

u/l

0.40

794

4051

Decubitus ulcer and pressure area

556

2497

2.57

76.07

4.2

3.8

239.19

248.22

u/l

0.74

518

2337

Diabetic retinopathy

2612

11205

1.55

76.06

3.3

3.7

239.28

238.85

u/l

0.06

2468

10533

Arthropathies in other diseases classified elsewhere

339

1199

3.38

75.97

3.2

4.6

231.67

248.11

u/l

1.45

321

1143

Bicuspidal aortic valve syndrome

338

1195

3.40

75.97

3.4

4.7

281.52

246.71

u/l

3.42

325

1140

Squamous cell neoplasms and carcinomas of the skin

632

2968

2.38

75.70

4.9

2.3

248.33

242.57

u/l

0.45

596

2703

Other/unspecified seropositive rheumatoid arthritis

1822

11756

1.64

75.46

2.8

4.2

250.87

244.86

u/l

1.02

1726

11026

Polyarthrosis

1414

7940

1.76

75.41

3.4

4.5

237.74

249.85

u/l

3.03

1290

7479

Psychiatric diseases

6854

27047

1.30

75.15

3.8

4.5

237.07

246.63

u/l

4.68

6425

25758

Inflammatory bowel disease

2009

13207

1.59

75.10

3.6

4.5

226.76

240.25

u/l

5.52

1907

12494

Mood disorders

6743

34510

1.29

75.00

3.6

4.3

231.00

243.35

u/l

10.16

6305

32759

Colectomy operation

1289

7690

1.82

74.77

3.7

4.1

228.98

245.71

u/l

4.84

1226

7227

Mood [affective] disorders

6724

34471

1.29

74.77

3.6

4.3

231.01

243.31

u/l

10.06

6290

32721

Injury, poisoning and certain other consequences of external causes

3596

12924

1.43

74.58

4.1

4.2

238.42

247.18

u/l

2.17

3398

12302

Malignant neoplasm of bone and articular cartilage

131

241

8.10

74.47

7.4

2.8

230.18

235.04

u/l

0.23

131

226

Elevated blood glucose level

647

3094

2.34

74.37

3.8

4.2

243.44

245.48

u/l

0.11

608

2928

Disorder of lipoprotein metabolism, unspecified

1019

5688

1.96

74.34

3.3

4.3

249.31

247.56

u/l

0.12

954

5357

Drug-induced cataract

254

777

4.21

74.28

6.5

4.5

242.25

249.61

u/l

0.26

244

738

Hypothyroidism, other/unspecified

5929

30438

1.31

73.94

4.3

4.0

241.89

241.44

u/l

0.08

5591

28746

Adrenocortical insufficiency

325

1140

3.41

73.90

4.7

4.6

262.26

254.26

u/l

0.15

309

1080

Eosinophilia

199

522

5.23

73.75

4.7

4.2

255.09

244.12

u/l

0.26

192

496

Abnormal results of function studies

646

3094

2.31

73.47

4.1

4.2

240.09

247.06

u/l

0.53

597

2930

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

393

1519

2.98

73.42

3.8

2.5

265.01

236.72

u/l

1.25

380

1394

Exclusions for E4_PCOS_BROAD

1126

6458

1.86

73.27

4.1

4.5

245.15

243.51

u/l

0.09

1068

6130

Asthma, including avohilmo

7968

36100

1.27

72.89

3.5

4.3

235.30

244.03

u/l

6.38

7521

34147

Spondylosis

3663

21965

1.41

72.59

3.6

4.4

237.66

246.03

u/l

3.30

3439

20851

Coxarthrosis

3470

16617

1.43

72.58

3.8

4.5

242.02

247.45

u/l

1.33

3244

15714

Secondary right heart disease

402

1604

3.01

72.26

5.7

3.8

287.62

247.55

u/l

2.81

390

1502

Other disorders of adrenal gland

377

1443

3.04

72.14

4.6

4.5

259.90

254.40

u/l

0.12

360

1367

Depression or dysthymia

4704

19631

1.36

71.97

3.8

4.8

234.01

249.04

u/l

8.04

4400

18762

Malignant neoplasm of breast, HER2-negative

1952

8255

1.60

71.92

3.9

2.7

263.37

236.97

u/l

5.55

1829

7636

Viral and other specified intestinal infections

1600

9683

1.66

71.88

4.4

4.0

231.14

237.38

u/l

1.22

1519

9177

Amiodarone users

852

4584

2.09

71.86

7.1

4.2

266.25

243.55

u/l

3.40

816

4321

COPD-related respiratory insufficiency

980

5489

1.98

71.85

3.0

4.1

243.60

248.14

u/l

0.56

917

5152

Malignant neoplasm of ovary, including Hilmo

412

1639

2.81

71.41

4.8

2.9

253.69

237.78

u/l

1.44

396

1516

Hypothyreosis and Thyroxine purchase for inclusion criteria

6123

31620

1.30

71.38

4.3

4.0

241.38

241.40

u/l

0.00

5773

29855

Anosmia

125

207

6.53

71.06

4.0

2.4

234.42

222.33

u/l

0.67

120

195

Vitreous haemorrhage

796

4178

2.11

71.06

4.0

4.3

251.59

244.56

u/l

0.53

761

3948

Malignant neoplasm of liver and intrahepatic bile ducts

265

845

3.80

71.00

3.6

2.5

245.44

237.24

u/l

0.63

258

777

Nonalcoholic fatty liver disease

685

3399

2.22

70.75

3.3

4.5

227.03

242.13

u/l

3.01

650

3229

Non-allergic asthma (mode)

1118

6370

1.83

70.61

3.6

3.9

241.92

245.90

u/l

0.31

1057

5968

Sleep disorders (combined)

7685

32488

1.27

70.55

3.5

4.4

233.37

245.24

u/l

10.88

7221

30809

Malignant neoplasm of stomach, including Hilmo

450

1887

2.68

70.23

3.9

2.5

260.55

237.51

u/l

0.39

426

1741

Seronegative rheumatoid arthritis

808

4251

2.06

70.11

3.4

4.4

248.49

244.78

u/l

0.37

760

4026

Injuries to the hip and thigh

3370

22359

1.42

70.03

3.6

4.1

242.65

246.86

u/l

0.96

3112

21025

Other disorders of ear

6183

31990

1.30

70.02

4.1

4.3

241.09

243.96

u/l

0.82

5804

30282

Acute pancreatitis (for exclusion)

1438

8945

1.72

70.00

4.2

248.16

243.02

u/l

0.36

1348

8435

Other pulmonary heart/vessel disease

433

1816

2.82

69.87

5.6

3.9

283.50

247.18

u/l

2.71

419

1701

Insulin, fast-acting (human)

923

5056

1.95

69.76

3.3

4.3

239.45

239.43

u/l

0.00

881

4776

Sicca syndrome [Sjögren]

611

2927

2.32

69.60

3.1

4.2

236.07

247.52

u/l

1.25

583

2757

Crohn disease

853

4569

2.01

69.60

3.5

4.5

223.98

239.25

u/l

2.92

813

4335

Osteonecrosis due to drugs

193

526

5.37

69.38

10.7

4.2

254.35

241.26

u/l

0.35

183

498

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3015

21657

1.44

69.29

2.8

4.6

233.06

242.74

u/l

2.44

2820

20561

Gout due to impairment of renal function

164

401

6.45

68.99

3.7

4.1

247.80

242.15

u/l

0.27

156

379

Procreative management

1799

9730

1.60

68.57

5.1

4.4

236.16

241.25

u/l

0.74

1711

9258

Disturbances of skin sensation

1645

10551

1.63

68.55

3.7

4.1

227.71

238.20

u/l

2.63

1543

9988

Mental and behavioural disorders due to alcohol

3435

24343

1.40

68.54

2.9

4.5

234.03

243.50

u/l

2.57

3220

23113

Cardiac arrest

471

1708

2.59

68.52

4.5

4.6

274.79

237.39

u/l

5.29

442

1606

Cholangitis (primary sclerosing, PSC)

526

2404

2.49

68.46

3.4

4.1

245.52

246.30

u/l

0.03

504

2268

Vitamin B12 deficiency anaemia

793

4200

2.07

68.08

3.8

3.9

261.63

251.01

u/l

0.47

746

3939

Hypocalcemia

236

728

4.13

67.95

4.1

4.3

266.66

259.87

u/l

0.15

227

686

Arthrosis

4646

19391

1.35

67.92

3.7

4.5

237.45

245.40

u/l

3.27

4348

18355

Postprocedural endocrine and metabolic disorders, not elsewhere classified

753

3896

2.07

67.77

8.8

4.2

233.87

239.11

u/l

0.47

718

3699

Dilated cardiomyopathy

960

5449

1.95

67.48

9.3

4.3

261.88

242.33

u/l

2.73

911

5142

Alcohol use disorder, ICD-based

2785

19936

1.45

67.35

2.8

4.6

232.47

242.09

u/l

2.22

2603

18927

Allergic asthma (mode), excluding more controls

1122

6375

1.79

67.24

3.2

3.7

226.81

232.66

u/l

0.91

1069

6015

Chronic hepatitis, not elsewhere classified

300

1060

3.37

67.24

3.6

4.5

255.76

246.67

u/l

0.23

293

1012

Other and unspecified myopathies

703

3611

2.18

67.15

2.9

4.1

266.38

246.35

u/l

2.41

644

3392

Spondylopathies in diseases classified elsewhere

168

423

5.79

66.83

9.3

4.5

243.88

248.31

u/l

0.17

163

405

Personality disorders, excluding more controls

1395

8631

1.68

66.67

3.0

4.5

224.31

236.16

u/l

2.95

1305

8264

Open wound of lower leg

1056

6131

1.85

66.52

3.4

4.4

244.23

244.49

u/l

0.02

991

5797

Herpesviral [herpes simplex] infections

794

4229

2.04

66.45

6.3

4.1

244.57

245.01

u/l

0.03

752

3990

Cholangitis (primary sclerosing, PSC), with reimbursement 202

189

507

4.73

66.40

3.2

5.0

225.30

234.28

u/l

0.60

183

488

Artificial opening status

458

2010

2.62

65.94

3.8

3.9

242.38

248.55

u/l

0.27

440

1893

Chronic tubulo-interstitial nephritis

310

1120

3.20

65.87

3.3

4.0

227.61

249.74

u/l

1.41

300

1045

Other diseases of arteries and capillaries

683

3486

2.17

65.75

3.6

4.1

243.63

244.82

u/l

0.06

651

3277

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1640

10596

1.61

65.65

3.0

4.3

226.57

233.94

u/l

1.03

1517

10092

Anxiety (asthma-related co-morbidities)

3418

19458

1.40

65.52

3.5

4.5

224.98

240.17

u/l

9.85

3200

18568

Viral and other specified intestinal infections

1213

7101

1.74

65.47

4.8

3.9

231.69

238.69

u/l

1.06

1151

6729

Intestinal adhesions without obstruction

642

3215

2.21

65.09

3.8

4.1

229.35

253.62

u/l

3.86

608

3051

Gonarthrosis

4247

18318

1.36

64.86

3.6

4.5

240.94

246.16

u/l

1.26

3971

17336

Disorders of skin appendages

2892

20896

1.43

64.80

4.7

4.2

234.83

239.42

u/l

1.01

2734

19806

Isolated proteinuria

274

946

3.54

64.74

5.2

4.1

224.80

247.75

u/l

1.61

264

893

Subjective visual disturbances

1642

10706

1.62

64.53

3.8

4.2

237.35

241.53

u/l

0.46

1544

10108

Transient ischemic attack

3735

22782

1.38

64.04

4.0

4.2

242.55

246.55

u/l

1.03

3518

21447

Urticaria

1745

11530

1.58

63.43

4.9

4.2

241.38

239.50

u/l

0.16

1651

10919

Poisoning by drugs, medicaments and biological substances

1368

8557

1.67

63.23

2.7

4.4

233.63

235.91

u/l

0.17

1271

8136

Mesothelioma

134

294

6.78

63.15

3.0

2.3

203.40

241.50

u/l

8.85

134

272

Non-small cell lung cancer, squamous

366

1466

2.82

63.11

4.4

2.3

223.63

239.89

u/l

2.32

356

1334

Intracranial injury

3884

27897

1.36

63.09

3.6

4.2

237.54

245.06

u/l

2.96

3614

26387

Mesothelioma, including Hilmo

160

402

5.48

62.85

3.0

2.5

208.49

243.54

u/l

8.28

160

372

Other symptoms and signs involving cognitive functions and awareness

3200

21560

1.40

62.63

3.4

4.2

242.42

246.83

u/l

0.71

2937

20349

Exclusions for E4_PCOS_CONSORTIUM

4088

19417

1.35

62.20

3.9

4.0

237.39

239.77

u/l

0.46

3830

18350

Sleep apnoea, including avohilmo

6510

32485

1.27

61.73

3.6

4.4

235.94

244.68

u/l

5.82

6104

30833

Abnormal findings on examination of urine, without diagnosis

380

1582

2.80

61.72

5.0

4.1

225.13

247.35

u/l

2.82

364

1497

Unstable angina pectoris

2603

14701

1.46

61.60

3.5

4.3

254.80

242.33

u/l

1.80

2442

13776

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

133

11.28

61.59

7.2

3.3

225.26

239.07

u/l

0.64

126

Other local infections of skin and subcutaneous tissue

738

3946

2.04

61.57

4.4

244.00

243.12

u/l

0.05

716

3724

Other disorders of glucose regulation and pancreatic internal secretion

623

3146

2.18

61.50

3.1

4.2

244.66

248.54

u/l

0.21

585

2974

Stomatitis and related lesions

1250

7734

1.71

61.46

5.3

4.3

250.09

242.09

u/l

0.66

1184

7301

Diabetes mellitus in pregnancy

1384

5465

1.67

61.35

3.2

3.8

222.24

227.70

u/l

0.76

1319

5196

Other and unspecified local infections of skin and subcutaneous tissue

702

3702

2.08

61.16

4.4

4.3

245.03

243.79

u/l

0.06

683

3494

Folate deficiency anaemia

133

299

6.60

60.95

4.4

4.5

274.80

242.82

u/l

0.70

127

283

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

276

972

3.23

60.92

3.4

4.6

242.31

239.74

u/l

0.11

265

927

Degeneration of macula and posterior pole

3470

20757

1.39

60.82

3.6

4.1

248.74

247.51

u/l

0.10

3232

19505

Poisoning by medicine

1234

7606

1.70

60.62

2.7

4.5

234.29

236.27

u/l

0.13

1149

7243

Need for immunization against other single viral diseases

202

607

4.23

60.51

5.1

4.1

227.65

242.91

u/l

0.92

197

574

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

394

1645

2.58

60.44

3.4

4.2

215.05

234.95

u/l

2.49

374

1565

Unspecified privation

772

4215

2.00

60.34

3.9

4.3

237.98

245.87

u/l

0.87

732

3992

Other abnormalities of plasma proteins

184

526

4.68

60.34

6.4

4.2

233.34

241.57

u/l

0.47

176

497

Other anxiety disorders

2527

15587

1.45

60.34

3.4

4.2

225.07

237.42

u/l

5.04

2374

14850

Invasive ventilation

568

2815

2.26

59.91

3.8

4.3

254.58

250.96

u/l

0.21

544

2668

Asthma/COPD (KELA code 203)

6156

33950

1.27

59.79

3.3

4.3

236.77

243.54

u/l

3.15

5808

32126

All anxiety disorders

3466

20504

1.37

59.65

3.5

4.3

224.84

239.78

u/l

9.71

3248

19545

Other viral diseases, not elsewhere classified

1121

6768

1.74

59.53

5.6

4.5

244.81

242.29

u/l

0.24

1080

6411

Sequelae of cerebrovascular disease

2626

16395

1.45

59.35

3.9

4.1

243.80

248.73

u/l

1.07

2436

15416

Abnormalities of gait and mobility

935

5459

1.88

59.30

2.7

4.2

239.72

247.12

u/l

0.72

875

5130

Complications of cardiac and vascular prosthetic devices, implants and grafts

226

742

3.88

59.13

6.0

3.9

260.16

251.72

u/l

0.26

220

697

Other and unspecified effects of external causes

1619

10693

1.58

59.08

3.6

4.4

228.19

238.96

u/l

2.96

1525

10130

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2069

14374

1.50

59.08

4.6

4.2

236.04

242.81

u/l

1.34

1958

13577

Complications of internal orthopaedic prosthetic devices, implants and grafts

1582

10464

1.60

59.03

3.4

3.9

243.78

247.58

u/l

0.52

1461

9808

Fibromyalgia

542

2625

2.22

58.63

2.4

4.2

211.13

242.75

u/l

9.32

505

2495

Disorders of sclera, cornea, iris and ciliary body

3460

26171

1.36

58.45

4.2

240.57

242.48

u/l

0.27

3294

24738

Shoulder lesions

4995

23799

1.30

58.09

3.8

4.4

237.25

245.61

u/l

3.25

4711

22519

Other/unspecified rheumatoid arthritis

885

5099

1.88

58.02

3.0

4.0

249.28

247.25

u/l

0.18

826

4779

Other viral diseases, not elsewhere classified

1492

9671

1.60

57.59

5.2

4.3

243.26

239.71

u/l

0.44

1435

9158

Other viral hepatitis

409

1792

2.51

57.31

3.5

4.6

238.81

235.19

u/l

0.18

387

1708

Hypothyroidism, strict autoimmune, 3 medication purchases required

5393

29013

1.29

57.25

4.1

4.0

244.14

241.45

u/l

0.60

5085

27378

Benign neoplasm: Stomach

729

3999

2.01

57.00

4.6

4.2

233.78

248.95

u/l

2.34

678

3762

Migraine

2714

15991

1.41

56.78

3.8

4.3

227.88

239.05

u/l

4.34

2568

15217

Ventral hernia

1623

10864

1.58

56.78

4.0

4.3

240.51

246.70

u/l

0.70

1531

10210

Pruritus

727

3959

1.98

56.74

4.2

4.0

246.18

244.70

u/l

0.11

681

3732

Superficial injury of head

1553

10278

1.59

56.72

3.1

4.3

237.28

245.99

u/l

1.77

1442

9660

Hernia of abdominal wall

3059

22887

1.39

56.47

3.9

4.3

241.09

243.86

u/l

0.40

2897

21636

Other general symptoms and signs

323

1261

2.79

56.47

3.0

3.6

262.27

246.66

u/l

0.36

315

1191

Malignant neoplasm of oropharynx, including Hilmo

188

562

4.12

56.11

5.7

2.7

235.23

236.92

u/l

0.06

182

529

Biological medication for rheuma

984

5861

1.77

55.55

2.6

4.6

223.42

239.20

u/l

4.66

938

5578

Epilepsy

2020

14082

1.49

55.53

4.2

4.4

246.42

248.25

u/l

0.13

1906

13309

Other diseases of stomach and duodenum

495

2394

2.31

55.50

3.2

4.3

223.73

254.26

u/l

6.25

470

2264

Exposure to other specified factors

4694

34096

1.29

55.02

4.0

4.3

234.95

242.51

u/l

3.00

4400

32367

Other diseases of biliary tract

661

3550

2.05

55.00

4.0

4.1

266.90

250.04

u/l

0.62

630

3326

Melanocytic naevi

1787

12239

1.52

54.98

5.7

4.1

234.73

238.80

u/l

0.48

1718

11549

5-aminosalicylic acid

1180

7380

1.67

54.49

3.7

4.3

225.62

234.91

u/l

2.28

1117

6978

Other or ill-defined heart diseases

369

1580

2.57

54.45

5.3

4.1

249.46

236.91

u/l

0.71

346

1484

Allergic asthma (mode)

1122

6750

1.68

54.41

3.2

3.8

226.81

234.74

u/l

1.50

1069

6375

Melanocytic naevi of trunk

795

4512

1.90

54.40

5.8

4.2

236.71

241.90

u/l

0.30

765

4270

Disorders of oesophagus in diseases classified elsewhere

219

742

3.71

54.20

5.0

4.4

252.00

253.87

u/l

0.05

208

701

Other symptoms and signs involving the circulatory and respiratory systems

466

2209

2.32

54.16

3.3

4.2

247.48

245.61

u/l

0.07

432

2086

Personal history of other diseases and conditions

604

3106

2.05

54.12

5.5

3.7

264.09

238.31

u/l

0.96

564

2936

Viral hepatitis

472

2247

2.30

54.07

3.6

4.5

237.74

239.98

u/l

0.11

446

2135

Benign neoplasm: Ascending colon

1024

6277

1.77

54.06

4.0

4.2

227.35

245.05

u/l

5.84

974

5920

Polyuria

1565

10533

1.57

53.75

3.6

4.3

231.94

247.15

u/l

4.26

1447

9957

Acidosis

213

713

3.73

53.65

3.0

4.7

258.11

246.29

u/l

0.24

199

679

Personal history of malignant neoplasm

445

2081

2.35

53.58

5.1

3.9

247.82

245.33

u/l

0.11

429

1976

Diabetic retinopathy, strict definition

1270

7240

1.67

53.41

3.4

3.9

239.09

237.07

u/l

0.29

1197

6805

Malignant neoplasm of bladder

490

2382

2.26

53.39

3.6

2.4

231.74

241.08

u/l

0.74

464

2177

Other disorders of veins

2467

17878

1.42

53.39

3.5

4.1

244.35

242.33

u/l

0.31

2303

16850

Spondyloarthritis

1128

7035

1.69

53.35

3.2

4.3

228.69

240.68

u/l

2.92

1060

6638

Pneumonia derived septicemia

302

1209

2.92

53.33

4.9

4.1

245.33

254.58

u/l

0.34

289

1134

Dermatitis due to substances taken internally

410

1867

2.45

53.26

5.9

4.0

252.63

246.77

u/l

0.31

384

1766

Conductive and sensorineural hearing loss

5344

28979

1.28

53.09

4.0

4.3

242.48

245.26

u/l

0.70

4987

27395

Injuries to the knee and lower leg

7800

36004

1.22

52.98

3.6

4.3

236.59

243.48

u/l

4.32

7358

34080

Pneumothorax

531

2683

2.19

52.84

4.1

242.25

242.44

u/l

0.01

508

2522

Delirium, not induced by alcohol and other psychoactive substances

939

5649

1.80

52.75

3.0

3.9

247.36

247.78

u/l

0.03

852

5298

Early onset COPD

1504

10080

1.58

52.66

3.6

4.6

240.04

245.14

u/l

0.56

1411

9554

Viral warts

631

3369

2.02

52.34

5.0

4.3

231.03

244.43

u/l

1.93

605

3182

Diseases of the ear and mastoid process

7533

31327

1.23

52.19

4.1

4.2

238.84

242.62

u/l

1.08

7076

29737

Papulosquamous disorders

2466

18080

1.42

51.76

3.6

4.3

237.78

244.13

u/l

1.37

2324

17089

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

159

450

4.41

51.68

3.6

2.9

273.54

234.54

u/l

1.16

154

421

Herpesviral [herpes simplex] infections

1392

9180

1.58

51.24

5.3

4.2

238.22

238.85

u/l

0.06

1334

8669

Pyogenic arthritis

498

2482

2.21

51.14

3.8

4.7

243.33

244.86

u/l

0.07

470

2358

Sensorineural hearing loss

5124

27987

1.28

50.59

3.8

4.3

243.06

245.42

u/l

0.54

4773

26455

Hypoglycaemia, other or unspecified

491

2444

2.21

50.56

3.3

4.1

243.90

248.32

u/l

0.21

461

2322

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1941

13717

1.47

50.54

3.8

4.3

240.86

243.01

u/l

0.26

1809

12948

Giant cell arteritis

368

1662

2.59

50.45

2.9

4.0

234.87

250.25

u/l

0.98

340

1560

Ulcerative colitis

1481

9944

1.56

50.29

3.6

4.4

227.82

238.86

u/l

3.10

1400

9420

Donors of organs and tissues

134

340

4.83

50.24

15.2

4.3

215.87

230.03

u/l

1.02

129

325

Adverse effects, not elsewhere classified

1153

7333

1.65

50.22

3.8

4.4

225.06

242.23

u/l

5.36

1091

6932

Paracetamol or NSAID medication

1062

3204

1.73

50.20

4.1

4.5

245.72

254.62

u/l

0.68

1005

3082

6-mercaptopurine

226

791

3.20

50.10

7.7

4.1

270.63

235.41

u/l

0.67

220

750

Soft tissue disorders related to use, overuse and pressure

1728

11984

1.51

50.05

3.7

4.5

244.94

246.25

u/l

0.08

1613

11345

Other headache syndromes

2440

17886

1.40

50.05

3.5

4.3

228.79

242.96

u/l

6.25

2283

16961

Acute generalized exanthematous pustulosis

345

1507

2.60

49.92

6.4

4.1

244.89

248.72

u/l

0.19

323

1425

Intestinal malabsorption

351

1546

2.57

49.67

3.2

4.3

216.76

249.98

u/l

4.44

337

1459

Malignant neoplasm of stomach

362

1608

2.50

49.63

3.6

2.5

267.15

236.61

u/l

0.42

341

1482

Other and unspecified disorders of skin and subcutaneous tissue

469

2322

2.24

49.40

4.8

4.0

236.70

249.12

u/l

0.85

430

2189

Wegener granulomatosis

163

489

4.27

49.19

3.4

4.4

256.81

245.71

u/l

0.32

155

464

Other diseases of pancreas

609

3312

2.03

48.98

4.0

4.3

236.36

245.77

u/l

0.85

574

3132

Drug-induced adrenocortical insufficiency

177

561

3.94

48.69

5.3

4.4

287.63

243.78

u/l

0.68

169

532

Disorders of continuity of bone

606

3273

1.99

48.49

4.4

236.61

243.49

u/l

0.70

567

3114

Myositis

236

878

3.20

48.47

3.7

4.6

269.45

243.81

u/l

2.19

230

840

Operations for atrial fibrillation

178

582

4.15

48.22

3.1

4.4

273.55

246.78

u/l

1.04

170

549

Fracture of femur

1929

12460

1.47

48.18

3.6

3.8

244.76

248.92

u/l

0.62

1769

11620

Duodenal ulcer

802

4735

1.83

48.18

3.2

4.3

239.21

249.95

u/l

0.87

754

4472

Chronic viral hepatitis

335

1453

2.54

48.13

3.3

4.5

233.78

231.95

u/l

0.08

314

1381

Other arthrosis

3320

17647

1.34

47.99

3.5

4.6

240.88

246.24

u/l

1.14

3109

16739

Vascular diseases of the intestine

338

1498

2.60

47.87

4.0

3.8

259.62

248.48

u/l

0.41

318

1408

Polycystic ovarian syndrome, consortium definition

3782

17406

1.32

47.80

3.6

3.9

235.21

239.72

u/l

1.16

3540

16420

Other diseases of lip and oral mucosa

2431

18029

1.40

47.33

4.7

4.3

235.29

243.62

u/l

2.05

2284

17050

Injuries to the shoulder and upper arm

5461

35973

1.25

47.15

3.9

4.3

236.66

244.67

u/l

4.73

5114

34052

Malignant neoplasm of breast, ER-negative, including Hilmo

1043

6238

1.66

47.11

4.3

2.7

251.50

239.57

u/l

1.83

969

5740

Malignant neoplasm of oral cavity, including Hilmo

307

1302

2.64

46.94

4.2

2.7

235.07

234.16

u/l

0.03

298

1219

Disorders of muscles

671

3783

1.90

46.81

3.9

4.6

246.34

241.32

u/l

0.44

642

3592

Amputation of foot

257

1030

3.06

46.67

2.9

4.1

245.46

248.94

u/l

0.19

242

970

Selective serotonin reuptake inhibitors

6587

28467

1.23

46.47

3.5

4.5

235.55

245.61

u/l

5.00

6145

27062

Vasculitis limited to skin, not elsewhere classified

232

875

3.15

46.46

4.1

242.60

253.82

u/l

0.43

223

821

Unspecified jaundice

398

1898

2.35

46.45

3.7

4.1

260.28

249.28

u/l

0.59

379

1792

L02BB Anti-androgens

790

4743

1.84

46.17

6.0

3.9

270.54

244.05

u/l

2.60

754

4433

Non-selective monoamine reuptake inhibitors

2362

16884

1.39

45.59

3.1

4.5

236.08

248.15

u/l

3.33

2182

15996

Pneumococcal septicemia

284

1191

2.77

45.56

4.9

4.0

242.32

256.85

u/l

0.63

271

1119

Generalized skin eruption due to drugs and medicaments

303

1306

2.64

45.29

6.5

4.2

246.78

249.52

u/l

0.11

283

1233

Disorders of magnesium metabolism

107

259

6.17

45.14

3.3

5.0

244.34

244.07

u/l

0.01

100

245

Other and unspecified vasculitis limited to skin

214

787

3.25

45.06

4.2

4.1

244.59

254.67

u/l

0.34

207

737

Status post-ami

1866

10162

1.47

44.94

4.4

4.3

249.00

242.47

u/l

1.27

1742

9507

Benign neoplasm: Sigmoid colon

1315

8883

1.57

44.86

4.0

4.3

233.25

246.51

u/l

2.23

1254

8367

Seropositive rheumatoid arthritis, strict definition

945

5918

1.70

44.77

2.8

4.3

251.41

243.90

u/l

0.78

894

5584

Benign neoplasm: Rectum, anus and anal canal

1393

9525

1.55

44.61

4.0

4.2

238.84

246.60

u/l

1.28

1308

8964

Follow-up examination after treatment for malignant neoplasms

674

3862

1.87

44.48

4.2

3.8

240.80

252.14

u/l

0.90

640

3628

Somatoform disorder

949

5940

1.68

44.33

3.5

4.3

228.69

241.73

u/l

2.19

864

5631

Portal vein thrombosis

164

528

3.91

44.23

5.2

4.5

277.98

255.42

u/l

0.43

159

499

Cholecystectomy

4510

31428

1.27

44.22

4.1

239.04

243.58

u/l

1.09

4266

29630

Other and unspecified urticaria

1123

7310

1.61

44.20

4.7

4.2

246.81

241.84

u/l

0.35

1063

6912

Malignant neoplasm of ovary

286

1204

2.63

44.12

5.2

3.1

257.99

235.50

u/l

1.77

275

1110

Seborrhoeic keratosis

1485

10301

1.52

43.81

4.9

4.0

237.94

248.33

u/l

1.55

1417

9681

Unknown and unspecified causes of morbidity

424

2092

2.18

43.79

4.9

3.5

241.45

238.46

u/l

0.21

410

1970

Mental and behavioural disorders due to opioids

243

949

2.84

43.78

2.5

4.6

230.87

233.31

u/l

0.08

228

903

Recurrent aphthous stomatitis , including avohilmo

886

5490

1.71

43.67

5.8

4.2

248.99

245.35

u/l

0.18

848

5183

Migraine with aura

1257

8376

1.55

43.57

3.6

4.2

230.64

238.19

u/l

1.13

1197

7958

Acquired absence of limb

117

306

5.16

43.54

3.1

4.0

244.01

241.02

u/l

0.07

105

284

Cerebral palsy and other paralytic syndromes

723

4257

1.82

43.43

4.1

4.2

264.60

245.62

u/l

0.65

678

4008

Lupus nephritis

11.32

43.31

3.3

4.0

228.53

236.57

u/l

0.24

Malignant neoplasm of breast, ER-positive, including Hilmo

1439

7551

1.52

43.16

3.4

2.6

264.89

238.31

u/l

3.53

1352

6987

Ulcerative colitis, NAS

841

5150

1.73

43.14

3.9

4.5

224.26

239.73

u/l

3.53

795

4887

Recurrent or chronic depression

2251

11645

1.39

42.89

3.5

5.0

227.62

245.53

u/l

7.02

2113

11185

Carcinoma in situ of skin of other and unspecified parts of face

676

3969

1.88

42.81

5.1

3.8

266.33

248.33

u/l

1.28

644

3694

Diseases of male genital organs

3487

13709

1.32

42.72

4.2

4.8

237.08

248.52

u/l

3.56

3323

13062

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

540

2950

2.00

42.54

4.5

4.2

252.13

248.02

u/l

0.16

514

2786

Heart failure and hypertrophic cardiomyopathy

187

670

3.52

42.35

10.9

4.1

268.08

244.94

u/l

1.30

176

628

Other symptoms and signs involving the nervous and musculoskeletal systems

2537

19241

1.36

42.27

3.7

4.3

238.89

243.70

u/l

0.66

2405

18161

Other problems related to primary support group, including family circumstances

594

3218

1.89

42.17

5.8

4.3

257.43

241.25

u/l

0.71

572

3063

Other specified/unspecified bacterial intestinal infections

469

2457

2.10

42.10

4.3

4.4

238.51

251.09

u/l

0.74

434

2332

Crohn's disease of small intestine

441

2250

2.13

42.06

3.6

4.4

217.43

241.84

u/l

2.97

425

2146

Benign neoplasm: Rectum

1247

8449

1.57

42.03

4.1

4.2

236.95

246.30

u/l

1.62

1169

7968

Respiratory conditions due to other external agents

199

737

3.31

41.91

5.0

3.9

247.55

252.00

u/l

0.13

192

693

Other disorders of bone

1120

7372

1.59

41.88

4.5

4.4

232.79

239.83

u/l

1.22

1064

6995

Psoriasis

1712

12246

1.45

41.84

3.5

4.4

239.58

243.02

u/l

0.40

1616

11568

Benign neoplasm: Caecum

777

4750

1.78

41.79

3.8

4.2

228.96

244.54

u/l

3.15

736

4474

Abnormal serum enzyme levels

2149

15607

1.40

41.66

4.3

257.75

244.31

u/l

2.04

2064

14773

Cardiac murmurs and other cardiac sounds

541

2914

1.95

41.51

4.1

4.6

241.14

250.41

u/l

0.68

509

2777

Lumbar disc prolapse

3905

23930

1.28

41.37

3.9

4.4

238.21

244.21

u/l

1.39

3702

22769

Fracture of shoulder and upper arm

2265

16956

1.38

41.21

3.8

4.3

234.92

245.66

u/l

3.74

2113

15972

Supervision of high-risk pregnancy

838

3025

1.72

41.15

3.4

3.8

227.85

227.57

u/l

0.01

795

2871

ILD-related respiratory insufficiency

298

1351

2.60

40.89

4.7

4.0

289.60

247.48

u/l

3.68

290

1282

Primary biliary cholangitis (PBC)

176

610

3.39

40.83

3.0

4.6

235.86

253.38

u/l

0.57

167

573

Maternal care for other known or suspected fetal problems

962

3803

1.65

40.80

3.4

3.7

219.04

223.43

u/l

0.50

919

3625

Tumor necrosis factor alpha inhibitors

834

5157

1.70

40.79

2.6

4.6

222.80

238.35

u/l

4.13

795

4897

Diseases of salivary glands

1890

13795

1.42

40.78

3.9

4.2

234.93

241.98

u/l

1.35

1777

13014

Type of accident

1759

12691

1.44

40.76

3.9

4.2

242.82

242.41

u/l

0.04

1638

11975

Other diseases of upper respiratory tract

7349

32429

1.20

40.65

4.0

4.2

239.38

244.85

u/l

1.94

6914

30677

Small fibre neuropathy

255

1080

2.79

40.63

6.2

4.0

239.27

250.51

u/l

0.54

241

1018

Thyrotoxicosis, other and/or unspecified

1156

7720

1.57

40.49

5.5

4.0

236.23

242.53

u/l

0.77

1095

7251

Lung diseases due to external agents

996

6479

1.64

40.48

3.3

4.0

250.98

246.41

u/l

0.35

926

6073

Hyperhidrosis

193

696

3.07

40.45

3.7

3.1

215.22

241.71

u/l

1.77

176

658

Poor fetal growth

552

3042

1.90

40.37

3.3

3.7

224.87

225.79

u/l

0.05

529

2892

Other Crohn's disease

423

2156

2.12

40.29

3.5

4.5

223.01

242.46

u/l

1.88

405

2048

Single delivery by caesarean section

825

2843

1.73

40.27

3.7

3.9

240.51

231.66

u/l

0.37

798

2708

Crohn's disease NAS

413

2094

2.14

40.13

3.7

4.5

225.83

243.58

u/l

1.68

391

1995

Personality disorders

1395

9663

1.49

40.01

3.0

4.4

224.31

233.84

u/l

2.11

1305

9206

Serous carcinoma of ovary, including Hilmo

219

857

2.89

39.84

5.6

3.5

257.84

235.55

u/l

1.47

214

796

Superficial injury of lower leg

1444

10098

1.49

39.79

3.4

4.4

238.91

241.28

u/l

0.28

1358

9526

Mental and behavioural disorders due to tobacco

562

3165

1.92

39.79

2.7

4.6

223.73

243.86

u/l

3.38

508

3014

Benign neoplasm: Transverse colon

777

4810

1.75

39.77

3.8

4.3

234.39

243.69

u/l

1.25

741

4545

Vitamin deficiency

345

1652

2.32

39.70

3.3

4.2

254.86

250.34

u/l

0.09

331

1569

Vitamin deficiency, wide

345

1652

2.32

39.70

3.3

4.2

254.86

250.34

u/l

0.09

331

1569

Excessive, frequent and irregular menstruation

2068

8280

1.41

39.46

3.6

3.8

234.08

242.21

u/l

0.94

1933

7798

Rheumatism, unspecified

800

4950

1.71

39.43

3.2

4.4

237.69

247.33

u/l

1.05

755

4689

Spondylopathies (FG)

764

4662

1.72

39.41

2.8

4.7

224.99

236.73

u/l

2.02

711

4439

Diseases of external ear

2105

15725

1.39

39.35

4.0

4.2

239.00

244.02

u/l

0.64

1927

14841

Smoking dependency

562

3176

1.91

39.34

2.7

4.6

223.73

244.34

u/l

3.51

508

3024

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

867

5460

1.66

39.20

2.9

4.5

229.96

234.15

u/l

0.30

803

5182

Postmenopausal osteoporosis with pathological fracture

457

2441

2.08

39.19

3.6

3.8

254.78

252.51

u/l

0.11

423

2262

COPD, hospital admissions 1, only main diagnosis

2439

15936

1.36

39.16

3.2

4.1

238.99

249.20

u/l

2.73

2274

14968

Left bundle-branch block

467

2492

2.03

39.11

4.0

4.1

247.33

239.27

u/l

0.70

438

2319

Hypoparathyroidism

279

1242

2.57

39.03

4.8

4.3

250.81

252.33

u/l

0.06

252

1163

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1379

9453

1.49

39.02

4.6

4.0

242.06

233.75

u/l

0.81

1310

8986

Injuries to the ankle and foot

4029

28946

1.26

38.99

4.0

4.3

234.87

240.99

u/l

2.15

3816

27487

Malignant neoplasm of breast, HER-negative

915

5732

1.63

38.85

4.3

2.7

253.27

240.78

u/l

1.70

851

5260

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3185

24428

1.30

38.78

4.0

4.4

234.94

244.45

u/l

3.53

3011

23215

Sequelae of other external causes

390

1972

2.18

38.67

4.3

4.1

241.49

249.00

u/l

0.45

374

1866

Special screening examination for other diseases and disorders

633

3688

1.81

38.67

4.0

242.37

246.25

u/l

0.24

617

3493

Asthma and allergy, excluding more controls

552

3032

1.86

38.57

3.0

3.7

222.98

231.89

u/l

0.86

532

2869

Thyroiditis, ILD-related definition

644

3787

1.80

38.45

4.0

4.3

230.48

242.60

u/l

1.54

614

3573

Cholecystitis

954

6214

1.63

38.29

4.1

244.66

245.81

u/l

0.07

892

5816

2138

14011

1.39

38.24

3.4

3.9

245.93

250.07

u/l

0.61

1972

13099

Inflammatory diseases of female pelvic organs

3117

17962

1.30

38.21

3.5

3.9

233.04

239.54

u/l

1.20

2905

16972

Amputation of ankle bones

207

819

3.03

38.18

3.6

3.8

252.08

249.92

u/l

0.08

193

774

Suicide or other Intentional self-harm

1315

9105

1.50

38.05

3.0

4.5

233.33

236.71

u/l

0.28

1207

8664

Meniscus derangement

3417

18257

1.29

37.96

3.8

4.5

240.67

246.11

u/l

1.27

3236

17321

Psoriatic and enteropathic arthropathies

672

4017

1.77

37.81

3.0

4.8

240.07

239.20

u/l

0.04

634

3815

Malignant neoplasm of breast, HER-positive

1387

7503

1.48

37.74

3.4

2.6

264.06

238.32

u/l

3.44

1301

6939

Glucagon-like peptide-1 (GLP-1) analogues

1662

12040

1.43

37.69

3.2

4.8

228.78

245.83

u/l

5.11

1551

11504

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1662

12040

1.43

37.69

3.2

4.8

228.78

245.83

u/l

5.11

1551

11504

Migraine without aura

938

6054

1.60

37.61

3.7

4.2

223.96

235.48

u/l

1.94

883

5772

Malignant neoplasm of endocrine gland

368

1825

2.16

37.57

5.5

3.0

234.18

232.09

u/l

0.14

349

1708

Iron deficiency

183

671

3.06

37.54

3.4

4.1

210.34

248.68

u/l

2.14

170

638

Coeliac disease

727

4453

1.73

37.49

3.6

4.2

229.60

244.26

u/l

2.08

694

4213

Injuries to unspecified part of trunk, limb or body region

670

4031

1.78

37.46

4.3

4.2

246.86

246.04

u/l

0.04

634

3805

Acute pharyngitis

772

4733

1.69

37.40

5.4

4.4

231.57

239.74

u/l

0.87

746

4533

Chronic sinusitis

2503

19243

1.34

37.40

4.2

4.4

237.14

242.77

u/l

1.09

2363

18250

Diabetic maculopathy

895

5473

1.66

37.30

3.2

3.9

238.46

237.52

u/l

0.10

856

5140

Haemorrhoids and perianal venous thrombosis

1984

14766

1.39

37.23

4.0

4.2

232.42

250.15

u/l

7.00

1849

13921

Inflammatory diseases of the central nervous system

533

3013

1.91

37.20

4.2

4.3

247.67

246.23

u/l

0.04

502

2855

Chronic Coagulation defects

176

639

3.16

37.20

3.4

4.5

224.87

250.74

u/l

0.89

166

605

IBD patients in KELA-register

1271

8789

1.50

37.14

3.6

4.5

222.52

237.69

u/l

4.96

1211

8361

Rash and other nonspecific skin eruption

607

3565

1.82

36.99

4.5

4.1

234.52

247.82

u/l

1.76

582

3361

Postpartum care and examination

563

1975

1.87

36.87

3.8

3.4

225.38

219.39

u/l

0.52

539

1859

Tubulo-interstitial nephritis, not specified as acute or chronic

437

2324

2.03

36.87

3.3

4.0

237.12

243.67

u/l

0.41

404

2163

Arterial embolism and thrombosis

433

2310

2.06

36.86

4.1

3.8

261.13

245.74

u/l

0.79

405

2167

Malignant neoplasm of other and ill-defined sites, including Hilmo

132

411

3.82

36.72

5.3

2.5

255.45

237.88

u/l

0.99

126

379

Disorders of adult personality and behaviour

1445

10254

1.45

36.30

3.1

4.4

223.01

233.70

u/l

2.78

1343

9773

Neuromuscular dysfunction of bladder

609

3608

1.82

36.23

3.1

4.4

223.41

244.97

u/l

4.31

564

3427

Other symptoms and signs involving the urinary system

711

4393

1.73

36.08

3.7

4.5

221.37

244.59

u/l

6.02

684

4165

Other overlap syndromes

156

545

3.42

36.06

3.4

3.9

235.71

257.43

u/l

0.68

147

517

Iridocyclitis

1353

9541

1.48

36.03

4.4

4.3

235.15

241.74

u/l

1.26

1302

8990

Conjunctivitis (acute, non atopic)

1573

11320

1.43

36.02

5.0

4.3

233.58

240.31

u/l

1.06

1495

10728

Chronic rhinitis, nasopharyngitis and pharyngitis

1823

13482

1.40

35.99

3.7

4.5

236.77

243.37

u/l

0.77

1720

12797

Presence of other devices

1550

11156

1.44

35.98

4.0

3.9

236.64

246.29

u/l

2.30

1465

10455

Complications following infusion, transfusion and therapeutic injection

137

445

3.74

35.98

6.9

4.2

240.70

256.07

u/l

0.35

128

421

Other nutritional anaemias

109

308

4.54

35.96

5.2

4.2

336.19

236.76

u/l

0.98

290

Discitis, unspecified

160

572

3.43

35.96

5.4

4.4

229.45

242.09

u/l

0.83

154

541

Deforming dorsopathies

1621

11781

1.42

35.81

3.7

4.5

239.09

245.40

u/l

1.10

1524

11186

Disorders of synovium and tendon

3136

21822

1.29

35.56

3.8

4.4

238.51

243.95

u/l

1.35

2956

20706

Infection of intervertebral disc (pyogenic)

141

476

3.78

35.55

3.2

4.4

239.90

245.56

u/l

0.25

136

454

Lichen simplex chronicus and prurigo

427

2295

2.03

35.44

3.2

4.3

239.43

248.58

u/l

0.60

411

2170

Shock, not elsewhere classified

259

4.79

35.33

8.6

3.1

262.58

250.05

u/l

0.24

243

Diabetic neuropathy

843

5465

1.67

35.17

2.9

3.8

233.98

237.66

u/l

0.40

805

5135

Malnutrition

184

715

3.05

34.96

3.9

4.3

264.05

247.69

u/l

0.69

167

673

Temporal arteritis

303

1468

2.37

34.93

2.9

3.9

239.93

250.63

u/l

0.48

281

1376

Maternal care for other conditions predominantly related to pregnancy

846

5319

1.61

34.71

3.1

3.9

218.89

231.80

u/l

2.33

811

5051

Late syphilis

152

541

3.42

34.38

3.2

4.1

229.63

238.68

u/l

0.64

142

515

Migraine with aura and triptan purchases

748

4688

1.66

34.32

3.5

4.1

219.09

234.98

u/l

2.66

703

4444

Pneumonia due to Streptococcus pneumoniae

277

1285

2.37

34.27

5.7

3.8

238.25

240.10

u/l

0.08

262

1213

Speech therapy

1628

11960

1.42

34.24

4.4

4.2

245.53

244.05

u/l

0.11

1568

11242

Unspecified misadventure during surgical and medical care

391

2076

2.08

34.05

4.4

4.2

260.10

248.90

u/l

0.50

375

1966

Failed induction of labour

274

1256

2.32

33.94

3.2

3.7

217.13

223.68

u/l

0.61

269

1183

Symptoms and signs involving speech and voice

2012

15277

1.36

33.75

4.2

4.1

232.51

244.99

u/l

5.28

1897

14387

Primary hyperparathyroidism

689

4297

1.72

33.68

4.0

4.1

228.36

250.65

u/l

3.39

647

4039

Abnormality of red blood cells

160

6.67

33.60

3.1

4.7

234.58

241.04

u/l

0.17

153

Focal epilepsy

1293

9165

1.47

33.47

4.3

252.40

242.15

u/l

0.73

1218

8653

Malignant neoplasm of oral cavity

224

964

2.61

33.39

4.3

2.6

233.26

233.89

u/l

0.01

218

902

Other follicular disorders

429

2342

1.96

33.34

4.3

4.2

220.65

241.70

u/l

2.90

400

2228

Giant cell arteritis with polymyalgia rheumatica

303

1496

2.32

33.28

2.9

3.8

239.93

250.00

u/l

0.45

281

1400

Abscess of lung

149

536

3.39

33.10

3.7

4.4

234.97

251.63

u/l

0.61

143

506

Barrett oesophagus

368

1940

2.11

33.00

3.0

4.6

224.28

251.46

u/l

4.21

346

1844

Superficial injury of hip and thigh

948

6360

1.57

32.97

3.6

3.9

237.46

245.09

u/l

1.20

888

5950

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

138

472

3.46

32.95

5.0

2.6

284.91

238.76

u/l

1.32

132

440

Acute gastritis

491

2811

1.88

32.91

3.9

4.4

232.94

251.62

u/l

2.48

459

2653

Other congenital malformations

477

2694

1.88

32.88

4.8

4.6

237.83

248.02

u/l

0.63

464

2572

Asthma and allergy

552

3179

1.77

32.88

3.0

3.9

222.98

234.43

u/l

1.28

532

3011

Tobacco use

345

1771

2.13

32.76

2.9

4.3

227.72

241.76

u/l

0.78

331

1679

Right hemicolectomy

437

2440

1.98

32.72

3.9

237.37

248.91

u/l

0.84

418

2293

Dermatophytosis

845

5559

1.61

32.69

4.6

4.2

254.16

243.38

u/l

0.67

804

5266

Other obstructive and reflux uropathy

272

1275

2.33

32.63

3.9

4.0

232.29

243.42

u/l

0.55

258

1192

Hyperplasia of prostate

2558

11326

1.33

32.60

4.1

4.7

237.61

247.73

u/l

2.77

2420

10770

Inflammatory bowel disease, strict (require KELA)

1271

9009

1.46

32.56

3.6

4.5

222.52

236.98

u/l

4.65

1211

8562

Thyrotoxicosis

1422

10287

1.43

32.55

5.0

4.0

236.00

242.80

u/l

1.10

1346

9675

Malignant neoplasm of brain, including Hilmo

282

1340

2.28

32.52

4.7

3.0

252.90

233.55

u/l

1.87

272

1253

Other diseases of oesophagus

629

3864

1.74

32.51

3.4

4.2

240.37

249.81

u/l

0.88

589

3648

Nonorganic sleeping disorders, excluding more controls

991

6695

1.53

32.48

3.3

4.5

224.21

239.16

u/l

4.19

927

6392

Polyarthritis, unspecified

262

1221

2.39

32.47

3.7

4.6

236.74

244.63

u/l

0.46

254

1161

Familial hypercholesterolemia

998

6803

1.55

32.38

3.6

4.3

243.83

248.03

u/l

0.35

943

6400

Cardiomyopathy, Hypertrophic obstructive

149

537

3.25

32.33

9.1

4.1

273.74

247.73

u/l

0.69

144

498

Infections with a predominantly sexual mode of transmission

1447

10457

1.42

32.31

4.0

4.1

227.55

232.22

u/l

0.78

1349

9946

Bipolar affective disorders

948

6357

1.55

32.22

2.9

4.5

219.74

236.08

u/l

3.79

869

6072

Unspecified nephritic syndrome

183

737

2.89

32.17

3.6

4.3

239.30

251.89

u/l

0.41

174

696

Alcohol dependence

1660

12345

1.39

32.16

2.7

4.7

233.87

243.10

u/l

1.59

1545

11750

Special screening examination for infectious and parasitic diseases

1093

5484

1.50

32.09

3.6

4.0

222.71

240.70

u/l

4.39

1016

5248

Drug-induced osteoporosis

123

405

3.79

32.05

5.3

4.4

270.50

265.50

u/l

0.07

114

378

Visual impairment including blindness (binocular or monocular)

464

2640

1.90

32.00

3.2

3.8

260.66

251.60

u/l

0.25

420

2479

Other epidermal thickening

309

1546

2.21

31.86

4.7

4.1

230.14

246.76

u/l

1.66

294

1459

Bronchiectasis

554

3327

1.81

31.84

4.6

4.3

235.07

250.60

u/l

1.91

524

3120

Toxic liver disease

134

462

3.46

31.73

5.5

4.4

263.81

253.01

u/l

0.24

127

437

Gingival hyperplasia

259

1218

2.39

31.66

5.9

4.4

249.59

250.89

u/l

0.04

250

1160

Heartburn

629

3880

1.71

31.43

4.5

4.3

231.53

243.64

u/l

1.23

589

3660

Pain in thoracic spine

858

5682

1.58

31.35

3.7

4.4

231.50

242.24

u/l

1.91

802

5394

Hypertrophic cardiomyopathy

316

1613

2.20

31.25

8.0

4.2

260.35

248.38

u/l

0.71

301

1528

Malignant neoplasm of rectum, including Hilmo

662

4144

1.68

31.21

3.1

2.7

255.61

238.69

u/l

1.13

634

3810

Use of pramipexole

1379

10027

1.44

31.20

3.6

4.2

239.72

245.37

u/l

0.80

1260

9414

Reactive arthropathies

520

3065

1.80

31.10

3.2

4.8

235.83

243.37

u/l

0.52

491

2919

Ovarian cyst

1848

7978

1.37

30.72

3.4

3.9

231.01

242.83

u/l

3.04

1751

7521

Abscess of anal and rectal regions

500

2924

1.81

30.71

4.1

4.6

252.02

247.01

u/l

0.15

477

2798

Viral warts

1140

8011

1.48

30.69

5.0

4.3

229.97

238.55

u/l

1.92

1084

7591

Adalimumab

511

3003

1.80

30.68

2.7

4.7

221.75

242.18

u/l

3.41

487

2853

Drug-induced polyneuropathy

102

313

4.35

30.43

11.7

3.9

250.24

244.76

u/l

0.15

102

299

Respiratory disorders in diseases classified elsewhere

131

461

3.49

30.40

4.7

4.2

270.13

257.15

u/l

0.28

126

437

Ulcer of oesophagus

487

2859

1.85

30.40

3.5

4.3

239.88

248.60

u/l

0.71

459

2713

Emphysema

520

3112

1.81

30.20

3.6

4.3

254.71

250.29

u/l

0.19

494

2915

Postprocedural disorders of digestive system, not elsewhere classified

241

1122

2.42

30.20

3.4

4.3

230.67

258.44

u/l

1.80

230

1064

Specific personality disorders

1165

8230

1.46

30.18

3.1

4.4

222.07

233.83

u/l

2.76

1084

7836

Focal epilepsy, strict definition

1195

8515

1.46

30.17

4.5

4.3

253.67

242.86

u/l

0.72

1125

8041

Disorders of vitreous body and globe

3177

24833

1.26

30.15

4.1

4.3

245.72

245.41

u/l

0.03

3024

23433

Focal epilepsy, mode (most common among epilepsy diagnosis)

1130

7974

1.48

30.13

4.2

4.3

252.65

242.60

u/l

0.78

1064

7536

Polyarteritis nodosa and related conditions

124

422

3.53

30.12

4.0

4.4

238.75

259.64

u/l

0.48

118

404

Coxibs

1871

7400

1.37

30.12

3.5

4.6

230.20

251.09

u/l

9.54

1740

7069

Attention to artificial openings

281

1386

2.24

30.10

3.9

4.0

229.30

244.71

u/l

1.01

262

1306

Malignant neoplasm of thyroid gland, including Hilmo

364

1942

1.99

30.09

5.4

3.0

233.40

231.97

u/l

0.08

345

1810

L04AC Interleukin inhibitors

340

1783

2.05

30.01

2.7

4.6

224.55

244.15

u/l

1.89

325

1698

Right bundle-branch block

251

1185

2.34

29.98

4.0

245.77

241.57

u/l

0.15

233

1104

Carcinoma in situ of skin

616

3870

1.73

29.98

4.6

4.0

254.09

245.53

u/l

0.55

583

3636

Later onset COPD

2065

12746

1.34

29.95

2.9

4.0

238.22

251.12

u/l

4.86

1925

11915

Rotator cuff syndrome

3792

22436

1.24

29.91

3.8

4.4

241.50

246.05

u/l

0.83

3580

21245

Traumatic subdural haemorrhage

929

6090

1.54

29.72

4.2

4.3

242.75

251.89

u/l

1.11

865

5748

Other noninfective disorders of lymphatic vessels and lymph nodes

249

1178

2.35

29.70

4.8

3.9

252.66

245.70

u/l

0.26

236

1112

Injury of unspecified body region

497

2945

1.81

29.65

4.4

4.0

248.99

247.67

u/l

0.05

473

2782

Diplopia

806

5356

1.59

29.60

4.1

4.2

239.43

243.09

u/l

0.30

762

5055

Reactive arthropathies, FINNGEN

409

2283

1.91

29.58

3.4

4.7

234.21

240.43

u/l

0.31

387

2167

Acute and subacute iridocyclitis

1108

7818

1.48

29.53

4.4

4.3

237.14

240.27

u/l

0.37

1065

7396

Gonarthrosis,primary

5768

30405

1.19

29.42

3.7

4.3

242.55

245.72

u/l

0.76

5406

28746

Alcohol-induced chronic pancreatitis

428

2448

1.90

29.24

2.7

4.6

235.10

244.77

u/l

0.39

405

2332

Melanocytic naevi, other sites/unspecified

478

2810

1.82

29.13

6.2

4.3

229.86

243.24

u/l

0.93

467

2666

Hypopituitarism

415

2341

1.90

29.10

3.9

4.9

238.65

248.92

u/l

0.54

396

2233

Benign neoplasm of mouth and pharynx

680

4379

1.65

28.99

4.3

4.2

234.39

245.06

u/l

0.98

632

4131

Open wound of ankle and foot

625

3938

1.68

28.96

3.9

4.4

243.74

242.46

u/l

0.08

594

3730

Late syphilis

126

447

3.45

28.82

3.2

4.2

232.43

241.86

u/l

0.57

118

423

Menorrhagia

1788

7459

1.36

28.77

3.6

3.9

237.17

245.60

u/l

0.82

1663

7013

Injuries to the elbow and forearm

4159

30591

1.22

28.73

3.9

4.2

234.33

242.87

u/l

4.51

3893

28945

Fissure and fistula of anal and rectal regions

1356

9932

1.41

28.69

4.4

4.3

236.83

247.05

u/l

1.68

1267

9416

Keratitis

2031

15767

1.32

28.69

4.3

244.68

242.35

u/l

0.20

1926

14869

Crohn disease (strict definition, require KELA, min 2 HDR)

364

1980

1.97

28.68

3.4

4.5

217.11

241.62

u/l

2.42

350

1887

Irregular menses

2170

13325

1.31

28.64

3.8

3.9

226.97

236.72

u/l

3.13

2049

12617

Infections with a predominantly sexual mode of transmission

1841

13086

1.34

28.63

4.1

4.0

225.97

232.11

u/l

1.41

1722

12459

Panic disorder

706

4559

1.61

28.57

3.4

4.3

219.34

233.80

u/l

2.43

646

4330

Other encephalitis

198

868

2.57

28.56

4.2

4.4

281.78

253.88

u/l

0.40

185

819

Benign neoplasm of other and unspecified endocrine glands

796

5319

1.58

28.53

3.8

4.4

230.07

244.34

u/l

2.47

747

5040

Other peripheral vascular diseases

482

2858

1.80

28.43

3.8

4.1

243.75

244.07

u/l

0.02

452

2690

Prurigo nodularis

194

850

2.63

28.43

2.8

4.0

242.58

255.21

u/l

0.37

188

805

Encephalitis

208

933

2.50

28.40

4.1

4.3

278.24

250.65

u/l

0.41

193

877

Exfoliative dermatitis

110

365

3.76

28.38

5.5

4.4

258.58

245.43

u/l

0.40

105

345

Mucosal proctocolitis

698

4522

1.62

28.34

3.9

4.7

222.92

238.89

u/l

3.15

667

4299

Anterior Iridocyclitis

1170

8400

1.45

28.27

4.3

236.79

241.16

u/l

0.59

1125

7938

Disorders of vitreous body

3070

24230

1.26

28.10

4.2

4.3

245.74

245.47

u/l

0.03

2926

22870

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

354

1913

1.96

28.09

3.3

4.6

239.76

236.66

u/l

0.12

329

1831

Other and unspecified tonsillitis

1618

10208

1.36

27.90

4.3

4.2

227.60

237.31

u/l

1.67

1545

9778

Other benign neoplasms of skin

2271

17967

1.30

27.88

4.4

4.1

238.82

245.02

u/l

1.24

2116

16906

Syphilis

193

849

2.58

27.80

3.3

4.3

235.93

248.54

u/l

0.54

182

811

Syphilis

193

849

2.58

27.80

3.3

4.3

235.93

248.54

u/l

0.54

182

811

Fracture of foot, except ankle

1300

9507

1.41

27.72

4.3

4.4

233.65

239.10

u/l

0.97

1226

9013

Crohn disease (strict definition, require KELA)

366

2016

1.94

27.72

3.4

4.6

216.76

241.02

u/l

2.43

352

1923

Fracture of lower leg, including ankle

3256

26489

1.24

27.71

3.5

4.4

238.25

243.86

u/l

1.54

3073

25083

Cervicalgia

1189

8582

1.44

27.66

3.4

4.4

235.44

244.35

u/l

1.46

1106

8124

Psoriasis vulgaris

1080

7680

1.46

27.66

3.6

4.4

236.76

240.55

u/l

0.42

1019

7288

Extreme obesity with alveolar hypoventilation

284

1455

2.16

27.58

2.5

4.7

235.07

246.86

u/l

0.84

254

1377

Infective dermatitis

689

4494

1.62

27.57

3.9

4.2

239.10

243.28

u/l

0.35

657

4252

Acute lymphadenitis

334

1793

1.99

27.40

5.2

4.3

229.30

244.79

u/l

1.27

318

1694

Bacterial, viral and other infectious agents

481

2877

1.77

27.32

5.1

4.5

237.40

242.78

u/l

0.38

464

2739

Crohn's disease of large intestine

302

1573

2.07

27.27

3.2

4.5

222.86

243.34

u/l

1.70

287

1498

Renal cell carcinoma of kidney

215

994

2.39

27.10

4.0

2.4

253.53

239.27

u/l

0.51

206

916

Childhood asthma (age<16), excluding more controls

509

2388

1.72

27.06

3.5

3.6

217.93

228.20

u/l

0.95

483

2286

Other congenital malformations

659

4259

1.62

26.94

4.5

239.07

245.04

u/l

0.40

636

4051

Orchitis and epididymitis

619

3977

1.65

26.74

4.6

229.47

245.52

u/l

1.60

587

3764

Other aneurysm

381

2166

1.92

26.69

4.3

4.0

247.64

245.01

u/l

0.14

365

2035

Other abnormal uterine and vaginal bleeding

1238

6434

1.42

26.45

3.4

4.0

242.61

248.24

u/l

0.67

1138

6033

Oesophagitis

363

2036

1.93

26.43

3.4

4.5

229.55

250.15

u/l

2.74

343

1935

Non-small cell lung cancer, squamous, helper endpoint

366

2066

1.94

26.38

4.4

3.8

223.63

248.42

u/l

3.54

356

1917

Pain associated with micturition

678

4449

1.60

26.32

4.1

4.2

227.04

244.06

u/l

3.09

618

4216

Malignant neoplasm of corpus uteri, including Hilmo

460

2745

1.77

26.25

3.8

2.6

249.67

242.78

u/l

0.53

431

2536

Bacterial, viral and other infectious agents

501

3063

1.73

26.13

5.0

4.5

236.85

242.41

u/l

0.42

484

2914

Pregnancy examination and test

580

2218

1.67

26.12

3.4

3.5

220.35

220.64

u/l

0.02

562

2091

Ulcerative colitis (strict) with PSC

194

4.64

26.02

2.5

4.7

211.11

231.08

u/l

0.91

189

1478

10516

1.38

25.93

3.4

3.7

246.67

250.66

u/l

0.43

1344

9807

Psoriatic arthropathies

566

3574

1.67

25.86

3.1

4.8

243.04

244.63

u/l

0.07

533

3402

Acute suppurative otitis media

1218

8285

1.41

25.84

4.4

4.2

234.71

233.38

u/l

0.08

1148

7892

Retinal detachments and breaks

2248

17947

1.29

25.80

4.3

4.2

244.84

246.89

u/l

0.31

2110

16920

Other shoulder lesions

526

3264

1.70

25.78

3.6

4.6

226.71

242.08

u/l

3.13

490

3095

Other renal tubulo-interstitial diseases

154

628

2.73

25.77

4.1

3.9

263.31

242.08

u/l

0.37

149

584

Other disorders of bladder

784

5344

1.55

25.76

3.5

4.4

236.17

247.83

u/l

1.08

715

5061

Cerebral cysts

342

1893

1.94

25.67

3.7

4.1

263.17

250.29

u/l

0.36

319

1796

Other disorders of eye and adnexa

766

5177

1.54

25.62

4.4

4.3

233.43

243.12

u/l

1.08

722

4890

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

380

2172

1.86

25.45

3.3

4.5

216.80

240.89

u/l

2.58

365

2071

Other blood glucose lowering drugs, excl. Insulins

1027

7367

1.46

25.42

2.8

4.4

235.54

250.51

u/l

2.64

963

6940

Thiazolidinediones

748

5071

1.56

25.41

2.7

4.5

237.98

250.31

u/l

1.18

695

4803

Colitis, primary sclerosing, strict definition

274

3.88

25.39

3.1

4.3

204.29

236.07

u/l

2.41

260

Retinal vascular occlusion

798

5481

1.54

25.35

3.9

4.1

246.11

245.38

u/l

0.05

749

5123

Trochanteric bursitis

788

5371

1.53

25.31

3.4

4.3

243.99

247.14

u/l

0.11

727

5078

Malignant neoplasm of thyroid gland

315

1701

1.96

25.19

5.6

3.0

230.98

231.38

u/l

0.02

299

1590

Special screening examination for neoplasms

348

1949

1.91

25.05

3.6

4.3

251.21

249.54

u/l

0.04

324

1839

Childhood asthma (age<16)

509

2443

1.69

24.93

3.5

3.8

217.93

229.29

u/l

1.11

483

2341

Persistent mood disorders

1046

7519

1.44

24.91

3.5

4.3

230.42

241.62

u/l

1.89

963

7081

Alcohol abuse, main dg, excluding more controls

816

5612

1.51

24.87

2.7

4.8

236.39

241.73

u/l

0.41

775

5373

Umbilical hernia

1616

12431

1.34

24.85

3.8

4.5

244.29

243.96

u/l

0.02

1542

11810

Retinal vascular disorders

807

5577

1.53

24.79

3.8

4.1

246.09

245.86

u/l

0.02

756

5215

Abnormal findings on antenatal screening of mother

323

1757

1.91

24.73

2.7

3.6

206.56

222.26

u/l

1.98

304

1665

Other bursopathies

785

5384

1.53

24.62

3.8

4.6

241.27

244.88

u/l

0.31

737

5092

Mental and behavioural disorders due to sedatives or hypnotics

373

2141

1.85

24.61

3.1

4.5

231.37

241.15

u/l

0.57

332

2034

Disorders of iron metabolism

120

447

3.12

24.57

3.3

4.8

218.04

235.56

u/l

1.29

114

428

Other and unspecified erythematous conditions

212

1017

2.32

24.57

4.3

4.2

242.66

251.73

u/l

0.33

201

964

Malignant neoplasm of renal pelvis, including Hilmo

317

3.60

24.51

4.8

2.6

236.15

240.27

u/l

0.20

296

Speech disturbances, not elsewhere classified

583

3776

1.64

24.50

4.7

4.1

231.96

248.17

u/l

2.11

538

3549

Other erythematous conditions

230

1138

2.23

24.49

4.3

4.2

243.23

250.63

u/l

0.29

219

1080

N06DA Anticholinesterases

1525

15604

0.75

24.45

2.8

3.8

245.80

250.46

u/l

0.51

1368

14559

Use of anticholinesterases

1525

15604

0.75

24.45

2.8

3.8

245.80

250.46

u/l

0.51

1368

14559

Carcinoma in situ of skin of upper limb, including shoulder

215

1057

2.37

24.40

4.7

3.8

253.16

245.33

u/l

0.32

206

992

Type 1 diabetes, definitions combined

452

2721

1.73

24.29

4.3

4.8

229.98

241.26

u/l

1.32

442

2598

Malignant neoplasm of oesophagus, including Hilmo

224

1100

2.23

24.21

2.8

2.6

226.46

235.00

u/l

0.54

213

1024

Carcinoma in situ of skin of trunk

261

1374

2.16

24.20

5.0

3.8

238.01

249.55

u/l

0.73

251

1293

Malignant neoplasm of tongue, including Hilmo

166

724

2.55

24.12

3.9

2.6

217.62

236.73

u/l

2.22

160

679

Other disorders of nervous system

427

2580

1.78

23.93

3.9

4.2

243.04

247.86

u/l

0.26

399

2442

Oter anti-inflammatory and antirheumatic agents, non-steroids

1517

6334

1.36

23.92

3.5

4.6

237.88

254.98

u/l

3.97

1402

6034

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

229

4.06

23.90

8.3

2.8

260.79

230.15

u/l

0.85

217

Atopic dermatitis, strict definition with reimbursement

1392

10129

1.36

23.89

4.0

4.2

241.71

234.85

u/l

0.49

1326

9647

Assault

640

4217

1.58

23.89

2.7

4.6

226.84

235.56

u/l

0.81

594

4027

Cervical disc disorders

2117

16908

1.28

23.87

3.9

4.5

234.53

245.07

u/l

4.10

1971

16092

Leisure time condition

1032

7475

1.43

23.76

3.4

4.3

244.25

242.71

u/l

0.11

941

7060

Gestational diabetes (for exclusion)

1400

7295

1.36

23.71

3.2

3.8

222.23

227.47

u/l

0.77

1329

6949

Moderate visual impairment, binocular

221

1094

2.25

23.71

3.0

3.4

232.93

262.24

u/l

1.76

194

1034

Postzoster neuralgia

134

542

2.92

23.69

6.9

3.9

265.65

244.93

u/l

0.73

129

511

Drug-induced systemic lupus erythematosus

186

4.69

23.66

3.9

4.5

257.78

244.86

u/l

0.41

179

Sulfonylureas

2367

15240

1.27

23.64

2.8

4.3

235.92

253.21

u/l

7.09

2205

14323

Generalized anxiety disorder

725

4906

1.52

23.60

3.4

4.2

215.38

235.47

u/l

4.54

656

4674

Type 1 diabetes, strict (exclude DM2)

448

2714

1.71

23.53

4.3

4.9

230.41

241.45

u/l

1.27

438

2591

Other congenital malformations of skin

235

1184

2.15

23.52

6.0

4.3

211.95

256.14

u/l

3.92

228

1129

Other juvenile arthritis

204

971

2.24

23.34

3.2

5.0

249.46

243.52

u/l

0.11

198

937

Maternal care for known or suspected abnormality of pelvic organs

976

4707

1.44

23.32

3.7

4.0

229.04

231.26

u/l

0.15

939

4470

Otitis externa

1227

9159

1.38

23.24

4.0

4.3

236.87

240.58

u/l

0.27

1144

8672

Carcinoma in situ of skin of scalp and neck

220

1114

2.30

23.12

5.5

3.9

235.74

246.28

u/l

0.85

213

1046

Other specified disorders of kidney and ureter

227

1147

2.20

23.02

5.0

4.4

266.00

253.33

u/l

0.38

216

1090

Personal history of medical treatment

309

3.59

23.02

4.1

4.7

242.38

234.90

u/l

0.33

293

Mixed and other personality disorders

397

2359

1.77

22.97

2.8

4.6

222.84

239.29

u/l

1.42

371

2248

Artificial joint operation, meniscal resection

5757

32603

1.16

22.94

3.7

4.3

239.84

245.38

u/l

2.09

5411

30818

Contact with and exposure to communicable diseases

1386

10462

1.35

22.92

3.6

4.2

226.79

233.23

u/l

1.26

1330

9960

Other surgical follow-up care

195

926

2.29

22.78

4.3

4.0

244.06

232.80

u/l

0.33

190

872

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

369

2160

1.81

22.75

2.7

4.2

222.44

241.22

u/l

1.91

347

2054

Other ulcerative colitis

331

1884

1.88

22.67

3.2

4.4

231.23

244.78

u/l

0.87

316

1799

Malignant neoplasm of corpus uteri

399

2388

1.77

22.66

3.7

2.7

249.83

243.88

u/l

0.42

374

2201

Neuroendocrine tumor and carcinoma of small intestine

344

3.33

22.42

3.5

2.8

227.20

238.85

u/l

0.59

321

Congenital malformations of cardiac septa

371

2115

1.80

22.36

4.0

4.8

274.35

259.00

u/l

0.57

355

2015

Hidradenitis suppurativa

199

958

2.24

22.35

2.3

4.3

208.58

239.85

u/l

3.24

182

915

Suppurative and unspecified otitis media

1770

12309

1.30

22.33

4.5

4.1

235.48

234.32

u/l

0.08

1670

11698

Amputation of thigh

228

1170

2.18

22.31

4.0

3.7

266.53

252.50

u/l

0.34

207

1100

Ankylosing spondylitis

496

3149

1.66

22.26

2.9

4.7

228.31

241.29

u/l

1.66

459

2999

Other and unspecified visual disturbances

583

3846

1.60

22.26

4.7

4.1

232.00

246.23

u/l

2.41

548

3634

Speech and linguistic disorders, excluding more controls

380

2106

1.77

22.22

5.0

4.5

246.16

253.72

u/l

0.37

364

2009

Paralytic ileus

258

1376

2.05

22.19

3.4

4.2

236.30

257.98

u/l

1.07

239

1310

Pleural plaque

675

4624

1.56

22.10

3.4

4.0

238.50

248.65

u/l

1.09

633

4321

Internal derangement of knee

2074

16573

1.27

22.07

3.7

4.6

231.08

245.17

u/l

5.95

1941

15738

Amenorrhoea

310

1731

1.87

22.05

4.5

3.9

235.41

234.15

u/l

0.05

294

1641

Melanoma in situ

315

1804

1.93

22.01

5.5

3.9

238.47

249.63

u/l

0.56

300

1699

Abnormal findings on diagnostic imaging of central nervous system

281

1538

1.97

22.01

4.9

4.2

225.49

246.28

u/l

1.76

262

1457

Pneumonitis due to solids and liquids

548

3586

1.62

22.00

2.8

3.9

252.85

248.73

u/l

0.17

504

3351

Spontaneous rupture of synovium and tendon

493

3143

1.66

22.00

4.3

4.5

243.67

245.75

u/l

0.13

454

2977

Abnormal involuntary movements

776

5430

1.49

21.99

3.6

4.2

234.58

243.27

u/l

1.05

724

5136

Migraine without aura and triptan purchases

697

4748

1.51

21.95

3.4

4.1

220.08

234.30

u/l

2.25

657

4499

Corns and callosities

403

2450

1.76

21.94

4.3

4.2

244.58

249.07

u/l

0.15

378

2310

Qualitative platelet defects

104

6.36

21.86

5.2

3.9

244.09

237.71

u/l

0.10

Superficial injury of wrist and hand

1039

7621

1.40

21.86

3.4

4.5

232.60

239.04

u/l

0.51

972

7240

Inguinal hernia

3705

20984

1.20

21.72

4.1

4.4

241.10

246.09

u/l

1.25

3509

19857

Disorders of conjunctiva

4743

32937

1.17

21.62

4.3

4.2

240.24

241.75

u/l

0.22

4480

31189

Juvenile arthritis (FINNGEN)

221

1115

2.10

21.59

3.1

4.9

249.07

244.67

u/l

0.08

214

1067

Phobic anxiety disorders

585

3852

1.56

21.59

3.4

4.3

220.50

234.69

u/l

2.44

556

3666

Glaucoma secondary to other eye disorders

279

1541

1.97

21.59

3.7

4.2

248.13

249.76

u/l

0.06

270

1462

Chronic laryngitis and laryngotracheitis

812

5747

1.47

21.58

3.5

4.4

239.24

243.22

u/l

0.38

745

5429

Secondary malignant neoplasm of respiratory and digestive organs

120

478

2.88

21.57

2.4

2.6

271.57

242.10

u/l

0.92

113

447

Carpal tunnel syndrome

3555

26561

1.20

21.48

3.6

4.3

240.03

242.95

u/l

0.55

3351

25131

Striking against or struck by other objects

1775

14040

1.29

21.46

4.0

4.5

242.09

239.96

u/l

0.19

1680

13350

Neovascular glaucoma

276

1522

1.98

21.46

3.8

3.9

248.37

248.57

u/l

0.01

267

1431

Allergic purpura

181

857

2.31

21.45

3.6

3.9

232.52

250.22

u/l

0.86

172

812

Benign neoplasm: Small intestine

285

1596

1.97

21.45

4.2

3.9

231.95

249.57

u/l

1.61

266

1514

Bullous disorders

382

2314

1.78

21.40

3.7

4.0

240.58

246.16

u/l

0.34

362

2176

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

190

913

2.23

21.37

5.1

4.6

238.55

256.44

u/l

0.91

185

868

Acetic acid derivatives and related substances

1803

7337

1.31

21.34

3.7

4.6

237.68

251.27

u/l

1.84

1693

7009

Xerosis cutis

129

539

2.80

21.31

5.8

3.8

235.48

244.89

u/l

0.60

121

507

Malignant neoplasm of rectum

490

3135

1.64

21.28

3.0

2.7

259.44

238.03

u/l

1.10

468

2890

Disorders of vestibular function (Vertigo)

2797

22902

1.23

21.28

3.8

4.1

236.53

245.63

u/l

3.63

2593

21576

Laparoscopic right hemicolectomy

397

2447

1.77

21.12

3.2

4.0

221.92

249.50

u/l

4.93

377

2303

Carcinoma in situ of other and unspecified digestive organs

246

1324

2.08

21.12

4.6

4.3

234.10

250.27

u/l

1.09

241

1254

Carcinoma in situ of skin of ear and external auricular canal

144

643

2.71

21.10

4.2

3.4

239.19

249.09

u/l

0.41

135

605

Appendectomy

3545

28767

1.20

21.09

4.2

4.3

234.34

240.60

u/l

1.98

3354

27292

Diseases of middle ear and mastoid

3069

21003

1.21

21.07

4.5

4.1

236.64

239.34

u/l

0.36

2907

19894

Infection due to other mycobacteria

117

466

2.87

21.01

6.6

3.7

243.01

238.11

u/l

0.14

111

428

Neuralgia and neuritis, unspecified

298

1685

1.89

20.96

3.7

4.6

240.96

245.59

u/l

0.15

275

1605

Benign neoplasm: Duodenum

198

994

2.26

20.92

4.1

4.2

231.55

249.49

u/l

1.63

184

946

Other disorders of eyelid

2776

22028

1.23

20.88

4.0

4.1

239.70

248.24

u/l

2.42

2628

20709

Post-traumatic stress disorder

360

2134

1.75

20.75

3.8

4.0

207.70

236.43

u/l

4.35

331

2040

Urolithiasis

2014

16290

1.27

20.69

4.0

4.2

238.53

245.17

u/l

0.83

1896

15402

Calculus of kidney and ureter

1851

14836

1.28

20.65

4.0

4.3

239.11

244.75

u/l

0.60

1739

14026

Maternal care for known or suspected fetal abnormality and damage

575

3260

1.56

20.65

3.4

3.7

215.41

226.29

u/l

1.21

552

3099

Combinations of oral blood glucose lowering drugs

1733

13796

1.30

20.60

3.4

4.7

231.29

249.79

u/l

5.44

1632

13122

Vitamin D deficiency

122

498

2.74

20.58

2.6

4.6

227.82

239.25

u/l

0.74

117

473

Arterial embolism and thrombosis of lower extremity artery

248

1343

2.02

20.48

4.4

4.0

273.51

252.07

u/l

0.61

229

1264

Pulmonary oedema

147

660

2.55

20.47

5.6

3.6

258.09

244.69

u/l

0.68

138

622

Benign neoplasm: Adrenal gland

475

3065

1.65

20.46

3.7

4.4

235.20

248.34

u/l

1.17

446

2898

Inflammatory disease of uterus

623

4218

1.53

20.44

3.4

4.0

235.02

236.14

u/l

0.03

586

3984

!Aliquae complicationes praecoces traumatis

271

1506

1.95

20.41

4.6

4.3

244.35

245.63

u/l

0.04

255

1424

Early complications of trauma

271

1506

1.95

20.41

4.6

4.3

244.35

245.63

u/l

0.04

255

1424

Nummular dermatitis

500

3261

1.63

20.38

4.3

4.2

228.99

245.57

u/l

2.82

472

3080

Malignant neoplasm of brain

181

872

2.24

20.35

4.2

3.0

246.86

233.08

u/l

0.79

173

820

Follow-up care involving plastic surgery

215

1105

2.10

20.33

3.9

230.01

230.19

u/l

0.01

183

1043

Other condition

769

5445

1.47

20.27

4.5

4.4

240.97

241.57

u/l

0.04

735

5153

Systemic sclerosis (FG)

152

690

2.44

20.21

3.1

4.6

254.31

256.30

u/l

0.04

147

658

Pain and other conditions associated with female genital organs and menstrual cycle

878

5809

1.42

20.19

2.9

3.9

213.18

237.67

u/l

12.00

818

5510

Total colectomy

254

1392

1.98

20.01

4.4

4.3

217.95

250.98

u/l

3.23

243

1328

Total colectomy operation

254

1392

1.98

20.01

4.4

4.3

217.95

250.98

u/l

3.23

243

1328

Other arterial embolism and thrombosis

199

1011

2.18

19.92

3.6

3.8

242.77

250.96

u/l

0.36

189

951

Other disorders of the musculoskeletal system and connective tissue

847

6132

1.44

19.87

3.6

4.3

240.81

243.82

u/l

0.30

793

5786

Asthma and opportunity respiratory infection

313

1839

1.86

19.85

3.9

4.1

235.27

252.86

u/l

1.34

297

1725

Scoliosis

442

2806

1.65

19.77

3.6

4.2

242.92

244.72

u/l

0.10

414

2660

Superficial injury of abdomen, lower back and pelvis

816

5865

1.44

19.67

3.4

4.3

232.91

240.73

u/l

1.00

760

5527

Seborrhoeic dermatitis

561

3774

1.56

19.63

4.5

4.1

235.73

242.43

u/l

0.51

526

3578

Varicose veins

3682

23783

1.19

19.63

4.1

4.0

248.59

245.14

u/l

0.63

3437

22389

Other inflammation of eyelid

759

5401

1.46

19.61

5.0

4.2

229.81

246.02

u/l

4.02

709

5089

Olecranon bursitis

399

2496

1.71

19.58

3.4

5.0

245.37

240.14

u/l

0.24

378

2371

Other and unspecified rosacea

471

3051

1.63

19.57

4.5

4.3

249.14

247.47

u/l

0.08

445

2880

Other specified/unspecified soft tissue disorders

295

1700

1.86

19.52

3.1

4.0

236.52

248.65

u/l

1.03

278

1612

Synovial cyst of popliteal space [Baker]

436

2780

1.66

19.52

4.0

4.3

243.41

247.05

u/l

0.19

411

2631

Other other unspecified disorders of the circulatory system

243

1329

2.00

19.50

3.2

4.3

283.94

254.42

u/l

1.45

236

1253

Dissection of aorta

230

1240

2.05

19.44

3.7

4.0

267.60

243.06

u/l

1.49

218

1166

Rosacea

608

4156

1.53

19.43

4.7

4.2

245.39

243.36

u/l

0.11

574

3929

Alcohol-induced acute pancreatitis

235

1273

2.02

19.43

2.8

4.5

212.06

241.24

u/l

5.86

217

1216

Cyst of kidney

460

2987

1.65

19.42

4.0

4.3

233.79

245.89

u/l

1.13

441

2817

Erosion of teeth , including avohilmo

1218

9310

1.34

19.42

4.3

4.4

232.89

235.93

u/l

0.39

1139

8840

therapeutic use

216

1142

2.10

19.41

4.5

4.0

249.03

250.36

u/l

0.04

193

1078

Idiopathic pulmonary fibrosis

529

3549

1.59

19.29

3.9

288.53

246.22

u/l

4.66

490

3324

Etanercept

335

2001

1.77

19.27

2.5

4.5

230.58

247.50

u/l

1.54

313

1898

Arthropathic psoriasis

613

4209

1.52

19.23

3.0

4.5

244.14

244.16

u/l

0.00

579

4002

Open wound of forearm

543

3642

1.56

19.17

3.8

4.1

230.90

243.95

u/l

1.74

494

3437

Other extrapyramidal and movement disorders in other diseases

1375

10734

1.32

19.16

3.3

4.2

237.34

245.63

u/l

1.19

1264

10106

Volvulus

182

911

2.20

18.90

4.1

4.3

237.78

254.84

u/l

0.72

174

868

Impetigo

233

1258

1.97

18.89

5.2

5.0

259.18

252.95

u/l

0.08

222

1196

Other and unspecified parapsoriasis

181

4.68

18.88

4.8

4.2

217.92

243.46

u/l

1.63

170

Erythema nodosum

182

910

2.19

18.86

5.2

4.0

259.55

250.78

u/l

0.20

171

863

Dissociative [conversion] disorders

191

963

2.11

18.86

2.3

4.0

216.40

238.53

u/l

0.85

176

909

Disorders of porphyrin and bilirubin metabolism

328

3.15

18.72

5.0

212.82

249.27

u/l

2.46

316

Voice disturbances

1463

11531

1.30

18.72

4.0

4.2

232.23

244.19

u/l

4.16

1389

10871

Testicular hypofunction

203

1060

2.09

18.65

5.5

4.8

236.81

237.64

u/l

0.02

193

1011

Other female pelvic inflammatory diseases

765

5488

1.44

18.60

3.0

4.1

229.26

243.53

u/l

2.29

695

5162

Other disorders of optic [2nd] nerve and visual pathways

366

2267

1.72

18.56

4.2

4.3

242.57

252.69

u/l

0.53

348

2152

Adenocarcinoma and papilloma adenocarcinoma of rectum

474

3111

1.60

18.44

3.1

2.7

255.97

237.70

u/l

1.14

453

2864

Faecal incontinence

502

3340

1.58

18.43

3.2

4.0

259.13

252.36

u/l

0.25

476

3137

Carrier of infectious disease

154

730

2.32

18.41

4.1

221.91

251.13

u/l

1.49

146

688

Malignant neoplasm of bone and articular cartilage of limbs

105

5.44

18.38

7.9

2.8

240.23

230.11

u/l

0.30

100

Chorioretinal inflammation

185

942

2.16

18.33

4.3

4.2

235.94

245.45

u/l

0.39

174

888

Emotionally unstable personality disorder

537

3608

1.54

18.31

2.8

4.4

214.03

232.12

u/l

2.99

492

3440

Coxarthrosis, primary

3803

27835

1.18

18.26

3.7

4.2

240.36

247.41

u/l

2.76

3561

26216

Ocular pain

432

2786

1.63

18.23

4.8

4.3

226.77

242.87

u/l

1.99

406

2627

Injuries to the wrist and hand

6005

36957

1.14

18.13

3.9

4.3

237.84

242.51

u/l

1.32

5645

35053

Sickle-cell disorders

7.04

18.11

8.9

3.5

264.39

238.91

u/l

0.31

Testicular dysfunction

226

1235

1.99

18.08

5.2

4.8

234.25

236.87

u/l

0.07

216

1176

Other/unspecified synovitis and tenosynovitis

617

4290

1.50

18.01

3.6

4.6

240.70

244.69

u/l

0.29

586

4063

Crohn disease (strict definition, all UC cases excluded)

275

1588

1.84

17.99

3.6

4.6

219.69

245.43

u/l

1.92

264

1510

Conjunctivitis

4107

29785

1.17

17.93

4.2

238.05

241.34

u/l

0.51

3867

28204

Familial hypercholesterolemia, with ischemic heart disease

612

4281

1.51

17.93

3.3

4.3

243.62

243.05

u/l

0.03

572

4001

Necrosis of pulp, including avohilmo

3066

26022

1.19

17.90

4.0

4.4

232.67

240.47

u/l

2.20

2905

24739

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

489

3252

1.57

17.90

3.1

2.7

256.66

238.20

u/l

1.20

467

2995

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

406

2589

1.64

17.88

3.3

4.3

233.65

237.77

u/l

0.20

383

2450

Fall on and from stairs and steps

1441

11402

1.30

17.86

3.6

4.3

237.94

242.16

u/l

0.52

1360

10720

Other and unspecified follicular disorders

233

1288

1.95

17.84

6.0

4.2

233.25

245.60

u/l

0.68

221

1215

Malignant neoplasm of pancreas, including Hilmo

428

2768

1.62

17.83

3.8

2.7

257.46

238.57

u/l

1.18

410

2543

Nail disorders

442

2883

1.61

17.80

5.8

4.4

235.45

246.96

u/l

1.19

420

2727

Other/unspecified reactive arthropathies

364

2279

1.69

17.62

3.5

4.3

235.89

244.42

u/l

0.39

344

2163

Otitis externa, unspecified

580

4005

1.51

17.61

4.1

4.4

227.52

245.32

u/l

2.77

545

3795

Ankylosing spondylitis, ICD10

473

3139

1.58

17.60

2.9

4.4

227.32

242.13

u/l

1.81

437

2977

Diseases of inner ear

3234

26808

1.19

17.53

3.8

4.1

237.41

245.38

u/l

3.23

3008

25313

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1775

14302

1.26

17.52

4.0

4.3

230.76

236.49

u/l

1.02

1684

13608

Transport accidents

2513

18087

1.21

17.47

3.8

4.5

234.91

245.60

u/l

3.66

2378

17254

Oxicams

1511

6775

1.30

17.46

3.5

4.6

241.94

253.80

u/l

1.98

1411

6464

Nonorganic sleeping disorders

991

7478

1.36

17.41

3.3

4.4

224.21

238.13

u/l

3.73

927

7084

Lesion of lateral popliteal nerve

298

1784

1.79

17.38

4.5

4.3

255.18

245.80

u/l

0.25

283

1695

Wet age-related macular degeneration

1162

8741

1.34

17.37

3.3

3.7

244.46

250.91

u/l

0.84

1084

8124

Unspecified urinary incontinence

495

3331

1.56

17.34

3.1

4.1

235.24

249.03

u/l

2.03

437

3138

Other hearing loss

1765

14040

1.26

17.33

4.1

3.9

238.36

248.69

u/l

2.85

1661

13169

Diseases of tongue

346

2149

1.70

17.25

3.8

231.52

251.45

u/l

1.85

326

2018

Fall involving bed

227

1269

1.97

17.22

2.9

3.7

250.98

258.60

u/l

0.29

202

1193

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

127

573

2.45

17.17

2.8

2.7

214.10

239.49

u/l

3.60

121

538

Benign neoplasm: Descending colon

450

2993

1.60

17.13

3.9

4.3

232.00

247.09

u/l

1.71

427

2829

Hypermobility syndrome

227

1250

1.91

17.12

3.2

4.1

214.32

240.39

u/l

2.11

218

1193

Carbimazole or st.post thyroidectomy, condition for graves disease

1043

7954

1.35

17.12

5.9

4.1

232.07

242.29

u/l

2.09

986

7500

Atrial septal defect

212

1145

1.98

17.06

4.5

4.9

266.19

268.75

u/l

0.05

204

1094

Radiculopathy

945

7123

1.37

17.06

3.5

4.3

240.34

246.68

u/l

0.84

886

6707

Other hammer toe(s) (acquired)

966

6731

1.37

16.98

3.3

4.4

249.58

249.46

u/l

0.01

896

6339

Other and unspecified psoriasis

392

2528

1.64

16.87

3.3

4.4

235.44

248.56

u/l

1.20

366

2406

Hallux valgus (acquired)

1765

10281

1.26

16.81

3.6

4.4

247.13

246.87

u/l

0.02

1655

9709

Nonspecific lymphadenitis

301

1813

1.75

16.80

4.1

4.7

222.74

245.41

u/l

2.35

291

1724

Visual field defects

501

3408

1.55

16.78

3.9

4.1

233.14

247.50

u/l

1.57

469

3215

Other specified/unspecified inflammatory spondylopathies

238

1342

1.87

16.76

2.3

4.7

226.14

242.28

u/l

1.22

223

1283

Assault by bodily force

358

2250

1.66

16.69

2.6

4.6

218.10

239.03

u/l

2.95

332

2144

Injuries to the neck

1173

9117

1.32

16.68

3.7

4.3

220.77

237.46

u/l

7.46

1106

8634

Systemic sclerosis

152

747

2.24

16.66

3.1

4.4

254.31

256.27

u/l

0.04

147

707

Artrosis, including avohilmo

5087

24573

1.15

16.57

3.7

4.5

235.81

245.49

u/l

5.41

4758

23334

Drug-induced hypoglycaemia without coma

120

541

2.51

16.56

2.6

3.9

241.70

250.28

u/l

0.33

110

511

Campylobacter enteritis

166

843

2.15

16.55

4.9

4.4

226.58

261.80

u/l

1.90

161

803

Cutaneous lupus erythematosus

155

770

2.22

16.55

3.3

3.9

241.52

248.31

u/l

0.20

146

729

Enthesopathies of lower limb, excluding foot

1135

8792

1.32

16.53

3.8

4.6

233.85

243.29

u/l

1.82

1061

8343

Disorders of optic nerve and visual pathways

494

3354

1.54

16.45

3.8

4.3

237.42

246.06

u/l

0.63

471

3181

Leiomyoma of uterus

2997

14438

1.19

16.41

4.0

3.9

241.14

242.93

u/l

0.27

2804

13580

Allergic urticaria

412

2691

1.60

16.41

5.6

4.3

232.36

246.79

u/l

1.38

397

2544

Fracture of skull and facial bones

1141

8866

1.32

16.30

3.9

4.5

238.66

241.80

u/l

0.34

1067

8394

Use of donepezil

804

10266

0.73

16.28

2.6

3.6

248.19

250.06

u/l

0.11

721

9521

Mental and behavioural disorders due to use of other stimulants, including caffeine

140

666

2.25

16.26

2.1

4.7

226.95

233.79

u/l

0.23

132

638

Deficiency of other B group vitamins

144

702

2.28

16.23

4.1

4.0

236.81

245.18

u/l

0.28

135

662

Superficial injury of thorax

827

6160

1.39

16.18

4.4

4.3

235.45

242.70

u/l

1.05

781

5816

Complications of other internal prosthetic devices, implants and grafts

247

1437

1.85

16.05

3.8

246.36

245.79

u/l

0.02

234

1360

Ulcerative colitis (strict definition, require KELA)

835

6228

1.38

16.00

3.7

4.5

224.23

237.99

u/l

3.30

790

5913

Psoriatic arthropathies, ICD10

552

3852

1.49

16.00

3.1

4.4

243.45

244.51

u/l

0.04

521

3655

Viral agents as the cause of diseases classified to other chapters

139

671

2.28

15.99

5.3

4.2

258.29

251.44

u/l

0.18

131

642

Event of undetermined intent

333

2089

1.68

15.91

3.8

4.4

252.32

244.23

u/l

0.26

309

1984

Lesion of ulnar nerve

758

5587

1.41

15.90

3.8

4.6

245.30

240.67

u/l

0.16

714

5317

Nonsuppurative otitis media

1109

7423

1.32

15.87

4.8

4.1

237.88

236.33

u/l

0.08

1063

7049

Schizophrenia or delusion, excluding more controls

1456

11559

1.27

15.75

2.7

4.6

232.71

241.79

u/l

1.72

1340

11033

Systemic sclerosis, icd10

151

757

2.20

15.73

3.1

4.2

254.86

254.05

u/l

0.02

146

712

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

805

5988

1.38

15.72

3.8

4.5

223.62

238.38

u/l

3.57

762

5682

Other specified and unspecified personality disorders

429

2851

1.56

15.71

3.0

4.5

233.70

238.94

u/l

0.29

403

2713

Viral infections of the central nervous system

376

2435

1.62

15.69

4.8

4.2

232.57

245.21

u/l

1.02

362

2302

Other symptoms and signs involving general sensations and perceptions

236

1363

1.85

15.66

3.0

4.1

264.15

252.57

u/l

0.17

216

1291

Malignant neoplasm of parotid gland, including Hilmo

267

3.17

15.63

6.1

2.9

229.05

235.98

u/l

0.31

249

Acute nephritic syndrome

141

693

2.26

15.58

3.6

4.6

226.91

255.94

u/l

1.43

135

660

Papillary adenocarcinoma of thyroid gland

223

1261

1.86

15.57

6.0

3.2

228.64

230.97

u/l

0.11

214

1182

Benign paroxysmal vertigo

1654

13515

1.25

15.54

3.7

4.2

232.84

245.94

u/l

4.40

1532

12723

Encephalopathy

340

2.95

15.54

3.8

4.6

233.04

276.49

u/l

1.22

323

Mixed hyperlipidaemia

247

1452

1.83

15.51

3.7

4.4

247.66

244.63

u/l

0.13

230

1382

Protein-energy malnutrition of moderate and mild degree

313

3.06

15.40

4.3

4.1

250.20

245.13

u/l

0.13

297

Pediculosis, acariasis and other infestations

314

1963

1.69

15.29

4.6

4.4

245.04

241.16

u/l

0.15

295

1870

Viral agents as the cause of diseases classified to other chapters

152

772

2.15

15.19

5.2

4.4

255.46

249.28

u/l

0.18

144

734

Disorders of ocular muscles, binocular movement, accommodation and refraction

2422

20331

1.20

15.12

4.6

4.2

242.53

240.73

u/l

0.17

2303

19241

severe traumatic brain injury, does not include concussion

1363

10950

1.28

15.11

4.0

242.47

247.34

u/l

0.62

1264

10262

Alcohol abuse, main dg

816

6127

1.37

15.09

2.7

4.7

236.39

238.28

u/l

0.12

775

5833

Universal erythroderma, KELA reimbursement

103

454

2.57

15.04

4.0

4.2

235.03

236.06

u/l

0.04

431

Redundant prepuce, phimosis and paraphimosis

1120

8689

1.31

15.02

3.8

4.8

234.26

246.33

u/l

1.44

1069

8272

Benign neoplasm of eye and adnexa

579

4133

1.47

15.01

4.6

4.2

230.58

246.59

u/l

2.45

551

3895

Carcinoma in situ of skin of lower limb, including hip

159

835

2.15

14.99

4.4

3.8

241.71

244.78

u/l

0.12

154

785

Preterm labour and delivery

1040

8059

1.32

14.96

4.2

4.1

241.09

237.60

u/l

0.21

986

7623

False labour

1047

5009

1.32

14.94

3.0

4.1

215.19

230.67

u/l

1.81

982

4768

Excessive vomiting in pregnancy

324

2041

1.65

14.91

3.8

4.4

212.14

239.91

u/l

4.39

307

1927

Hydrocele

744

5536

1.40

14.91

4.9

4.5

247.80

249.03

u/l

0.06

709

5232

Paraplegia, diplegia of upper limbs

142

711

2.20

14.90

4.6

4.3

295.98

248.19

u/l

0.39

132

674

Melanocytic naevi of lower limb, including hip

240

1413

1.81

14.86

7.8

4.3

224.27

245.87

u/l

1.90

232

1344

Algoneurodystrophy

164

857

2.04

14.84

2.5

4.2

220.37

250.52

u/l

1.47

152

818

Other congenital malformations of the digestive system

274

1658

1.74

14.79

3.9

4.8

233.30

262.53

u/l

2.49

265

1580

Overexertion and strenuous or repetitive movements

511

3567

1.49

14.78

3.6

4.4

227.32

242.10

u/l

1.73

489

3381

Alcohol withdrawal state with delirium

409

2746

1.57

14.76

2.7

4.5

254.98

243.67

u/l

0.31

373

2616

Other enthesopathies

1520

12353

1.26

14.75

3.4

4.6

238.13

243.89

u/l

0.44

1419

11731

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

308

1893

1.67

14.75

4.6

231.65

256.93

u/l

2.14

298

1803

Other disorders of iris and ciliary body

174

938

2.02

14.71

3.0

4.1

233.87

252.86

u/l

0.95

165

889

Benign neoplasm of major salivary glands

563

4016

1.47

14.68

4.0

4.2

237.31

244.05

u/l

0.58

536

3794

Hyperosmolality and hypernatraemia

101

446

2.56

14.67

2.9

4.4

242.40

238.59

u/l

0.11

420

KRA_PSY_EATING, excluding more controls

315

1966

1.64

14.61

3.4

3.9

210.85

233.70

u/l

2.92

291

1883

Family history of malignant neoplasm

479

3300

1.50

14.60

4.2

3.7

230.51

235.76

u/l

0.41

455

3122

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

704

5181

1.39

14.59

3.5

4.0

220.72

235.42

u/l

2.86

649

4892

Colonic or urogenital fistula

1461

11860

1.26

14.55

4.3

236.19

243.01

u/l

1.03

1363

11199

Fracture of forearm

3035

24033

1.17

14.52

3.8

4.2

236.68

244.06

u/l

2.54

2850

22690

Other disorders starting during childhood or adolecense, excluding more controls

193

1015

1.90

14.52

4.6

4.7

244.48

256.43

u/l

0.32

184

968

Ptosis of eyelid

653

4788

1.42

14.50

3.7

4.2

242.56

247.02

u/l

0.30

619

4504

Fall on same level involving ice and snow

3228

28069

1.17

14.50

3.6

4.3

236.91

243.08

u/l

1.97

3038

26534

Septal defects

322

2007

1.65

14.47

3.6

4.9

269.75

260.34

u/l

0.27

308

1914

Bronchitis, not specified as acute or chronic

469

3236

1.51

14.45

4.3

4.4

232.82

247.91

u/l

1.94

437

3042

Viral infections of the central nervous system

395

2634

1.57

14.43

4.7

4.3

232.37

244.76

u/l

1.07

380

2493

Convalescence

266

1618

1.73

14.41

3.6

3.7

252.50

233.80

u/l

0.98

251

1524

Disorders of myoneural junction and muscle in diseases classified elsewhere

235

3.28

14.40

2.7

4.6

257.05

240.90

u/l

0.63

223

Sequelae of injuries, of poisoning and of other consequences of external causes

1212

9642

1.29

14.39

3.7

4.5

236.17

239.59

u/l

0.36

1135

9165

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

889

6798

1.34

14.38

3.7

4.6

224.16

237.02

u/l

3.20

844

6458

Other psoriatic arthropathies

531

3755

1.47

14.37

3.1

4.4

244.62

244.21

u/l

0.02

500

3560

Post-traumatic wound infection, not elsewhere classified

164

873

2.04

14.35

3.8

4.3

230.01

240.63

u/l

0.46

154

829

Follicular cysts of skin and subcutaneous tissue

979

7601

1.33

14.29

4.6

4.4

238.07

239.49

u/l

0.13

928

7209

Unspecified protein-energy malnutrition

189

3.68

14.25

2.9

4.0

254.75

240.74

u/l

0.32

178

Exposure to other and unspecified inanimate mechanical forces

378

2506

1.58

14.22

4.3

4.4

234.40

242.63

u/l

0.58

360

2372

Chondrocostal junction syndrome [Tietze]

206

1177

1.87

14.22

3.5

4.1

225.11

253.73

u/l

2.02

196

1119

Maltreatment syndromes

235

1385

1.78

14.18

2.6

4.5

229.86

235.57

u/l

0.29

222

1324

Postprocedural disorders of nervous system

315

1999

1.64

14.18

3.1

4.2

218.82

237.73

u/l

2.17

299

1909

Benign neoplasm: salivary glands, exclude unknown (D119)

503

3542

1.49

14.16

4.0

4.2

232.83

245.75

u/l

1.49

485

3351

Restless leg syndrome

712

5303

1.39

14.10

3.4

4.1

233.90

244.30

u/l

1.41

658

4988

Other abnormal immunological findings in serum

119

568

2.29

14.04

3.0

4.3

227.34

253.96

u/l

0.84

114

541

Personal history of certain other diseases

425

2.46

13.88

3.1

3.2

222.10

229.87

u/l

0.35

402

Speech and linguistic disorders

392

2513

1.55

13.87

4.9

4.6

246.90

250.65

u/l

0.18

376

2382

Noninflammatory disorders of female genital tract

2005

8365

1.22

13.85

4.1

3.8

233.90

242.02

u/l

0.91

1901

7880

Other maternal disorders predominantly related to pregnancy

2412

12822

1.19

13.82

3.5

4.1

228.35

238.02

u/l

3.04

2285

12156

Other congenital malformations of skin

391

2625

1.55

13.80

5.3

4.3

219.88

244.74

u/l

3.06

377

2491

Temporomandibular joint disorders, including avohilmo

2034

16854

1.21

13.78

3.4

4.1

227.37

235.98

u/l

2.70

1906

15994

Adult respiratory distress syndrome

103

474

2.49

13.77

6.4

4.0

303.59

241.39

u/l

2.79

446

Pemphigoid

186

1051

1.95

13.76

4.0

3.7

240.01

253.94

u/l

0.61

173

983

Varicella [chickenpox]

238

1426

1.76

13.72

7.1

4.7

256.93

237.89

u/l

0.94

227

1368

Monoarthritis, not elsewhere classified

231

1376

1.78

13.67

3.5

4.6

228.24

248.30

u/l

1.87

220

1312

Primary gonarthrosis, bilateral

3161

23605

1.17

13.66

3.4

4.3

239.45

247.93

u/l

3.22

2930

22293

Other and unspecified injuries of lower leg

374

2494

1.56

13.63

3.6

4.4

223.54

248.64

u/l

3.20

354

2360

Periapical abscess

2433

20815

1.19

13.63

3.9

4.4

236.26

242.67

u/l

1.47

2297

19752

Atopic dermatitis, strict definition

1278

10057

1.27

13.59

4.0

4.3

242.18

234.84

u/l

0.49

1222

9575

Other and unspecified injuries of head

390

2633

1.55

13.58

3.3

4.0

242.69

250.77

u/l

0.51

364

2486

Corneal ulcer

929

7206

1.32

13.58

4.2

4.4

237.60

238.21

u/l

0.06

880

6828

Oesophageal obstruction

225

1342

1.81

13.57

3.5

4.2

238.28

256.20

u/l

0.79

208

1274

Disorders of tooth development and eruption

769

4676

1.36

13.54

3.9

230.49

246.74

u/l

2.51

736

4434

Varicella [chickenpox]

264

1628

1.70

13.53

7.0

4.8

255.88

239.99

u/l

0.82

252

1557

Alzheimer disease, including avohilmo

1775

14947

0.82

13.49

2.8

3.8

245.98

251.34

u/l

0.74

1577

13971

Impacted cerumen

594

4344

1.43

13.46

3.3

4.1

237.75

247.22

u/l

0.85

503

4086

D07AA Corticosteroids, weak (group I)

733

5497

1.37

13.43

3.9

4.5

243.28

243.32

u/l

0.00

700

5212

Other and unspecified nerve root and plexus disorders, also in other diseases

1018

8002

1.31

13.43

3.7

4.5

235.90

239.56

u/l

0.39

959

7590

Orthopaedic devices associated with adverse incidents

133

682

2.20

13.42

2.8

4.2

231.24

253.39

u/l

0.92

113

644

Acute laryngitis and tracheitis

488

3366

1.46

13.37

4.0

4.2

232.73

241.82

u/l

0.71

465

3204

Degenerative macular diseases

725

5473

1.38

13.34

3.3

4.0

262.67

247.93

u/l

0.39

675

5109

Status epilepticus

219

1299

1.80

13.33

3.9

4.3

243.02

257.66

u/l

0.65

211

1233

Disorders of orbit

240

1457

1.75

13.30

4.4

230.22

254.36

u/l

1.40

230

1373

Dementia in Alzheimer disease

731

8119

0.74

13.29

2.8

3.5

245.51

251.19

u/l

0.46

604

7543

Spondylolisthesis/Spondylolysis

960

7507

1.31

13.25

3.8

4.6

238.54

244.48

u/l

0.70

900

7127

Ulcerative ileocolitis

209

1223

1.81

13.20

3.3

4.3

229.73

247.21

u/l

0.76

203

1168

Unspecified human immunodeficiency virus [HIV] disease

305

2.83

13.16

3.4

4.1

220.15

248.89

u/l

0.87

290

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS